Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1255 articles:
HTML format



Single Articles


    June 2022
  1. GAN J, Liu S, Chen Z, Yang Y, et al
    Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;1.
    PubMed     Abstract available


  2. TIAN J, Wang T, Jia K, Guo L, et al
    Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220447. doi: 10.3233/JAD-220447.
    PubMed     Abstract available


  3. BUKHBINDER AS, Ling Y, Hasan O, Jiang X, et al
    Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220361. doi: 10.3233/JAD-220361.
    PubMed     Abstract available


  4. WEISSBERGER GH, Samek A, Mosqueda L, Nguyen AL, et al
    Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220187. doi: 10.3233/JAD-220187.
    PubMed     Abstract available


  5. MIELKE MM, Ransom JE, Mandrekar J, Turcano P, et al
    Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220159. doi: 10.3233/JAD-220159.
    PubMed     Abstract available


  6. KOBAYASHI M, Yamada Y, Shinkawa K, Nemoto M, et al
    Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215714. doi: 10.3233/JAD-215714.
    PubMed     Abstract available


  7. LEONHARDI J, Barthel H, Speerforck S, Dietzel J, et al
    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215619. doi: 10.3233/JAD-215619.
    PubMed     Abstract available


  8. JESTER H, Gosrani S, Ding H, Zhou X, et al
    Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215303. doi: 10.3233/JAD-215303.
    PubMed     Abstract available


  9. ZHU LY, Shi L, Luo Y, Leung J, et al
    Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215189. doi: 10.3233/JAD-215189.
    PubMed     Abstract available


  10. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 11. pii: JAD220292. doi: 10.3233/JAD-220292.
    PubMed     Abstract available


  11. BABILONI C, Noce G, Di Bonaventura C, Lizio R, et al
    Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220442. doi: 10.3233/JAD-220442.
    PubMed     Abstract available


  12. DUAN W, Sehrawat P, Zhou TD, Becker JT, et al
    Pattern of Altered Magnetization Transfer Rate in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220335. doi: 10.3233/JAD-220335.
    PubMed     Abstract available


  13. MA X, Zhang Y, Gou D, Ma J, et al
    Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 7. pii: JAD220227. doi: 10.3233/JAD-220227.
    PubMed     Abstract available


  14. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.
    J Alzheimers Dis. 2022 Jun 6. pii: JAD215630. doi: 10.3233/JAD-215630.
    PubMed     Abstract available


  15. WESSELS AM, Belger M, Johnston JA, Yu Y, et al
    Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220303. doi: 10.3233/JAD-220303.
    PubMed     Abstract available


  16. SUN L, Guo C, Song Y, Sheng J, et al
    Blood BMP6 Associated with Cognitive Performance and Alzheimer's Disease Diagnosis: A Longitudinal Study of Elders.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220279. doi: 10.3233/JAD-220279.
    PubMed     Abstract available


  17. GOMEZ LR, Albers MW, Baena A, Vila-Castelar C, et al
    Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220075. doi: 10.3233/JAD-220075.
    PubMed     Abstract available


  18. AGARWAL P, Holland TM, James BD, Cherian LJ, et al
    Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD215600. doi: 10.3233/JAD-215600.
    PubMed     Abstract available


  19. ARAUJO DC, Veloso AA, Gomes KB, Souza LC, et al
    A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220256. doi: 10.3233/JAD-220256.
    PubMed     Abstract available


  20. WANG Q, Shi Y, Qi X, Qi L, et al
    Platelet-Derived Amyloid-beta Protein Precursor as a Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220122. doi: 10.3233/JAD-220122.
    PubMed     Abstract available


  21. HUDA TI, Diaz MJ, Gozlan EC, Chobrutskiy A, et al
    Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220119. doi: 10.3233/JAD-220119.
    PubMed     Abstract available


  22. HANNONEN S, Andberg S, Karkkainen V, Rusanen M, et al
    Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD215551. doi: 10.3233/JAD-215551.
    PubMed     Abstract available


    May 2022
  23. SERWER P, Wright ET, Hunter B
    Additions to Alpha-Sheet Based Hypotheses for the Cause of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 30. pii: JAD220311. doi: 10.3233/JAD-220311.
    PubMed     Abstract available


  24. WANG Y, Li L, Zhao X, Sui S, et al
    Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2022 May 30. pii: JAD220076. doi: 10.3233/JAD-220076.
    PubMed     Abstract available


  25. RIPHAGEN JM, van Hooren RWE, Kenis G, Verhey FRJ, et al
    Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 May 28. pii: JAD215353. doi: 10.3233/JAD-215353.
    PubMed     Abstract available


  26. MCGRATTAN A, Stewart CJ, Cassidy A, Woodside JV, et al
    Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 23. pii: JAD220205. doi: 10.3233/JAD-220205.
    PubMed     Abstract available


  27. TSAI YL, Yen CT, Wang YF
    Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD220218. doi: 10.3233/JAD-220218.
    PubMed     Abstract available


  28. FRAME G, Schuller A, Smith MA, Crish SD, et al
    Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 May 18. pii: JAD220016. doi: 10.3233/JAD-220016.
    PubMed     Abstract available


  29. HAO J, Guo Y, Guo K, Yang Q, et al
    Peripheral Inflammatory Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD215422. doi: 10.3233/JAD-215422.
    PubMed     Abstract available


  30. WITTFELD K, Raman MR, Conner SC, Aslam A, et al
    Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.
    J Alzheimers Dis. 2022 May 16. pii: JAD220356. doi: 10.3233/JAD-220356.
    PubMed     Abstract available


  31. HOILUND-CARLSEN PF, Revheim ME, Alavi A
    Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start.
    J Alzheimers Dis. 2022 May 16. pii: JAD220190. doi: 10.3233/JAD-220190.
    PubMed     Abstract available


  32. CHENG Y, Jian JM, He CY, Ren JR, et al
    The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-beta and Tau Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 16. pii: JAD220126. doi: 10.3233/JAD-220126.
    PubMed     Abstract available


  33. TANCHEVA L, Lazarova M, Velkova L, Dolashki A, et al
    Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.
    J Alzheimers Dis. 2022 May 16. pii: JAD215693. doi: 10.3233/JAD-215693.
    PubMed     Abstract available


  34. HELBOE L, Rosenqvist N, Volbracht C, Pedersen LO, et al
    Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    J Alzheimers Dis. 2022 May 9. pii: JAD220125. doi: 10.3233/JAD-220125.
    PubMed     Abstract available


  35. WELTY S, Thathiah A, Levine AS
    DNA Damage Increases Secreted Abeta40 and Abeta42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220030. doi: 10.3233/JAD-220030.
    PubMed     Abstract available


  36. ZHANG Y, Hu Y, Han Z, Geng Y, et al
    Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220009. doi: 10.3233/JAD-220009.
    PubMed     Abstract available


  37. FERNANDES M, Chiaravalloti A, Manfredi N, Placidi F, et al
    Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2022 May 9. pii: JAD215734. doi: 10.3233/JAD-215734.
    PubMed     Abstract available


  38. ZHANG X, Guan Q, Li Y, Zhang J, et al
    Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    J Alzheimers Dis. 2022 May 9. pii: JAD215649. doi: 10.3233/JAD-215649.
    PubMed     Abstract available


  39. DAS TK, Blasco-Conesa MP, Korf J, Honarpisheh P, et al
    Bacterial Amyloid Curli Associated Gut Epithelial Neuroendocrine Activation Predominantly Observed in Alzheimer's Disease Mice with Central Amyloid-beta Pathology.
    J Alzheimers Dis. 2022 May 6. pii: JAD220106. doi: 10.3233/JAD-220106.
    PubMed     Abstract available


  40. DUAN L, Qian X, Wang Q, Huang L, et al
    Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2022 May 6. pii: JAD215720. doi: 10.3233/JAD-215720.
    PubMed     Abstract available


  41. KALARI M, Abbasi Z, Shasaltaneh MD, Khaleghian A, et al
    A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2022 May 6. pii: JAD215588. doi: 10.3233/JAD-215588.
    PubMed     Abstract available


  42. NARUKAWA M, Mori Y, Nishida R, Takahashi S, et al
    Expression of Olfactory-Related Genes in the Olfactory Epithelium of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 May 4. pii: JAD220213. doi: 10.3233/JAD-220213.
    PubMed     Abstract available


  43. MANDAL PK, Dwivedi D, Shukla D, Samkaria A, et al
    Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 4. pii: JAD215729. doi: 10.3233/JAD-215729.
    PubMed     Abstract available


  44. LIO CT, Kacprowski T, Klaedtke M, Jensen LR, et al
    Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 2. pii: JAD220110. doi: 10.3233/JAD-220110.
    PubMed     Abstract available


    April 2022
  45. KIM H, Levine A, Cohen D, Gehrman P, et al
    The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    J Alzheimers Dis. 2022 Apr 28. pii: JAD215417. doi: 10.3233/JAD-215417.
    PubMed     Abstract available


  46. LENG F, Zhan Z, Sun Y, Liu F, et al
    Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220102. doi: 10.3233/JAD-220102.
    PubMed     Abstract available


  47. DIAS IHK, Shokr H, Shephard F, Chakrabarti L, et al
    Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220083. doi: 10.3233/JAD-220083.
    PubMed     Abstract available


  48. SALEHIPOUR A, Bagheri M, Sabahi M, Dolatshahi M, et al
    Combination Therapy in Alzheimer's Disease: Is It Time?
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215680. doi: 10.3233/JAD-215680.
    PubMed     Abstract available


  49. CHEN D, Yi F, Qin Y, Zhang J, et al
    A Stacking Framework for Multi-Classification of Alzheimer's Disease Using Neuroimaging and Clinical Features.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215654. doi: 10.3233/JAD-215654.
    PubMed     Abstract available


  50. TONGSIRI S, Levkoff S, Gallagher-Thompson D, Teri L, et al
    Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215253. doi: 10.3233/JAD-215253.
    PubMed     Abstract available


  51. DONG L, Liu C, Sha L, Mao C, et al
    PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220194. doi: 10.3233/JAD-220194.
    PubMed     Abstract available


  52. BOSE A, Dutta M, Dash NS, Nandi R, et al
    Importance of Task Selection for Connected Speech Analysis in Patients with Alzheimer's Disease from an Ethnically Diverse Sample.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220166. doi: 10.3233/JAD-220166.
    PubMed     Abstract available


  53. LOBUE C, Kelley BJ, Hart J, Helphrey J, et al
    Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220112. doi: 10.3233/JAD-220112.
    PubMed     Abstract available


  54. GRAHAM A, Livingston G, Purnell L, Huntley J, et al
    Mild Traumatic Brain Injuries and Future Risk of Developing Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220069. doi: 10.3233/JAD-220069.
    PubMed     Abstract available


  55. LLAMAS-RODRIGUEZ J, Oltmer J, Greve DN, Williams E, et al
    Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215567. doi: 10.3233/JAD-215567.
    PubMed     Abstract available


  56. SALAZAR CR, Ritchie M, Gillen DL, Grill JD, et al
    Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215537. doi: 10.3233/JAD-215537.
    PubMed     Abstract available


  57. KARIKARI TK
    Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.
    J Alzheimers Dis. 2022 Apr 23. pii: JAD215730. doi: 10.3233/JAD-215730.
    PubMed     Abstract available


  58. CATO S, Ramer S, Hajjar I, Kulshreshtha A, et al
    Alzheimer's Disease Mortality as a Function of Urbanization Level: 1999-2019.
    J Alzheimers Dis. 2022 Apr 22. pii: JAD215586. doi: 10.3233/JAD-215586.
    PubMed     Abstract available


  59. HUTTEN DR, Bos JHJ, de Vos S, Hak E, et al
    Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.
    J Alzheimers Dis. 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
    PubMed     Abstract available


  60. RAMSDEN CE, Keyes GS, Calzada E, Horowitz MS, et al
    Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220071. doi: 10.3233/JAD-220071.
    PubMed     Abstract available


  61. MIRABNAHRAZAM G, Ma D, Lee S, Popuri K, et al
    Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220021. doi: 10.3233/JAD-220021.
    PubMed     Abstract available


  62. KETCHUM FB, Erickson CM, Chin NA, Gleason CE, et al
    What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215521. doi: 10.3233/JAD-215521.
    PubMed     Abstract available


  63. WONG HY, Zhong H, Zhong M, Zhou X, et al
    Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215312. doi: 10.3233/JAD-215312.
    PubMed     Abstract available


  64. DALY T, Mastroleo I
    The First Survivors of Alzheimer's: How Patients Recovered Life and Hope in Their Own Words by Dale Bredesen, Avery, 2021, 272 pp.
    J Alzheimers Dis. 2022 Apr 13. pii: JAD220185. doi: 10.3233/JAD-220185.
    PubMed    


  65. KAWARABAYASHI T, Nakamura T, Sato K, Seino Y, et al
    Lipid Rafts Act as a Common Platform for Amyloid-beta Oligomer-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 Apr 12. pii: JAD215662. doi: 10.3233/JAD-215662.
    PubMed     Abstract available


  66. MARINELLI L, Trompetto C, Puce L, Monacelli F, et al
    Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215526. doi: 10.3233/JAD-215526.
    PubMed     Abstract available


  67. HONE-BLANCHET A, Bhosali A, Krishnamurthy LC, Shahid SS, et al
    Frontal Metabolites and Alzheimer's Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215431. doi: 10.3233/JAD-215431.
    PubMed     Abstract available


  68. MOZERSKY J, Roberts SJ, Rumbaugh M, Chhatwal J, et al
    Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220113. doi: 10.3233/JAD-220113.
    PubMed     Abstract available


  69. ISELLA V, Rosazza C, Ferri F, Gazzotti M, et al
    Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220053. doi: 10.3233/JAD-220053.
    PubMed     Abstract available


  70. GARCIA PRETELT FJ, Suarez Relevo JX, Aguillon D, Lopera F, et al
    Automatic Classification of Subjects of the PSEN1-E280A Family at Risk of Developing Alzheimer's Disease Using Machine Learning and Resting State Electroencephalography.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD210148. doi: 10.3233/JAD-210148.
    PubMed     Abstract available


  71. GHERARDELLI C, Cisternas P, Vera-Salazar RF, Mendez-Orellana C, et al
    Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 7. pii: JAD215273. doi: 10.3233/JAD-215273.
    PubMed     Abstract available


  72. GABEL M, Bollinger RM, Coble DW, Grill JD, et al
    Retaining Participants in Longitudinal Studies of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215710. doi: 10.3233/JAD-215710.
    PubMed     Abstract available


  73. PILOTTO A, Parigi M, Bonzi G, Battaglio B, et al
    Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215646. doi: 10.3233/JAD-215646.
    PubMed     Abstract available


  74. UENO M, Yoshino Y, Mori H, Funahashi Y, et al
    Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215627. doi: 10.3233/JAD-215627.
    PubMed     Abstract available


  75. HANYU H, Koyama Y, Horita H, Aoki T, et al
    Characterization of Alzheimer's Disease Subtypes Based on Magnetic Resonance Imaging and Perfusion Single-Photon Emission Computed Tomography.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215674. doi: 10.3233/JAD-215674.
    PubMed     Abstract available


  76. LAZAROU I, Georgiadis K, Nikolopoulos S, Oikonomou VP, et al
    Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215421. doi: 10.3233/JAD-215421.
    PubMed     Abstract available


    March 2022
  77. WEI T, Guo Z, Wang Z, Li C, et al
    Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 31. pii: JAD220010. doi: 10.3233/JAD-220010.
    PubMed     Abstract available


  78. GONZALEZ CORDERO EM, Cuevas-Budhart MA, Perez-Moran D, Trejo Villeda MA, et al
    Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Mar 28. pii: JAD215224. doi: 10.3233/JAD-215224.
    PubMed     Abstract available



  79. Erratum to: Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2022 Mar 25. pii: JAD229002. doi: 10.3233/JAD-229002.
    PubMed    


  80. KIM CK, Lee YR, Ong L, Gold M, et al
    Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.
    J Alzheimers Dis. 2022 Mar 22. pii: JAD215699. doi: 10.3233/JAD-215699.
    PubMed     Abstract available


  81. ZHANG PF, Wang ZT, Liu Y, Hu H, et al
    Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD220057. doi: 10.3233/JAD-220057.
    PubMed     Abstract available


  82. JIAN JM, Fan DY, Cheng Y, Shen YY, et al
    Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215611. doi: 10.3233/JAD-215611.
    PubMed     Abstract available


  83. MURCHISON CF, Jaeger BC, Szychowski JM, Cutter GR, et al
    Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215553. doi: 10.3233/JAD-215553.
    PubMed     Abstract available


  84. WANG X, Sun H, Pan S, Bai X, et al
    Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215535. doi: 10.3233/JAD-215535.
    PubMed     Abstract available


  85. LARGENT EA, Bhardwaj T, Clapp JT, Sykes OS, et al
    You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.
    J Alzheimers Dis. 2022 Mar 18. pii: JAD220061. doi: 10.3233/JAD-220061.
    PubMed     Abstract available


  86. DOBROMYSLIN VI, Megherbi DB
    Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
    J Alzheimers Dis. 2022 Mar 15. pii: JAD215640. doi: 10.3233/JAD-215640.
    PubMed     Abstract available


  87. DE OLIVEIRA FF, Bertolucci PHF, Chen ES, Smith MC, et al
    Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215735. doi: 10.3233/JAD-215735.
    PubMed     Abstract available


  88. DU XL, Song L, Schulz PE, Xu H, et al
    Risk of Developing Alzheimer's Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215657. doi: 10.3233/JAD-215657.
    PubMed     Abstract available


  89. LUPPI JJ, Schoonhoven DN, van Nifterick AM, Gouw AA, et al
    Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215464. doi: 10.3233/JAD-215464.
    PubMed     Abstract available


  90. HUANG SY, Yang YX, Zhang YR, Kuo K, et al
    Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220050. doi: 10.3233/JAD-220050.
    PubMed     Abstract available


  91. TERNAK G, Nemeth M, Rozanovic M, Bogar L, et al
    Alzheimer's Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220018. doi: 10.3233/JAD-220018.
    PubMed     Abstract available


  92. CAO M, Liu J, Zhang X, Yang T, et al
    ABI3 Is a Novel Early Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215635. doi: 10.3233/JAD-215635.
    PubMed     Abstract available


  93. KRAUSE-SORIO B, Siddarth P, Kilpatrick L, Milillo MM, et al
    Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215563. doi: 10.3233/JAD-215563.
    PubMed     Abstract available


  94. NICSANU R, Cervellati C, Benussi L, Squitti R, et al
    Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215542. doi: 10.3233/JAD-215542.
    PubMed     Abstract available


  95. WOLFSGRUBER S, Kleineidam L, Weyrauch AS, Barkhoff M, et al
    Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215416. doi: 10.3233/JAD-215416.
    PubMed     Abstract available


  96. CHUNG SJ, Chang Y, Jeon J, Shin JI, et al
    Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Mar 10. pii: JAD220031. doi: 10.3233/JAD-220031.
    PubMed     Abstract available


  97. SHIM Y, Han HJ, Park KW, Kim BC, et al
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Mode
    J Alzheimers Dis. 2022 Mar 10. pii: JAD215277. doi: 10.3233/JAD-215277.
    PubMed     Abstract available



  98. Erratum to "Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease".
    J Alzheimers Dis. 2022 Mar 8. pii: JAD229001. doi: 10.3233/JAD-229001.
    PubMed    


  99. ANDROUIN A, Thierry M, Boluda S, Baskaran A, et al
    Alterations of Neuronal Lysosomes in Alzheimer's Disease and in APPxPS1-KI Mice.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215692. doi: 10.3233/JAD-215692.
    PubMed     Abstract available


  100. CIRSTEA MS, Kliger D, MacLellan AD, Yu AC, et al
    The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215520. doi: 10.3233/JAD-215520.
    PubMed     Abstract available


  101. WANG X, Li F, Gao Q, Jiang Z, et al
    Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215394. doi: 10.3233/JAD-215394.
    PubMed     Abstract available


  102. KOK FK, van Leerdam SL, de Lange ECM
    Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD210607. doi: 10.3233/JAD-210607.
    PubMed     Abstract available


  103. LACORTE E, Ancidoni A, Zaccaria V, Remoli G, et al
    Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD220046. doi: 10.3233/JAD-220046.
    PubMed     Abstract available


  104. LIU Y, Han PR, Hu H, Wang ZT, et al
    A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD215724. doi: 10.3233/JAD-215724.
    PubMed     Abstract available


  105. XIAO Y, Gong X, Deng R, Liu W, et al
    Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215705. doi: 10.3233/JAD-215705.
    PubMed     Abstract available


  106. ARMSTRONG MJ, Song S, Kurasz AM, Li Z, et al
    Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215587. doi: 10.3233/JAD-215587.
    PubMed     Abstract available


  107. FENG T, Hu X, Fukui Y, Bian Z, et al
    Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215246. doi: 10.3233/JAD-215246.
    PubMed     Abstract available


  108. BROUSSARD JI, Redell JB, Maynard ME, Zhao J, et al
    Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215023. doi: 10.3233/JAD-215023.
    PubMed     Abstract available


  109. BABULAL GM, Chen L, Doherty JM, Murphy SA, et al
    Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215708. doi: 10.3233/JAD-215708.
    PubMed     Abstract available


  110. MEYSAMI S, Raji CA, Mendez MF
    Quantified Brain Magnetic Resonance Imaging Volumes Differentiates Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215667. doi: 10.3233/JAD-215667.
    PubMed     Abstract available


  111. SHI Y, Bao Q, Chen W, Wang L, et al
    Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215666. doi: 10.3233/JAD-215666.
    PubMed     Abstract available


  112. MI Y, Qin Q, Xing Y, Tang Y, et al
    Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215565. doi: 10.3233/JAD-215565.
    PubMed     Abstract available


  113. JACUS JP, Voltzenlogel V, Antoine P, Cuervo-Lombard CV, et al
    Apathy Is the Best Dimension to Consider for Awareness Assessment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215550. doi: 10.3233/JAD-215550.
    PubMed     Abstract available


  114. ESCOBAR YH, O'Piela D, Wold LE, Mackos AR, et al
    Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215290. doi: 10.3233/JAD-215290.
    PubMed     Abstract available


  115. ALVES SR, da Cruz E Silva C, Martins I, Henriques AG, et al
    A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215059. doi: 10.3233/JAD-215059.
    PubMed     Abstract available


    February 2022
  116. KRISHNA-K K, Behnisch T, Sajikumar S
    Modulation of the Ubiquitin-Proteasome System Restores Plasticity in Hippocampal Pyramidal Neurons of the APP/PS1 Alzheimer's Disease-Like Mice.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215718. doi: 10.3233/JAD-215718.
    PubMed     Abstract available


  117. LI W, Yang D, Yan C, Chen M, et al
    Characterizing Network Selectiveness to the Dynamic Spreading of Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215596. doi: 10.3233/JAD-215596.
    PubMed     Abstract available


  118. KALECKY K, German DC, Montillo AA, Bottiglieri T, et al
    Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215448. doi: 10.3233/JAD-215448.
    PubMed     Abstract available


  119. CAO H, Zhou X, Chen Y, Ip FCF, et al
    Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215311. doi: 10.3233/JAD-215311.
    PubMed     Abstract available


  120. COLVERSON AJ, Trifilio E, Williamson JB
    Music, Mind, Mood, and Mingling in Alzheimer's Disease and Related Dementias: A Scoping Review.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215199. doi: 10.3233/JAD-215199.
    PubMed     Abstract available


  121. PAYNE S, Shofer JB, Shutes-David A, Li G, et al
    Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer Coordinating Center.
    J Alzheimers Dis. 2022 Feb 23. pii: JAD215428. doi: 10.3233/JAD-215428.
    PubMed     Abstract available


  122. CHOI H, Lee D, Mook-Jung I
    Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215235. doi: 10.3233/JAD-215235.
    PubMed     Abstract available


  123. ALVAREZ-SANCHEZ L, Pena-Bautista C, Baquero M, Chafer-Pericas C, et al
    Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215093. doi: 10.3233/JAD-215093.
    PubMed     Abstract available


  124. SCHINDLER SE
    Predicting Symptom Onset in Sporadic Alzheimer's Disease: "How Long Do I Have?"
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215722. doi: 10.3233/JAD-215722.
    PubMed     Abstract available


  125. AKSNES M, Aass HCD, Tiiman A, Terenius L, et al
    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215504. doi: 10.3233/JAD-215504.
    PubMed     Abstract available


  126. TSAMOU M, Carpi D, Pistollato F, Roggen EL, et al
    Sporadic Alzheimer's Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215434. doi: 10.3233/JAD-215434.
    PubMed     Abstract available


  127. JACOBS HIL, O'Donnell A, Satizabal CL, Lois C, et al
    Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215372. doi: 10.3233/JAD-215372.
    PubMed     Abstract available


  128. LIU Z, Paek EJ, Yoon SO, Casenhiser D, et al
    Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215137. doi: 10.3233/JAD-215137.
    PubMed     Abstract available


  129. HUA X, Church K, Walker W, L'Hostis P, et al
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.
    J Alzheimers Dis. 2022 Feb 18. pii: JAD215511. doi: 10.3233/JAD-215511.
    PubMed     Abstract available


  130. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215536. doi: 10.3233/JAD-215536.
    PubMed     Abstract available


  131. HANG Z, Cai S, Lei T, Zhang X, et al
    Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215495. doi: 10.3233/JAD-215495.
    PubMed     Abstract available


  132. GALLUCCI M, Cenesi L, White C, Antuono P, et al
    Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer's Disease Framework.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215432. doi: 10.3233/JAD-215432.
    PubMed     Abstract available


  133. SUAREZ-MENDEZ I, Bruna R, Lopez-Sanz D, Montejo P, et al
    Cognitive Training Modulates Brain Hypersynchrony in a Population at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215406. doi: 10.3233/JAD-215406.
    PubMed     Abstract available


  134. BIJU K, Oh E, Rosenberg P, Xue QL, et al
    Vestibular Function Predicts Balance and Fall Risk in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215366. doi: 10.3233/JAD-215366.
    PubMed     Abstract available


  135. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215276. doi: 10.3233/JAD-215276.
    PubMed     Abstract available


  136. WANG J, Ma SF, Yun Q, Liu WJ, et al
    FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle Regulation.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215144. doi: 10.3233/JAD-215144.
    PubMed     Abstract available


  137. KELBERMAN MA, Anderson CR, Chlan E, Rorabaugh JM, et al
    Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215546. doi: 10.3233/JAD-215546.
    PubMed     Abstract available


  138. TICINESI A, Mancabelli L, Carnevali L, Nouvenne A, et al
    Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215493. doi: 10.3233/JAD-215493.
    PubMed     Abstract available


  139. GALASKO DR, Grill JD, Lingler JH, Heidebrink JL, et al
    A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215490. doi: 10.3233/JAD-215490.
    PubMed     Abstract available


  140. PARRA MA
    Barriers to Effective Memory Assessments for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215445. doi: 10.3233/JAD-215445.
    PubMed     Abstract available


  141. DE PAULA FRANCA RESENDE E, Ketelle R, Karydas A, Allen I, et al
    Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215369. doi: 10.3233/JAD-215369.
    PubMed     Abstract available


  142. XU A, Kouznetsova VL, Tsigelny IF
    Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
    J Alzheimers Dis. 2022 Feb 5. pii: JAD215502. doi: 10.3233/JAD-215502.
    PubMed     Abstract available


  143. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 3. pii: JAD215405. doi: 10.3233/JAD-215405.
    PubMed     Abstract available


  144. JANSSON D, Wang M, Thomas R, Erickson MA, et al
    Markers of Cerebrovascular Injury, Inflammation, and Plasma Lipids Are Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Cognitively Normal Persons.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215400. doi: 10.3233/JAD-215400.
    PubMed     Abstract available


  145. ASSOGNA M, Motta C, Bonni S, Borghi I, et al
    Isolated Amyloid-beta Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215218. doi: 10.3233/JAD-215218.
    PubMed     Abstract available


  146. THOMPSON RE, Tuchman AJ, Alkon DL
    Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1.
    J Alzheimers Dis. 2022 Feb 1. pii: JAD215545. doi: 10.3233/JAD-215545.
    PubMed     Abstract available


    January 2022
  147. GEORGE DR, Whitehouse PJ
    How Not to Study a Disease: The Story of Alzheimer's by Karl Herrup, The MIT Press, 2021, 245 pp.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD220035. doi: 10.3233/JAD-220035.
    PubMed    


  148. JUTTEN RJ, Thompson L, Sikkes SAM, Maruff P, et al
    A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD215098. doi: 10.3233/JAD-215098.
    PubMed     Abstract available


  149. UM YH, Wang SM, Kang DW, Kim NY, et al
    Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    J Alzheimers Dis. 2022 Jan 21. pii: JAD215460. doi: 10.3233/JAD-215460.
    PubMed     Abstract available


  150. MESA-HERRERA F, Marin R, Torrealba E, Diaz M, et al
    Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215437. doi: 10.3233/JAD-215437.
    PubMed     Abstract available


  151. ZHANG W, Zhang M, Wu Q, Shi JS, et al
    Dendrobium nobile Lindl. Alkaloids Ameliorate Abeta25-35-Induced Synaptic Deficits by Targeting Wnt/beta-Catenin Pathway in Alzheimer's Disease Models.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215433. doi: 10.3233/JAD-215433.
    PubMed     Abstract available


  152. TEIXEIRA AL, Salem H, Martins LB, Gonzales MM, et al
    Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215314. doi: 10.3233/JAD-215314.
    PubMed     Abstract available


  153. PEDERSEN FN, Stokholm L, Pouwer F, Hass Rubin K, et al
    Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215313. doi: 10.3233/JAD-215313.
    PubMed     Abstract available


  154. RICHTER N, David LS, Grothe MJ, Teipel S, et al
    Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD210261. doi: 10.3233/JAD-210261.
    PubMed     Abstract available


  155. MCNERNEY MW, Heath A, Narayanan S, Yesavage J, et al
    Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215361. doi: 10.3233/JAD-215361.
    PubMed     Abstract available


  156. KUKSA PP, Liu CL, Fu W, Qu L, et al
    Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215055. doi: 10.3233/JAD-215055.
    PubMed     Abstract available


  157. MIRON J, Picard C, Labonte A, Auld D, et al
    MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215410. doi: 10.3233/JAD-215410.
    PubMed     Abstract available


  158. EASTMAN G, Sharlow ER, Lazo JS, Bloom GS, et al
    Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215357. doi: 10.3233/JAD-215357.
    PubMed     Abstract available


  159. STEPLER KE, Gillyard TR, Reed CB, Avery TM, et al
    ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215306. doi: 10.3233/JAD-215306.
    PubMed     Abstract available


  160. SCHAFFERT J, LoBue C, Hynan LS, Hart J, et al
    Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215200. doi: 10.3233/JAD-215200.
    PubMed     Abstract available


  161. PARK M, Baik K, Lee YG, Kang SW, et al
    Erratum to: Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2022 Jan 11. pii: JAD219020. doi: 10.3233/JAD-219020.
    PubMed    


  162. BIAN Z, Liu X, Feng T, Yu H, et al
    Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Jan 5. pii: JAD215318. doi: 10.3233/JAD-215318.
    PubMed     Abstract available


  163. DALY T, Mastroleo I, Henry V, Bourdenx M, et al
    An Argument for Simple Tests of Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215492. doi: 10.3233/JAD-215492.
    PubMed     Abstract available


  164. BENCA R, Herring WJ, Khandker R, Qureshi Z, et al
    Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215324. doi: 10.3233/JAD-215324.
    PubMed     Abstract available


  165. CONTARINO VE, Siggillino S, Arighi A, Scola E, et al
    Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia.
    J Alzheimers Dis. 2022;85:431-442.
    PubMed     Abstract available


  166. WILKINS HM, Troutwine BR, Menta BW, Manley SJ, et al
    Mitochondrial Membrane Potential Influences Amyloid-beta Protein Precursor Localization and Amyloid-beta Secretion.
    J Alzheimers Dis. 2022;85:381-394.
    PubMed     Abstract available


  167. YAN XD, Qu XS, Yin J, Qiao J, et al
    Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
    J Alzheimers Dis. 2022;85:343-357.
    PubMed     Abstract available


  168. SCHWARZ CG, Knopman DS, Ramanan VK, Lowe VJ, et al
    Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.
    J Alzheimers Dis. 2022;85:59-64.
    PubMed     Abstract available


  169. SONG Y, Du Z, Chen X, Zhang W, et al
    Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-beta142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    J Alzheimers Dis. 2022;85:167-178.
    PubMed     Abstract available


  170. JUNG KH, Park KI, Lee WJ, Son H, et al
    Association of Plasma Oligomerized Amyloid-beta and Cerebral White Matter Lesions in a Health Screening Population.
    J Alzheimers Dis. 2022;85:1835-1844.
    PubMed     Abstract available


  171. STREIT WJ, Rotter J, Winter K, Muller W, et al
    Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.
    J Alzheimers Dis. 2022;85:1701-1720.
    PubMed     Abstract available


  172. KURANO M, Tsukamoto K, Sakai E, Hara M, et al
    Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
    J Alzheimers Dis. 2022;85:1529-1544.
    PubMed     Abstract available


  173. SUN Y, Wang M, Zhao Y, Hu K, et al
    A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline.
    J Alzheimers Dis. 2022;85:1745-1754.
    PubMed     Abstract available


  174. KHAN N, Alimova Y, Clark SJ, Vekaria HJ, et al
    Human APOE varepsilon3 and APOE varepsilon4 Alleles Have Differential Effects on Mouse Olfactory Epithelium.
    J Alzheimers Dis. 2022;85:1481-1494.
    PubMed     Abstract available


  175. KHORANI M, Bobe G, Matthews DG, Magana AA, et al
    The Impact of the hAPP695SW Transgene and Associated Amyloid-beta Accumulation on Murine Hippocampal Biochemical Pathways.
    J Alzheimers Dis. 2022;85:1601-1619.
    PubMed     Abstract available


  176. CHENG J, Fairchild JK, McNerney MW, Noda A, et al
    Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.
    J Alzheimers Dis. 2022;85:1593-1600.
    PubMed     Abstract available


  177. GAO Z, Zhang R, Jiang L, Zhou H, et al
    Administration of miR-195 Inhibitor Enhances Memory Function Through Improving Synaptic Degradation and Mitochondrial Dysfunction of the Hippocampal Neurons in SAMP8 Mice.
    J Alzheimers Dis. 2022;85:1495-1509.
    PubMed     Abstract available


  178. WANG G, Zhou W, Kong D, Qu Z, et al
    Studying APOE varepsilon4 Allele Dose Effects with a Univariate Morphometry Biomarker.
    J Alzheimers Dis. 2022;85:1233-1250.
    PubMed     Abstract available


  179. ZHOU AL, Sharda N, Sarma VV, Ahlschwede KM, et al
    Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-beta Peptides and Insulin.
    J Alzheimers Dis. 2022;85:1031-1044.
    PubMed     Abstract available


  180. ZHANG XX, Ma YH, Hu HY, Ma LZ, et al
    Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study.
    J Alzheimers Dis. 2022;85:877-887.
    PubMed     Abstract available


  181. BAO J, Liang Z, Gong X, Yu J, et al
    High Fat Diet Mediates Amyloid-beta Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;85:863-876.
    PubMed     Abstract available


  182. KHAJEHPIRI B, Moghaddam HA, Forouzanfar M, Lashgari R, et al
    Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.
    J Alzheimers Dis. 2022;85:837-850.
    PubMed     Abstract available


  183. SHANG X, Hill E, Zhu Z, Liu J, et al
    Macronutrient Intake and Risk of Dementia in Community-Dwelling Older Adults: A Nine-Year Follow-Up Cohort Study.
    J Alzheimers Dis. 2022;85:791-804.
    PubMed     Abstract available


  184. SIL A, Erfani A, Lamb N, Copland R, et al
    Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.
    J Alzheimers Dis. 2022;85:755-778.
    PubMed     Abstract available


  185. TALAN J
    Obituary for John Q. Trojanowski, leading Alzheimer's Disease Researcher.
    J Alzheimers Dis. 2022;86:1-3.
    PubMed    


  186. SHAFIR A, Ritchie CS, Garrett SB, Bernstein Sideman A, et al
    "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.
    J Alzheimers Dis. 2022;86:787-800.
    PubMed     Abstract available


  187. KUNDU P, Zimmerman B, Quinn JF, Kaye J, et al
    Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.
    J Alzheimers Dis. 2022;86:1471-1481.
    PubMed     Abstract available


  188. WEINSTEIN G, O'Donnell A, Davis-Plourde K, Zelber-Sagi S, et al
    Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-beta and Tau Pathology in Middle-Aged Adults: The Framingham Study.
    J Alzheimers Dis. 2022;86:1371-1383.
    PubMed     Abstract available


  189. CHAN CK, Pettigrew C, Soldan A, Zhu Y, et al
    Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    J Alzheimers Dis. 2022;86:1415-1426.
    PubMed     Abstract available


  190. OWENS L, Bracewell J, Benedetto A, Dawson N, et al
    BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-beta Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAbetaPPalpha.
    J Alzheimers Dis. 2022;86:1201-1220.
    PubMed     Abstract available


  191. TANAKA T, Gyanwali B, Villaraza SG, Saridin FN, et al
    The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study.
    J Alzheimers Dis. 2022;86:1093-1105.
    PubMed     Abstract available


  192. SAJI N, Murotani K, Sato N, Tsuduki T, et al
    Relationship Between Plasma Neurofilament Light Chain, Gut Microbiota, and Dementia: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;86:1323-1335.
    PubMed     Abstract available


  193. TIAN Q, Bilgel M, Moghekar AR, Ferrucci L, et al
    Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2022;86:1275-1285.
    PubMed     Abstract available


  194. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
    J Alzheimers Dis. 2022;86:1243-1254.
    PubMed     Abstract available


  195. DORAISWAMY PM, Goldberg TE, Qian M, Linares AR, et al
    Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:1131-1136.
    PubMed     Abstract available


  196. RICE M, Davalos D, Thomas ML
    A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders.
    J Alzheimers Dis. 2022;86:1001-1024.
    PubMed     Abstract available


  197. ZHU Z, Zeng Q, Zhang R, Luo X, et al
    White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:741-751.
    PubMed     Abstract available


  198. CEYZERIAT K, Tournier BB, Millet P, Dipasquale G, et al
    Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.
    J Alzheimers Dis. 2022;86:641-653.
    PubMed     Abstract available


  199. CHEN WT, Chi NF, Cheng HM, Ko YT, et al
    Associations Between Cerebral Vasoreactivity and Cognitive Function in the Middle-Aged Non-Demented Population.
    J Alzheimers Dis. 2022;86:679-690.
    PubMed     Abstract available


  200. HSU YH, Huang SM, Lin SY, Yang JJ, et al
    Prospective Memory and Default Mode Network Functional Connectivity in Normal and Pathological Aging.
    J Alzheimers Dis. 2022;86:753-762.
    PubMed     Abstract available


  201. CARDOSO S, Silva D, Alves L, Guerreiro M, et al
    The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:629-640.
    PubMed     Abstract available


  202. YANG Z, Sheng X, Qin R, Chen H, et al
    Cognitive Improvement via Left Angular Gyrus-Navigated Repetitive Transcranial Magnetic Stimulation Inducing the Neuroplasticity of Thalamic System in Amnesic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2022;86:537-551.
    PubMed     Abstract available


  203. JOSEPHS KA, Pham NTT, Graff-Radford J, Machulda MM, et al
    Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
    J Alzheimers Dis. 2022;86:491-498.
    PubMed     Abstract available


  204. LEVY B, Priest A, Delaney T, Hogan J, et al
    Toward Pre-Diagnostic Detection of Dementia in Primary Care.
    J Alzheimers Dis. 2022;86:479-490.
    PubMed     Abstract available


  205. SOHN BK, Byun MS, Yi D, Jeon SY, et al
    Late-Life Physical Activities Moderate the Relationship of Amyloid-beta Pathology with Neurodegeneration in Individuals Without Dementia.
    J Alzheimers Dis. 2022;86:441-450.
    PubMed     Abstract available


  206. LIU M, Guo S, Huang D, Hu D, et al
    Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.
    J Alzheimers Dis. 2022;86:315-331.
    PubMed     Abstract available


  207. ZHANG LN, Li MJ, Shang YH, Liu YR, et al
    Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3beta Activation.
    J Alzheimers Dis. 2022;86:191-204.
    PubMed     Abstract available


  208. DENNISON JL, Volmar CH, Ke D, Wang J, et al
    JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2022;86:173-190.
    PubMed     Abstract available


  209. LERCH O, Laczo M, Vyhnalek M, Nedelska Z, et al
    APOEvarepsilon4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.
    J Alzheimers Dis. 2022;86:155-171.
    PubMed     Abstract available


  210. ZHANG Q, Zhang M, Chen Y, Cao Y, et al
    Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011-2014).
    J Alzheimers Dis. 2022;86:125-134.
    PubMed     Abstract available


  211. HENDERSON C, Knapp M, Martyr A, Gamble LD, et al
    The Use and Costs of Paid and Unpaid Care for People with Dementia: Longitudinal Findings from the IDEAL Cohort.
    J Alzheimers Dis. 2022;86:135-153.
    PubMed     Abstract available


  212. O'BRYANT SE, Petersen M, Hall J, Johnson L, et al
    Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    J Alzheimers Dis. 2022;86:1745-1750.
    PubMed     Abstract available


  213. HU H, Fu JT, Bi YL, Ma YH, et al
    Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study.
    J Alzheimers Dis. 2022;86:1849-1859.
    PubMed     Abstract available


  214. ZHANG L, Fu Y, Zhao Z, Cong Z, et al
    Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.
    J Alzheimers Dis. 2022;86:1695-1710.
    PubMed     Abstract available


  215. PARKER AF, Ohlhauser L, Scarapicchia V, Smart CM, et al
    A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls.
    J Alzheimers Dis. 2022;86:1545-1567.
    PubMed     Abstract available


  216. SANDBERG AA, Manning E, Wilkins HM, Mazzarino R, et al
    Mitochondrial Targeting of Amyloid-beta Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-beta.
    J Alzheimers Dis. 2022;86:1727-1744.
    PubMed     Abstract available


  217. LI C, Liu M, Xia J, Mei L, et al
    Predicting Brain Amyloid-beta PET Grades with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity.
    J Alzheimers Dis. 2022;86:1679-1693.
    PubMed     Abstract available


  218. KONCZ R, Wen W, Makkar SR, Lam BCP, et al
    The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    J Alzheimers Dis. 2022;86:1617-1628.
    PubMed     Abstract available


  219. RAHMANI F, Wang Q, McKay NS, Keefe S, et al
    Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.
    J Alzheimers Dis. 2022;86:1831-1848.
    PubMed     Abstract available


  220. ASHFORD JW, Schmitt FA, Bergeron MF, Bayley PJ, et al
    Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
    J Alzheimers Dis. 2022;87:305-315.
    PubMed     Abstract available


  221. MORTON H, Basu T, Bose C, Reddy PH, et al
    Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study.
    J Alzheimers Dis. 2022;87:33-49.
    PubMed     Abstract available


  222. CLEMENT A, Madsen MJ, Kastaniegaard K, Wiborg O, et al
    Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates.
    J Alzheimers Dis. 2022;87:259-272.
    PubMed     Abstract available


  223. SOO SA, Zailan FZ, Tan JY, Sandhu GK, et al
    Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders.
    J Alzheimers Dis. 2022;87:479-488.
    PubMed     Abstract available


  224. NING J, Huang SY, Chen SD, Zhang YR, et al
    Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022;87:211-222.
    PubMed     Abstract available


  225. KUCIKIENE D, Costa AS, Banning LCP, van Gils V, et al
    The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.
    J Alzheimers Dis. 2022;87:185-195.
    PubMed     Abstract available


  226. DHARMARAJ GL, Arigo FD, Young KA, Martins R, et al
    Novel Amylin Analogues Reduce Amyloid-beta Cross-Seeding Aggregation and Neurotoxicity.
    J Alzheimers Dis. 2022;87:373-390.
    PubMed     Abstract available


  227. MARINO GAMMAZZA A, Restivo V, Baschi R, Caruso Bavisotto C, et al
    Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2022;87:161-172.
    PubMed     Abstract available


  228. HOSSEINI AA, Brown T, Mannino L, Gran B, et al
    Clinical Utility of Cerebrospinal Fluid Abeta42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    J Alzheimers Dis. 2022;87:771-780.
    PubMed     Abstract available


  229. ZHANG R, Jiang L, Li G, Wu J, et al
    Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy.
    J Alzheimers Dis. 2022;87:843-861.
    PubMed     Abstract available


  230. GIRTLER N, Chincarini A, Brugnolo A, Doglione E, et al
    The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    J Alzheimers Dis. 2022;87:887-899.
    PubMed     Abstract available


  231. LIU X, Yan J, Liu F, Zhou P, et al
    Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice.
    J Alzheimers Dis. 2022;87:873-886.
    PubMed     Abstract available


  232. SOLOMON V, Hafez M, Xian H, Harrington MG, et al
    An Association Between Saturated Fatty Acid-Containing Phosphatidylcholine in Cerebrospinal Fluid with Tau Phosphorylation.
    J Alzheimers Dis. 2022;87:609-617.
    PubMed     Abstract available


  233. MARTINEZ-HERRERA M, Figueroa-Gerstenmaier S, Lopez-Camacho PY, Millan-Pacheco C, et al
    Multiadducts of C60 Modulate Amyloid-beta Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies.
    J Alzheimers Dis. 2022;87:741-759.
    PubMed     Abstract available


  234. GRANGEON L, Paquet C, Guey S, Zarea A, et al
    Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Abeta42, and Abeta40 in Probable Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;87:791-802.
    PubMed     Abstract available


  235. SIVASARAVANAPARAN M, Olesen LO, Severino M, von Linstow CU, et al
    Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2022;87:685-699.
    PubMed     Abstract available


  236. GE X, Qiao Y, Choi J, Raman R, et al
    Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.
    J Alzheimers Dis. 2022;87:557-568.
    PubMed     Abstract available


  237. ICHIMATA S, Yoshida K, Visanji NP, Lang AE, et al
    Patterns of Mixed Pathologies in Down Syndrome.
    J Alzheimers Dis. 2022;87:595-607.
    PubMed     Abstract available


  238. WHITEHOUSE PJ, Saini V
    Making the Case for the Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:999-1001.
    PubMed     Abstract available


  239. SCHWERTNER E, Pereira JB, Xu H, Secnik J, et al
    Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.
    J Alzheimers Dis. 2022;87:1307-1318.
    PubMed     Abstract available


  240. HAN SH, Noh DH, Jo EJ, Kam KY, et al
    Effects of Apolipoprotein E varepsilon4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    J Alzheimers Dis. 2022;87:1181-1188.
    PubMed     Abstract available


  241. RIPPON B, Palta P, Tahmi M, Sherwood G, et al
    Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2022;87:1229-1238.
    PubMed     Abstract available


  242. SHIMOSAKA M, Nishimoto H, Kinoshita A
    Analysis of the Clock-Reading Ability in Patients with Cognitive Impairment: Comparison of Analog Clocks and Digital Clocks.
    J Alzheimers Dis. 2022;87:1151-1165.
    PubMed     Abstract available


  243. SHENG C, Yang K, He B, Li T, et al
    Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    J Alzheimers Dis. 2022;87:1319-1333.
    PubMed     Abstract available


  244. JEONG S, Huang LK, Tsai MJ, Liao YT, et al
    Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.
    J Alzheimers Dis. 2022;87:1115-1130.
    PubMed     Abstract available


  245. WHITEHOUSE P, Gandy S, Saini V, George DR, et al
    Making the Case for Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:1003-1007.
    PubMed     Abstract available


  246. SARTO J, Maya G, Molina-Porcel L, Balasa M, et al
    Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank.
    J Alzheimers Dis. 2022;87:1659-1669.
    PubMed     Abstract available


  247. MCCARTER SJ, Lesnick TG, Lowe VJ, Rabinstein AA, et al
    Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    J Alzheimers Dis. 2022;87:1537-1547.
    PubMed     Abstract available


  248. SHAW BC, Snider HC, Turner AK, Zajac DJ, et al
    An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain.
    J Alzheimers Dis. 2022;87:1647-1657.
    PubMed     Abstract available


  249. ZHAO X, Du W, Jiang J, Han Y, et al
    Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
    J Alzheimers Dis. 2022;87:1581-1589.
    PubMed     Abstract available


  250. CASTILLO-PASSI RI, Vergara RC, Rogers NK, Ponce DP, et al
    Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment.
    J Alzheimers Dis. 2022;87:1695-1711.
    PubMed     Abstract available


  251. MCGRATH ER, Beiser AS, O'Donnell A, Yang Q, et al
    Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    J Alzheimers Dis. 2022;87:1517-1526.
    PubMed     Abstract available


  252. BOMMARITO G, Garibotto V, Frisoni GB, Ribaldi F, et al
    The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging.
    J Alzheimers Dis. 2022;87:1483-1490.
    PubMed     Abstract available


  253. LIBON DJ, Swenson R, Lamar M, Price CC, et al
    The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions.
    J Alzheimers Dis. 2022;87:1419-1432.
    PubMed     Abstract available


    December 2021
  254. DAY S, Roberts S, Launder NH, Goh AMY, et al
    Age of Symptom Onset and Longitudinal Course of Sporadic Alzheimer's Disease, Frontotemporal Dementia, and Vascular Dementia: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215360. doi: 10.3233/JAD-215360.
    PubMed     Abstract available


  255. WANG J, Wang P, Jiang Y, Wang Z, et al
    Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215239. doi: 10.3233/JAD-215239.
    PubMed     Abstract available


  256. GIANNAKOPOULOS P, Rodriguez C, Montandon ML, Garibotto V, et al
    Personality Impact on Alzheimer's Disease-Signature and Vascular Imaging Markers: A PET-MRI Study.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215062. doi: 10.3233/JAD-215062.
    PubMed     Abstract available


  257. BLACK SAG, Stepanchuk AA, Templeton GW, Hernandez Y, et al
    Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215402. doi: 10.3233/JAD-215402.
    PubMed     Abstract available


  258. LIU Q, Ling Z, Zhang J, Yu H, et al
    lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215194. doi: 10.3233/JAD-215194.
    PubMed     Abstract available


  259. BROBERG D, Wong D, Bellyou M, Montero-Odasso M, et al
    Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215188. doi: 10.3233/JAD-215188.
    PubMed     Abstract available


  260. JANG H, Park YH, Choe YS, Kang SH, et al
    Amyloid Positive Hydrocephalus: A Hydrocephalic Variant of Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215110. doi: 10.3233/JAD-215110.
    PubMed     Abstract available


  261. DUNK MM, Driscoll I
    Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215091. doi: 10.3233/JAD-215091.
    PubMed     Abstract available


  262. AHN H, Yi D, Chu K, Joung H, et al
    Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215292. doi: 10.3233/JAD-215292.
    PubMed     Abstract available


  263. DHAYNAUT M, Sprugnoli G, Cappon D, Macone J, et al
    Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215072. doi: 10.3233/JAD-215072.
    PubMed     Abstract available


  264. DONG L, Mao C, Liu C, Li J, et al
    Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215067. doi: 10.3233/JAD-215067.
    PubMed     Abstract available


  265. ZHAO Y, Bao J, Liu W, Gong X, et al
    Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215016. doi: 10.3233/JAD-215016.
    PubMed     Abstract available


  266. MASSETTI N, Russo M, Franciotti R, Nardini D, et al
    A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD210573. doi: 10.3233/JAD-210573.
    PubMed     Abstract available


  267. GOLDSMITH HS
    Alzheimer's Disease: A Decreased Cerebral Blood Flow to Critical Intraneuronal Elements is the Cause.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215479. doi: 10.3233/JAD-215479.
    PubMed     Abstract available


  268. ZHANG H, Lyu D, Jia J
    The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215456. doi: 10.3233/JAD-215456.
    PubMed     Abstract available


  269. SUO WZ
    GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215379. doi: 10.3233/JAD-215379.
    PubMed     Abstract available


  270. SCHAEFER SY, Malek-Ahmadi M, Hooyman A, King JB, et al
    Association Between Motor Task Performance and Hippocampal Atrophy Across Cognitively Unimpaired, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease Individuals.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD210665. doi: 10.3233/JAD-210665.
    PubMed     Abstract available


  271. YUEN SC, Lee SM, Leung SW
    Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215349. doi: 10.3233/JAD-215349.
    PubMed     Abstract available


  272. KWAK S, Oh DJ, Jeon YJ, Oh DY, et al
    Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215244. doi: 10.3233/JAD-215244.
    PubMed     Abstract available


  273. TROPEA MR, Sanfilippo G, Giannino F, Davi V, et al
    Innate Preferences Affect Results of Object Recognition Task in Wild Type and Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215209. doi: 10.3233/JAD-215209.
    PubMed     Abstract available


  274. RAMOS C, Villalba C, Garcia J, Lanata S, et al
    Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215169. doi: 10.3233/JAD-215169.
    PubMed     Abstract available


  275. YANG L, Xuan C, Yu C, Zheng P, et al
    Diagnostic Model of Alzheimer's Disease in the Elderly Based on Protein and Metabolic Biomarkers.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215119. doi: 10.3233/JAD-215119.
    PubMed     Abstract available


  276. SUN HL, Zhou FY, Chen DW, Tan CR, et al
    The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD210692. doi: 10.3233/JAD-210692.
    PubMed     Abstract available


  277. SALAMI A, Adolfsson R, Andersson M, Blennow K, et al
    Association of APOE varepsilon4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210673. doi: 10.3233/JAD-210673.
    PubMed     Abstract available


  278. VON LINSTOW CU, Waider J, Bergh MS, Anzalone M, et al
    The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210581. doi: 10.3233/JAD-210581.
    PubMed     Abstract available


  279. FAN F, Liu H, Shi X, Ai Y, et al
    The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215423. doi: 10.3233/JAD-215423.
    PubMed     Abstract available


  280. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215316. doi: 10.3233/JAD-215316.
    PubMed     Abstract available


  281. TEIPEL SJ, Dyrba M, Ballarini T, Brosseron F, et al
    Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215196. doi: 10.3233/JAD-215196.
    PubMed     Abstract available


  282. SMITH CA, Smith H, Roberts L, Coward L, et al
    Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD210464. doi: 10.3233/JAD-210464.
    PubMed     Abstract available


  283. SUN X, Zhang H, Yao D, Xu Y, et al
    Integrated Bioinformatics Analysis Identifies Hub Genes Associated with Viral Infection and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215232. doi: 10.3233/JAD-215232.
    PubMed     Abstract available


  284. WEN C, Bi YL, Hu H, Huang SY, et al
    Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215178. doi: 10.3233/JAD-215178.
    PubMed     Abstract available


  285. SCHUBERT CR, Paulsen AJ, Pinto AA, Merten N, et al
    Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215096. doi: 10.3233/JAD-215096.
    PubMed     Abstract available


  286. LI W, Zhao Z, Liu M, Yan S, et al
    Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    J Alzheimers Dis. 2021 Dec 10. pii: JAD215338. doi: 10.3233/JAD-215338.
    PubMed     Abstract available


  287. TALAN J
    Reactive Astrocytes and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215436. doi: 10.3233/JAD-215436.
    PubMed    


  288. YOO TJ
    Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215270. doi: 10.3233/JAD-215270.
    PubMed     Abstract available


  289. CUTULI D, Landolfo E, Petrosini L, Gelfo F, et al
    Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215193. doi: 10.3233/JAD-215193.
    PubMed     Abstract available


  290. KOUKI MA, Pritchard AB, Alder JE, Crean S, et al
    Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215103. doi: 10.3233/JAD-215103.
    PubMed     Abstract available


  291. BRITZ J, Ojo E, Dhukhwa A, Saito T, et al
    Assessing Sex-Specific Circadian, Metabolic, and Cognitive Phenotypes in the AbetaPP/PS1 and APPNL - F/NL - F Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210629. doi: 10.3233/JAD-210629.
    PubMed     Abstract available


  292. SACCHI L, Carandini T, Fumagalli GG, Pietroboni AM, et al
    Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210593. doi: 10.3233/JAD-210593.
    PubMed     Abstract available


  293. KOTHAPALLI SVVN, Benzinger TL, Aschenbrenner AJ, Perrin RJ, et al
    Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210503. doi: 10.3233/JAD-210503.
    PubMed     Abstract available


  294. SAKR F, Dyrba M, Brauer AU, Teipel S, et al
    Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD201504. doi: 10.3233/JAD-201504.
    PubMed     Abstract available


  295. SENEJANI AG, Maghsoudlou J, El-Zohiry D, Gaur G, et al
    Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.
    J Alzheimers Dis. 2021 Dec 5. pii: JAD215398. doi: 10.3233/JAD-215398.
    PubMed     Abstract available


  296. KURODA T, Honma M, Mori Y, Futamura A, et al
    White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215187. doi: 10.3233/JAD-215187.
    PubMed     Abstract available


  297. LIU XX, Wu PF, Liu YZ, Jiang YL, et al
    Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Populatio.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215104. doi: 10.3233/JAD-215104.
    PubMed     Abstract available


    November 2021
  298. METSLA K, Kirss S, Laks K, Sildnik G, et al
    alpha-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 30. pii: JAD215026. doi: 10.3233/JAD-215026.
    PubMed     Abstract available


  299. CHEN L, Shen Q, Xu S, Yu H, et al
    5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215217. doi: 10.3233/JAD-215217.
    PubMed     Abstract available


  300. CRESTINI A, Santilli F, Martellucci S, Carbone E, et al
    Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215171. doi: 10.3233/JAD-215171.
    PubMed     Abstract available


  301. SAPKOTA S, McFall GP, Masellis M, Dixon RA, et al
    Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215068. doi: 10.3233/JAD-215068.
    PubMed     Abstract available


  302. HAOUDY S, Jonveaux T, Puisieux S, Epstein J, et al
    Epilepsy in Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210681. doi: 10.3233/JAD-210681.
    PubMed     Abstract available


  303. NESHAN M, Malakouti SK, Kamalzadeh L, Makvand M, et al
    Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210480. doi: 10.3233/JAD-210480.
    PubMed     Abstract available


  304. GE F, Dong L, Zhu D, Lin X, et al
    Comparison of Serum Triiodothyronine with Biomarkers for Alzheimer's Disease Continuum in Euthyroid Subjects.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215092. doi: 10.3233/JAD-215092.
    PubMed     Abstract available


  305. ALTOMARI N, Bruno F, Lagana V, Smirne N, et al
    A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215061. doi: 10.3233/JAD-215061.
    PubMed     Abstract available


  306. WANG L, Chen H, Tang J, Guo Z, et al
    Peptidylarginine Deiminase and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215302. doi: 10.3233/JAD-215302.
    PubMed     Abstract available


  307. LARNER AJ, Marson AG
    Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215154. doi: 10.3233/JAD-215154.
    PubMed     Abstract available


  308. BROD SA
    Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215125. doi: 10.3233/JAD-215125.
    PubMed     Abstract available


  309. SUN X, Suo X, Xia X, Yu C, et al
    Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215074. doi: 10.3233/JAD-215074.
    PubMed     Abstract available


  310. LYNN J, Park M, Ogunwale C, Acquaah-Mensah GK, et al
    A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD210612. doi: 10.3233/JAD-210612.
    PubMed     Abstract available


  311. QIAO Y, Sun Y, Guo J, Chen Y, et al
    Disrupted White Matter Integrity and Cognitive Functions in Amyloid-beta Positive Alzheimer's Disease with Concomitant Lobar Cerebral Microbleeds.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD215251. doi: 10.3233/JAD-215251.
    PubMed     Abstract available


  312. BERGAMINO M, Keeling EG, Baxter LC, Sisco NJ, et al
    Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD210406. doi: 10.3233/JAD-210406.
    PubMed     Abstract available


  313. REALE M, Carrarini C, Russo M, Dono F, et al
    Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD215285. doi: 10.3233/JAD-215285.
    PubMed     Abstract available


  314. BARTHELEMY NR, Toth B, Manser PT, Sanabria-Bohorquez S, et al
    Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210677. doi: 10.3233/JAD-210677.
    PubMed     Abstract available


  315. HOY KE, Emonson MRL, Bailey NW, Humble G, et al
    Investigating Neurophysiological Markers of Symptom Severity in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210401. doi: 10.3233/JAD-210401.
    PubMed     Abstract available


  316. NOGUCHI-SHINOHARA M, Yuki-Nozaki S, Abe C, Mori A, et al
    Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD Study.
    J Alzheimers Dis. 2021 Nov 15. pii: JAD215153. doi: 10.3233/JAD-215153.
    PubMed     Abstract available


  317. CHUM PP, Hakim MA, Behringer EJ
    Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    J Alzheimers Dis. 2021 Nov 12. pii: JAD215223. doi: 10.3233/JAD-215223.
    PubMed     Abstract available


  318. KUMARI S, Singh A, Singh AK, Yadav Y, et al
    Circulatory GSK-3beta: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215347. doi: 10.3233/JAD-215347.
    PubMed     Abstract available


  319. MULLER EG, Edwin TH, Strand BH, Stokke C, et al
    Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215046. doi: 10.3233/JAD-215046.
    PubMed     Abstract available


  320. NIHASHI T, Sakurai K, Kato T, Iwata K, et al
    Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215024. doi: 10.3233/JAD-215024.
    PubMed     Abstract available


  321. TAN Y, Zhang J, Yang K, Xu Z, et al
    Anti-Stroke Chinese Herbal Medicines Inhibit Abnormal Amyloid-beta Protein Precursor Processing in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210652. doi: 10.3233/JAD-210652.
    PubMed     Abstract available


  322. DIPROSPERO ND, Keator DB, Phelan M, van Erp TGM, et al
    Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210572. doi: 10.3233/JAD-210572.
    PubMed     Abstract available


  323. FRANKLIN GL, Meira AT, Barbosa MT, Teive HAG, et al
    When My Child Has Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215234. doi: 10.3233/JAD-215234.
    PubMed     Abstract available


  324. FATIMA SHAD K, Soubra W, Cordato DJ
    The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215206. doi: 10.3233/JAD-215206.
    PubMed     Abstract available


  325. CHEN KL, Li PX, Sun YM, Chen SF, et al
    Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215167. doi: 10.3233/JAD-215167.
    PubMed     Abstract available


  326. WANG F, Xu J, Xu SJ, Guo JJ, et al
    Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215086. doi: 10.3233/JAD-215086.
    PubMed     Abstract available


  327. PAVLIK VN, Burnham SC, Kass JS, Helmer C, et al
    Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD210525. doi: 10.3233/JAD-210525.
    PubMed     Abstract available


  328. FU X, Liu Q, Sun X, Chang H, et al
    Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.
    J Alzheimers Dis. 2021 Nov 7. pii: JAD210656. doi: 10.3233/JAD-210656.
    PubMed     Abstract available


    October 2021
  329. MANDAL PK, Perry G
    SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD215354. doi: 10.3233/JAD-215354.
    PubMed    


  330. SAKURAI K, Iwase T, Kaneda D, Uchida Y, et al
    Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer's Disease and Argyrophilic Grain Disease.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210638. doi: 10.3233/JAD-210638.
    PubMed    


  331. MATTHIESEN ST, Rosenkjaer S, Ponten M, Jensen KB, et al
    Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210108. doi: 10.3233/JAD-210108.
    PubMed     Abstract available


  332. BJORKLI C, Louet C, Flo TH, Hemler M, et al
    In Vivo Microdialysis in Mice Captures Changes in Alzheimer's Disease Cerebrospinal Fluid Biomarkers Consistent with Developing Pathology.
    J Alzheimers Dis. 2021 Oct 29. pii: JAD210715. doi: 10.3233/JAD-210715.
    PubMed     Abstract available


  333. JEONG HJ, Lee YM, Park JM, Lee BD, et al
    Reduced Thickness of the Anterior Cingulate Cortex as a Predictor of Amnestic-Mild Cognitive Impairment Conversion to Alzheimer's Disease with Psychosis.
    J Alzheimers Dis. 2021 Oct 26. pii: JAD215005. doi: 10.3233/JAD-215005.
    PubMed     Abstract available


  334. SCHULTZ B, Taday J, Menezes L, Cigerce A, et al
    Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215182. doi: 10.3233/JAD-215182.
    PubMed     Abstract available


  335. TORRES AK, Jara C, Park-Kang HS, Polanco CM, et al
    Synaptic Mitochondria: An Early Target of Amyloid-beta and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215139. doi: 10.3233/JAD-215139.
    PubMed     Abstract available


  336. RUSANEN M, Selander T, Karkkainen V, Koivisto A, et al
    The Positive Effects of Pet Ownership on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210557. doi: 10.3233/JAD-210557.
    PubMed     Abstract available


  337. HIN N, Newman M, Pederson S, Lardelli M, et al
    Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210200. doi: 10.3233/JAD-210200.
    PubMed     Abstract available


  338. SHOJAIE M, Tabarestani S, Cabrerizo M, DeKosky ST, et al
    PET Imaging of Tau Pathology and Amyloid-beta, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210064. doi: 10.3233/JAD-210064.
    PubMed     Abstract available


  339. KARAMI V, Nittari G, Traini E, Amenta F, et al
    An Optimized Decision Tree with Genetic Algorithm Rule-Based Approach to Reveal the Brain's Changes During Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Oct 23. pii: JAD210626. doi: 10.3233/JAD-210626.
    PubMed     Abstract available


  340. ZHANG Q, Schultz JL, Aldridge GM, Simmering JE, et al
    COVID-19 Case Fatality and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215161. doi: 10.3233/JAD-215161.
    PubMed     Abstract available


  341. BRUUS AE, Waldemar G, Vogel A
    Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215113. doi: 10.3233/JAD-215113.
    PubMed     Abstract available


  342. CLUTE-REINIG N, Jayadev S, Rhoads K, Ny AL, et al
    Alzheimer's Disease Diagnostics Must Be Globally Accessible.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD210663. doi: 10.3233/JAD-210663.
    PubMed     Abstract available


  343. VRILLON A, Deramecourt V, Pasquier F, Magnin E, et al
    Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215226. doi: 10.3233/JAD-215226.
    PubMed     Abstract available


  344. ISMAEL S, Mirzahosseini G, Ahmed HA, Yoo A, et al
    Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215051. doi: 10.3233/JAD-215051.
    PubMed     Abstract available


  345. SWERDLOW NR, Kotz JE, Joshi YB, Talledo J, et al
    Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215029. doi: 10.3233/JAD-215029.
    PubMed     Abstract available


  346. HAN F, Zhao J, Zhao G
    Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD210374. doi: 10.3233/JAD-210374.
    PubMed     Abstract available


  347. HU D, Liu C, Xia K, Abramowitz A, et al
    Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD215160. doi: 10.3233/JAD-215160.
    PubMed     Abstract available


  348. LIU H, Lutz M, Luo S
    Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD210700. doi: 10.3233/JAD-210700.
    PubMed     Abstract available


  349. HOFMANN C, Sander A, Wang XX, Buerge M, et al
    Inhalational Anesthetics Do Not Deteriorate Amyloid-beta-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD201185. doi: 10.3233/JAD-201185.
    PubMed     Abstract available


  350. KURKINEN M, Tran L
    Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215105. doi: 10.3233/JAD-215105.
    PubMed    


  351. ARANDELOVIC J, Santrac A, Batinic B, Todorovic L, et al
    Positive and Negative Selective Allosteric Modulators of alpha5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215079. doi: 10.3233/JAD-215079.
    PubMed     Abstract available


  352. OH C
    Single-Task or Dual-Task? Gait Assessment as a Potential Diagnostic Tool for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210690. doi: 10.3233/JAD-210690.
    PubMed     Abstract available


  353. SILHAN D, Pashkovska O, Bartos A
    Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210372. doi: 10.3233/JAD-210372.
    PubMed     Abstract available


  354. SHUKLA D, Mandal PK, Mishra R, Punjabi K, et al
    Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215032. doi: 10.3233/JAD-215032.
    PubMed     Abstract available


  355. WASHIDA K, Kitajima E, Tanaka T, Ikeda S, et al
    A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215006. doi: 10.3233/JAD-215006.
    PubMed     Abstract available


  356. KIM H, Jun S, Kim BS, Kim IJ, et al
    Serum Adiponectin in Alzheimer's Disease (AD): Association with AD Biomarkers and Cognitive Outcome.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD210722. doi: 10.3233/JAD-210722.
    PubMed     Abstract available


  357. PACHECO-HERRERO M, Soto-Rojas LO, Reyes-Sabater H, Garces-Ramirez L, et al
    Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD200863. doi: 10.3233/JAD-200863.
    PubMed     Abstract available


  358. SHAFIEE N, Dadar M, Ducharme S, Collins DL, et al
    Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 1. pii: JAD210664. doi: 10.3233/JAD-210664.
    PubMed     Abstract available


    September 2021
  359. PANDEY JP, Namboodiri AM, Nietert PJ, Barnes LL, et al
    Inhibitory Fcgamma Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215174. doi: 10.3233/JAD-215174.
    PubMed     Abstract available


  360. ROBINSON AC, Davidson YS, Roncaroli F, Minshull J, et al
    Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer's Disease Pathology at Death.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215102. doi: 10.3233/JAD-215102.
    PubMed     Abstract available


  361. LARGENT EA, Bhardwaj T, Abera M, Stites SD, et al
    Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
    J Alzheimers Dis. 2021 Sep 30. pii: JAD210675. doi: 10.3233/JAD-210675.
    PubMed     Abstract available


  362. STANITSA E, Economou A, Beratis I, Kontaxopoulou D, et al
    Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210622. doi: 10.3233/JAD-210622.
    PubMed     Abstract available


  363. SONG XJ, Zhou HY, Sun YY, Huang HC, et al
    Phosphorylation and Glycosylation of Amyloid-beta Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210337. doi: 10.3233/JAD-210337.
    PubMed     Abstract available


  364. SONG J, Yang X, Zhang M, Wang C, et al
    Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210595. doi: 10.3233/JAD-210595.
    PubMed     Abstract available


  365. HAO J, Qiao Y, Li T, Yang J, et al
    Investigating Changes in the Serum Inflammatory Factors in Alzheimer's Disease and Their Correlation with Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210552. doi: 10.3233/JAD-210552.
    PubMed     Abstract available


  366. MATSUZONO K, Suzuki M, Miura K, Ozawa T, et al
    Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210490. doi: 10.3233/JAD-210490.
    PubMed     Abstract available


  367. FUKUDA H, Ono R, Maeda M, Murata F, et al
    Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD201508. doi: 10.3233/JAD-201508.
    PubMed     Abstract available


  368. LENNON MJ, Rigney G, Raymont V, Sachdev P, et al
    Genetic Therapies for Alzheimer's Disease: A Scoping Review.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD215145. doi: 10.3233/JAD-215145.
    PubMed     Abstract available


  369. WANG Q, Dong X, Zhang R, Zhao C, et al
    Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210735. doi: 10.3233/JAD-210735.
    PubMed     Abstract available


  370. NAN H, Kim YJ, Tsuchiya M, Fukao T, et al
    A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-beta Protein Precursor.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210706. doi: 10.3233/JAD-210706.
    PubMed     Abstract available


  371. BLOCK ML, Kodavanti UP
    The Use of Standardized Diesel Exhaust Particles in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215201. doi: 10.3233/JAD-215201.
    PubMed     Abstract available


  372. CULIBRK RA, Arabiyat AS, DeKalb CA, Hahn MS, et al
    Modeling Sympathetic Hyperactivity in Alzheimer's Related Bone Loss.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215007. doi: 10.3233/JAD-215007.
    PubMed     Abstract available


  373. KATZ J, Gao H
    The Alzheimer-E. coli Axis: What Can We Learn from an Electronic Health Record Platform.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215004. doi: 10.3233/JAD-215004.
    PubMed     Abstract available


  374. CHEN H, Chen F, Zhang M, Chen Y, et al
    A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210602. doi: 10.3233/JAD-210602.
    PubMed     Abstract available


  375. KANG SH, Cho H, Shin J, Kim HR, et al
    Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210392. doi: 10.3233/JAD-210392.
    PubMed     Abstract available


  376. GOLZARI-SORKHEH M, Brown C, Weaver DF, Reed M, et al
    The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210660. doi: 10.3233/JAD-210660.
    PubMed     Abstract available


  377. MULAK A
    Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210608. doi: 10.3233/JAD-210608.
    PubMed     Abstract available


  378. SEO SJ, Chang WS, Jeon JG, Choi Y, et al
    Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-beta Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210739. doi: 10.3233/JAD-210739.
    PubMed     Abstract available


  379. BRUGULAT-SERRAT A, Canas A, Canals L, Marne P, et al
    Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210640. doi: 10.3233/JAD-210640.
    PubMed     Abstract available


  380. TARAWNEH HY, Mulders WHAM, Sohrabi HR, Martins RN, et al
    Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210556. doi: 10.3233/JAD-210556.
    PubMed     Abstract available


  381. CIANFLONE A, Coppola L, Mirabelli P, Salvatore M, et al
    Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-beta Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    J Alzheimers Dis. 2021 Sep 17. pii: JAD210496. doi: 10.3233/JAD-210496.
    PubMed     Abstract available


  382. YAMADA Y, Shinkawa K, Kobayashi M, Caggiano V, et al
    Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Sep 16. pii: JAD210684. doi: 10.3233/JAD-210684.
    PubMed     Abstract available


  383. ALLEN HB
    A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology.
    J Alzheimers Dis. 2021 Sep 14. pii: JAD210429. doi: 10.3233/JAD-210429.
    PubMed     Abstract available


  384. KOLINKO Y, Marsalova L, Pena SP, Kralickova M, et al
    Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210738. doi: 10.3233/JAD-210738.
    PubMed     Abstract available


  385. SATO T, Hanyu H, Koyama Y, Horita H, et al
    Discrepancy Between the Degree of Cognitive Impairment and Brain Imaging Abnormalities in Alzheimer's Disease Patients Is Associated with Cognitive Reserve.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210728. doi: 10.3233/JAD-210728.
    PubMed     Abstract available


  386. ABDULKADIR TS, Dawud FA, Isa AS, Ayo JO, et al
    Taurine and Camel Milk Modulate Neurobehavioral and Biochemical Changes in Aluminum Chloride-Induced Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210130. doi: 10.3233/JAD-210130.
    PubMed     Abstract available


  387. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    PubMed     Abstract available


  388. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    PubMed     Abstract available


  389. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    PubMed     Abstract available


  390. ZHANG XQ, Xu L, Yang SY, Hu LB, et al
    Reduced Synaptic and Intrinsic Excitability of a Subtype of Pyramidal Neurons in the Medial Prefrontal Cortex in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 2. pii: JAD210585. doi: 10.3233/JAD-210585.
    PubMed     Abstract available


  391. CALDIERARO MA, Laufer-Silva T, Cassano P
    Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210586. doi: 10.3233/JAD-210586.
    PubMed     Abstract available


  392. HE F, Zhang Y, Wu X, Li Y, et al
    Early Microstructure Changes of White Matter Fiber Bundles in Patients with Amnestic Mild Cognitive Impairment Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210495. doi: 10.3233/JAD-210495.
    PubMed     Abstract available


  393. HADDAD M, Perrotte M, Ben Khedher MR, Madec E, et al
    Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210441. doi: 10.3233/JAD-210441.
    PubMed     Abstract available


    August 2021
  394. FARACE P, Tamburin S
    Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-beta Deposition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD215041. doi: 10.3233/JAD-215041.
    PubMed     Abstract available


  395. KATZOUROU I, Leonenko G, Ivanov D, Meggy A, et al
    Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD210685. doi: 10.3233/JAD-210685.
    PubMed     Abstract available


  396. PIEVANI M, Mega A, Quattrini G, Guidali G, et al
    Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer's Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design.
    J Alzheimers Dis. 2021 Aug 27. pii: JAD210659. doi: 10.3233/JAD-210659.
    PubMed     Abstract available


  397. HANDY A, Lord J, Green R, Xu J, et al
    Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD210462. doi: 10.3233/JAD-210462.
    PubMed     Abstract available


  398. LIU Z, Maiti T, Bender AR
    A Role for Prior Knowledge in Statistical Classification of the Transition from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD201398. doi: 10.3233/JAD-201398.
    PubMed     Abstract available


  399. HAMBLIN MR, Salehpour F
    Photobiomodulation of the Brain: Shining Light on Alzheimer's and Other Neuropathological Diseases.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210743. doi: 10.3233/JAD-210743.
    PubMed    


  400. ZHANG Z, Wang M, Yuan S, Cai H, et al
    Genetically Predicted Coffee Consumption and Risk of Alzheimer's Disease and Stroke.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210678. doi: 10.3233/JAD-210678.
    PubMed     Abstract available


  401. BOMMARITO G, Van De Ville D, Frisoni GB, Garibotto V, et al
    Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210534. doi: 10.3233/JAD-210534.
    PubMed     Abstract available


  402. SYVERSTAD SKAARAAS GHE, Melbye C, Puchades MA, Yi Leung DS, et al
    Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    J Alzheimers Dis. 2021 Aug 21. pii: JAD210571. doi: 10.3233/JAD-210571.
    PubMed     Abstract available


  403. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
    Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
    PubMed     Abstract available


  404. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    PubMed     Abstract available


  405. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    PubMed     Abstract available


  406. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    PubMed     Abstract available


  407. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    PubMed    


  408. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    PubMed     Abstract available


  409. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    PubMed     Abstract available


  410. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    PubMed     Abstract available


  411. WANG H, Xu Y, Ren R, Yao F, et al
    Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
    PubMed     Abstract available


  412. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    PubMed     Abstract available


  413. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    PubMed     Abstract available


  414. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    PubMed     Abstract available


  415. SCARTH M, Rissanen I, Scholten RJPM, Geerlings MI, et al
    Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD210218. doi: 10.3233/JAD-210218.
    PubMed     Abstract available


  416. SCHILD AK, Volk J, Scharfenberg D, Schuermann K, et al
    Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD201126. doi: 10.3233/JAD-201126.
    PubMed     Abstract available


  417. REHAN S, Giroud N, Al-Yawer F, Wittich W, et al
    Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD201521. doi: 10.3233/JAD-201521.
    PubMed     Abstract available


  418. FOTE G, Wu J, Mapstone M, Macciardi F, et al
    Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD200871. doi: 10.3233/JAD-200871.
    PubMed     Abstract available


  419. YU Y, Gao Y, Winblad B, Tjernberg L, et al
    A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD215008. doi: 10.3233/JAD-215008.
    PubMed     Abstract available


  420. PARK M, Baik K, Lee YG, Kang SW, et al
    Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210669. doi: 10.3233/JAD-210669.
    PubMed     Abstract available


  421. PUDUMJEE SB, Lundt ES, Albertson SM, Machulda MM, et al
    A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210251. doi: 10.3233/JAD-210251.
    PubMed     Abstract available


  422. KIM HR, Jang JH, Ham H, Choo SH, et al
    A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210650. doi: 10.3233/JAD-210650.
    PubMed     Abstract available


  423. AGUERO P, Sainz MJ, Tellez R, Lorda I, et al
    De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210420. doi: 10.3233/JAD-210420.
    PubMed     Abstract available


  424. LI Y, Wang R, Li Q, Wang YJ, et al
    Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210381. doi: 10.3233/JAD-210381.
    PubMed     Abstract available


  425. RASMUSSEN ID, Boayue NM, Mittner M, Bystad M, et al
    High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210378. doi: 10.3233/JAD-210378.
    PubMed     Abstract available


  426. TADOKORO K, Yamashita T, Kimura S, Nomura E, et al
    Retinal Amyloid Imaging for Screening Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210327. doi: 10.3233/JAD-210327.
    PubMed     Abstract available


  427. HE H, Liu A, Zhang W, Yang H, et al
    Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210307. doi: 10.3233/JAD-210307.
    PubMed     Abstract available


  428. VAN ZELLER M, Dias DM, Sebastiao AM, Valente CA, et al
    NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210268. doi: 10.3233/JAD-210268.
    PubMed     Abstract available


  429. CAI HY, Yang D, Qiao J, Yang JT, et al
    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210256. doi: 10.3233/JAD-210256.
    PubMed     Abstract available


  430. MUKHOPADHYAY S, Banerjee D
    A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD215065. doi: 10.3233/JAD-215065.
    PubMed     Abstract available


  431. NOUS A, Wittens MMJ, Vermeiren Y, De Deyn PP, et al
    Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210562. doi: 10.3233/JAD-210562.
    PubMed     Abstract available


  432. VAN DE MORTEL LA, Thomas RM, van Wingen GA
    Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210173. doi: 10.3233/JAD-210173.
    PubMed     Abstract available


  433. CARCAMO J, Kociolek AJ, Fernandez KK, Gu Y, et al
    Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210019. doi: 10.3233/JAD-210019.
    PubMed     Abstract available


    July 2021
  434. QIN W, Li W, Wang Q, Gong M, et al
    Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210549. doi: 10.3233/JAD-210549.
    PubMed     Abstract available


  435. WATSON Y, Nelson B, Kluesner JH, Tanzy C, et al
    Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210492. doi: 10.3233/JAD-210492.
    PubMed     Abstract available


  436. LIU P, Yang Q, Yu N, Cao Y, et al
    Phenylalanine Metabolism is Dysregulated in Human Hippocampus with Alzheimer's Disease Related Pathological Changes.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210461. doi: 10.3233/JAD-210461.
    PubMed     Abstract available


  437. WITTENS MMJ, Sima DM, Houbrechts R, Ribbens A, et al
    Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210450. doi: 10.3233/JAD-210450.
    PubMed     Abstract available


  438. LUCKEY AM, Robertson IH, Lawlor B, Mohan A, et al
    Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer's Disease in Females.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210404. doi: 10.3233/JAD-210404.
    PubMed     Abstract available


  439. WALDEN LM, Hu S, Madabhushi A, Prescott JW, et al
    Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210308. doi: 10.3233/JAD-210308.
    PubMed     Abstract available


  440. HLAVKA JP, Kinoshita AT, Fang S, Hunt A, et al
    Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210060. doi: 10.3233/JAD-210060.
    PubMed     Abstract available


  441. SMAILOVIC U, Kareholt I, Koenig T, Ashton NJ, et al
    Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 25. pii: JAD201234. doi: 10.3233/JAD-201234.
    PubMed     Abstract available


  442. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    PubMed     Abstract available


  443. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    PubMed     Abstract available


  444. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    PubMed     Abstract available


  445. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    PubMed     Abstract available


  446. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    PubMed    


  447. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    PubMed     Abstract available


  448. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    PubMed     Abstract available


  449. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    PubMed     Abstract available


  450. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    PubMed     Abstract available


  451. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    PubMed     Abstract available


  452. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    PubMed     Abstract available


  453. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    PubMed     Abstract available


    June 2021
  454. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    PubMed     Abstract available


  455. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    PubMed     Abstract available


  456. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    PubMed     Abstract available


  457. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    PubMed     Abstract available


  458. YAO W, Chen H, Sheng X, Zhao H, et al
    Core-Centered Connection Abnormalities Associated with Pathological Features Mediate the Progress of Cognitive Impairments in Alzheimer's Disease Spectrum Patients.
    J Alzheimers Dis. 2021 Jun 22. pii: JAD210481. doi: 10.3233/JAD-210481.
    PubMed     Abstract available


  459. CHAUDHARY S, Ashok A, McDonald D, Wise AS, et al
    Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2021 Jun 19. pii: JAD210221. doi: 10.3233/JAD-210221.
    PubMed     Abstract available


  460. KANG S, Gim J, Lee J, Gunasekaran TI, et al
    Potential Novel Genes for Late-Onset Alzheimer's Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study.
    J Alzheimers Dis. 2021 Jun 18. pii: JAD210145. doi: 10.3233/JAD-210145.
    PubMed     Abstract available


  461. XU LZ, Li FY, Li BQ, Cao SM, et al
    Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210516. doi: 10.3233/JAD-210516.
    PubMed     Abstract available


  462. MITOLO M, Stanzani-Maserati M, Manners DN, Capellari S, et al
    The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210211. doi: 10.3233/JAD-210211.
    PubMed     Abstract available


  463. TARGUM SD, Fosdick L, Drake KE, Rosenberg PB, et al
    Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210530. doi: 10.3233/JAD-210530.
    PubMed     Abstract available


  464. BAHAR B, Kanagasingam S, Tambuwala MM, Aljabali AAA, et al
    Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210465. doi: 10.3233/JAD-210465.
    PubMed     Abstract available


  465. FRANCOIS M, Karpe A, Liu JW, Beale D, et al
    Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210283. doi: 10.3233/JAD-210283.
    PubMed     Abstract available


  466. AKUSHEVICH I, Yashkin AP, Kravchenko J, Yashin AI, et al
    Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210273. doi: 10.3233/JAD-210273.
    PubMed     Abstract available


  467. PAULO SL, Ribeiro-Rodrigues L, Rodrigues RS, Mateus JM, et al
    Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201567. doi: 10.3233/JAD-201567.
    PubMed     Abstract available


  468. FERNANDEZ G, Parra MA
    Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201189. doi: 10.3233/JAD-201189.
    PubMed     Abstract available


  469. ESPAY AJ, Sturchio A, Schneider LS, Ezzat K, et al
    Soluble Amyloid-beta Consumption in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210415. doi: 10.3233/JAD-210415.
    PubMed     Abstract available


  470. QU M, Shi H, Wang K, Wang X, et al
    The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210384. doi: 10.3233/JAD-210384.
    PubMed     Abstract available


  471. LOURENCO MV, Ribeiro FC, Santos LE, Beckman D, et al
    Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210147. doi: 10.3233/JAD-210147.
    PubMed     Abstract available


  472. WANG ZT, Li KY, Tan CC, Xu W, et al
    Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210140. doi: 10.3233/JAD-210140.
    PubMed     Abstract available


  473. BABILONI C, Ferri R, Noce G, Lizio R, et al
    Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD201271. doi: 10.3233/JAD-201271.
    PubMed     Abstract available


  474. CASTILLO-MENDIETA T, Arana-Lechuga Y, Campos-Pena V, Sosa AL, et al
    Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 11. pii: JAD200912. doi: 10.3233/JAD-200912.
    PubMed     Abstract available


  475. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    PubMed     Abstract available


  476. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    PubMed     Abstract available


  477. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    PubMed     Abstract available


  478. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    PubMed     Abstract available


  479. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    PubMed     Abstract available


  480. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    PubMed     Abstract available


  481. VECCHIO F, Miraglia F, Alu F, Orticoni A, et al
    Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease versus Vascular Dementia Diagnosis.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210394. doi: 10.3233/JAD-210394.
    PubMed     Abstract available


  482. SCHOEMAKER D, Velilla L, Zuluaga Y, Baena A, et al
    Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210313. doi: 10.3233/JAD-210313.
    PubMed     Abstract available


  483. ZHAO X, Li C, Ding G, Heng Y, et al
    The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210225. doi: 10.3233/JAD-210225.
    PubMed     Abstract available


  484. SPERA V, Sitnikova T, Ward MJ, Farzam P, et al
    Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210058. doi: 10.3233/JAD-210058.
    PubMed     Abstract available


  485. BEN AYED I, Castor-Guyonvarch N, Amimour S, Naija S, et al
    Acute Exercise and Cognitive Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201317. doi: 10.3233/JAD-201317.
    PubMed     Abstract available


  486. GRECO FA, McKee AC, Kowall NW, Hanlon EB, et al
    Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201021. doi: 10.3233/JAD-201021.
    PubMed     Abstract available


    May 2021
  487. JIN N, Babiloni C, Drinkenburg WH, Hajos M, et al
    Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models.
    J Alzheimers Dis. 2021 May 29. pii: JAD210209. doi: 10.3233/JAD-210209.
    PubMed     Abstract available


  488. DELAZER M, Zamarian L, Djamshidian A
    Handwriting in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 28. pii: JAD210279. doi: 10.3233/JAD-210279.
    PubMed     Abstract available


  489. JEONG W, Joo JH, Kim H, Kim YK, et al
    Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD201319. doi: 10.3233/JAD-201319.
    PubMed     Abstract available


  490. BABIC LEKO M, Jurasovic J, Nikolac Perkovic M, Spanic E, et al
    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD210158. doi: 10.3233/JAD-210158.
    PubMed     Abstract available


  491. WEI W, Liu Y, Dai C, Baazaoui N, et al
    Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
    J Alzheimers Dis. 2021 May 27. pii: JAD201599. doi: 10.3233/JAD-201599.
    PubMed     Abstract available


  492. THOMSEN BB, Madsen C, Krohn KT, Thygesen C, et al
    Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 26. pii: JAD210040. doi: 10.3233/JAD-210040.
    PubMed     Abstract available


  493. KING-ROBSON J, Wilson H, Politis M
    Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 May 22. pii: JAD201457. doi: 10.3233/JAD-201457.
    PubMed     Abstract available


  494. BARRIO JR, Whitehouse P, Alavi A, Hoilund-Carlsen PF, et al
    New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 May 20. pii: JAD210383. doi: 10.3233/JAD-210383.
    PubMed    


  495. LI X, Tian Y, Yang YX, Ma YH, et al
    Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 May 20. pii: JAD210345. doi: 10.3233/JAD-210345.
    PubMed     Abstract available


  496. LAURIOLA M, D'Onofrio G, Ciccone F, Germano C, et al
    Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    J Alzheimers Dis. 2021 May 20. pii: JAD210166. doi: 10.3233/JAD-210166.
    PubMed     Abstract available


  497. YANG H, Luo Y, Hu Q, Tian X, et al
    Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation.
    J Alzheimers Dis. 2021 May 20. pii: JAD201554. doi: 10.3233/JAD-201554.
    PubMed     Abstract available


  498. BARTHELSON K, Dong Y, Newman M, Lardelli M, et al
    PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction.
    J Alzheimers Dis. 2021 May 19. pii: JAD210128. doi: 10.3233/JAD-210128.
    PubMed     Abstract available


  499. HAN H, Wang F, Chen J, Li X, et al
    Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 19. pii: JAD210021. doi: 10.3233/JAD-210021.
    PubMed     Abstract available



  500. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 May 18. pii: JAD219004. doi: 10.3233/JAD-219004.
    PubMed    


  501. FERNANDEZ-AGUILAR L, Lora Y, Satorres E, Ros L, et al
    Dimensional and Discrete Emotional Reactivity in Alzheimer's Disease: Film Clips as a Research Tool in Dementia.
    J Alzheimers Dis. 2021 May 18. pii: JAD210233. doi: 10.3233/JAD-210233.
    PubMed     Abstract available


  502. RODRIGO-HERRERO S, Luque-Tirado A, Mendez-Barrio C, Garcia-Solis D, et al
    TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    J Alzheimers Dis. 2021 May 18. pii: JAD210115. doi: 10.3233/JAD-210115.
    PubMed     Abstract available


  503. PISTONO A, Senoussi M, Guerrier L, Rafiq M, et al
    Language Network Connectivity Increases in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201584. doi: 10.3233/JAD-201584.
    PubMed     Abstract available


  504. BERNSTEIN AS, Rapcsak SZ, Hornberger M, Saranathan M, et al
    Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201583. doi: 10.3233/JAD-201583.
    PubMed     Abstract available


  505. MAO C, Sha L, Li J, Huang X, et al
    Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    J Alzheimers Dis. 2021 May 16. pii: JAD210344. doi: 10.3233/JAD-210344.
    PubMed     Abstract available


  506. DUAN W, Zhou GD, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    J Alzheimers Dis. 2021 May 16. pii: JAD210199. doi: 10.3233/JAD-210199.
    PubMed     Abstract available


  507. JIMENEZ EC, Sierra-Marcos A, Romeo A, Hashemi A, et al
    Altered Vergence Eye Movements and Pupil Response of Patients with Alzheimer's Disease and Mild Cognitive Impairment During an Oddball Task.
    J Alzheimers Dis. 2021 May 16. pii: JAD201301. doi: 10.3233/JAD-201301.
    PubMed     Abstract available


  508. ALVES SS, Silva-Junior RMPD, Servilha-Menezes G, Homolak J, et al
    Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    J Alzheimers Dis. 2021 May 15. pii: JAD210234. doi: 10.3233/JAD-210234.
    PubMed     Abstract available


  509. YIN X, Xie Q, Huang L, Liu L, et al
    Assessment of the Psychological Burden Among Family Caregivers of People Living with Alzheimer's Disease Using the Zarit Burden Interview.
    J Alzheimers Dis. 2021 May 15. pii: JAD210025. doi: 10.3233/JAD-210025.
    PubMed     Abstract available


  510. DU F, Yu Q, Yan SS
    PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2021 May 14. pii: JAD210095. doi: 10.3233/JAD-210095.
    PubMed     Abstract available


  511. YE F, Wu A
    The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210132. doi: 10.3233/JAD-210132.
    PubMed     Abstract available


  512. MASSETT HA, Mitchell AK, Alley L, Simoneau E, et al
    Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    J Alzheimers Dis. 2021 May 11. pii: JAD201463. doi: 10.3233/JAD-201463.
    PubMed     Abstract available


  513. OU GY, Lin WW, Zhao WJ
    Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210068. doi: 10.3233/JAD-210068.
    PubMed     Abstract available


  514. CAMARGO A, Wang Z
    Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    J Alzheimers Dis. 2021 May 5. pii: JAD210116. doi: 10.3233/JAD-210116.
    PubMed     Abstract available


  515. DU Y, Dennis B, Liu J, Meyer K, et al
    A Conceptual Model to Improve Care for Individuals with Alzheimer's Disease and Related Dementias and Their Caregivers: Qualitative Findings in an Online Caregiver Forum.
    J Alzheimers Dis. 2021 May 3. pii: JAD210167. doi: 10.3233/JAD-210167.
    PubMed     Abstract available


  516. HANNESTAD J, Duclos T, Chao W, Koborsi K, et al
    Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
    PubMed     Abstract available


    April 2021
  517. SERPENTE M, Fenoglio C, Arighi A, Fumagalli GG, et al
    Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210249. doi: 10.3233/JAD-210249.
    PubMed     Abstract available


  518. SOMAA F
    A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210157. doi: 10.3233/JAD-210157.
    PubMed     Abstract available


  519. SMIRNI D, Oliveri M, Misuraca E, Catania A, et al
    Verbal Fluency in Mild Alzheimer's Disease: Transcranial Direct Current Stimulation over the Dorsolateral Prefrontal Cortex.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210003. doi: 10.3233/JAD-210003.
    PubMed     Abstract available


  520. DE LA FUENTE M
    The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201587. doi: 10.3233/JAD-201587.
    PubMed     Abstract available


  521. BERTRAND E, van Duinkerken E, Laks J, Dourado MCN, et al
    Structural Gray and White Matter Correlates of Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201246. doi: 10.3233/JAD-201246.
    PubMed     Abstract available


  522. DE OLIVEIRA FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, et al
    Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210272. doi: 10.3233/JAD-210272.
    PubMed     Abstract available


  523. PLACIDO J, Ferreira JV, Araujo J, de Oliveira Silva F, et al
    Beyond the Mini-Mental State Examination: The Use of Physical and Spatial Navigation Tests to Help to Screen for Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210106. doi: 10.3233/JAD-210106.
    PubMed     Abstract available


  524. GUZMAN-MARTINEZ L, Farias GA, Tapia JP, Sanchez MP, et al
    Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10(R) in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201501. doi: 10.3233/JAD-201501.
    PubMed     Abstract available


  525. ZUPANIC E, von Euler M, Winblad B, Xu H, et al
    Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201459. doi: 10.3233/JAD-201459.
    PubMed     Abstract available


  526. LIN Y, Zeng Q, Hu M, Peng G, et al
    Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201244. doi: 10.3233/JAD-201244.
    PubMed     Abstract available


  527. XU L, Li T, Xiong L, Wang X, et al
    Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD210098. doi: 10.3233/JAD-210098.
    PubMed     Abstract available


  528. REN D, Lopez OL, Lingler JH, Conley Y, et al
    Association Between the APOEvarepsilon2/varepsilon4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD201613. doi: 10.3233/JAD-201613.
    PubMed     Abstract available


  529. HAJ ME, Moustafa AA, Gallouj K
    Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD210190. doi: 10.3233/JAD-210190.
    PubMed     Abstract available


  530. NERG O, Junkkari A, Hallikainen I, Rauramaa T, et al
    The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD201363. doi: 10.3233/JAD-201363.
    PubMed     Abstract available


  531. SZEGECZKI V, Perenyi H, Horvath G, Hinnah B, et al
    Physical Training Inhibits the Fibrosis Formation in Alzheimer's Disease Kidney Influencing the TGFbeta Signaling Pathways.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD201206. doi: 10.3233/JAD-201206.
    PubMed     Abstract available


  532. GOTTESMAN RT, Kociolek A, Fernandez K, Cosentino S, et al
    Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD200729. doi: 10.3233/JAD-200729.
    PubMed     Abstract available



  533. Erratum Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD219318. doi: 10.3233/JAD-219318.
    PubMed    


  534. FELDMAN R
    Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210294. doi: 10.3233/JAD-210294.
    PubMed     Abstract available


  535. LI J, Bur AM, Villwock MR, Shankar S, et al
    Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210175. doi: 10.3233/JAD-210175.
    PubMed     Abstract available


  536. NORINS LC
    Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210080. doi: 10.3233/JAD-210080.
    PubMed     Abstract available


  537. SAKURAI K, Kaneda D, Inui S, Uchida Y, et al
    Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer's Disease and Other Limbic Tauopathies.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210043. doi: 10.3233/JAD-210043.
    PubMed     Abstract available


  538. MULLER L, Kirschstein T, Kohling R, Kuhla A, et al
    Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201540. doi: 10.3233/JAD-201540.
    PubMed     Abstract available


  539. BEUCKMANN CT, Suzuki H, Musiek ES, Ueno T, et al
    Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201054. doi: 10.3233/JAD-201054.
    PubMed     Abstract available


  540. EEZA MNH, Singer R, Hofling C, Matysik J, et al
    Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201575. doi: 10.3233/JAD-201575.
    PubMed     Abstract available


  541. HALMINEN O, Vesikansa A, Mehtala J, Horhammer I, et al
    Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201502. doi: 10.3233/JAD-201502.
    PubMed     Abstract available


  542. TSAMOU M, Pistollato F, Roggen EL
    A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201418. doi: 10.3233/JAD-201418.
    PubMed     Abstract available


  543. HASHIMOTO M, Ho G, Sugama S, Takenouchi T, et al
    Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD210206. doi: 10.3233/JAD-210206.
    PubMed     Abstract available


  544. MARRA C, Piccininni C, Iacobucci GM, Caprara A, et al
    Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD201452. doi: 10.3233/JAD-201452.
    PubMed     Abstract available


  545. O'BRYANT S, Zhang F, Petersen M, Johnson L, et al
    A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201610. doi: 10.3233/JAD-201610.
    PubMed     Abstract available


  546. BOSTROM G, Freyhult E, Virhammar J, Alcolea D, et al
    Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201565. doi: 10.3233/JAD-201565.
    PubMed     Abstract available


  547. ZHOU Y, Wang Y, Quan M, Zhao H, et al
    Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201497. doi: 10.3233/JAD-201497.
    PubMed     Abstract available


  548. ZHENG YM, Zhao YY, Zhang T, Hou XH, et al
    Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201222. doi: 10.3233/JAD-201222.
    PubMed     Abstract available


  549. AITKEN WW, Lombard J, Wang K, Toro M, et al
    Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201179. doi: 10.3233/JAD-201179.
    PubMed     Abstract available


    March 2021
  550. QIU H, Zhao R, Fei G, Pan X, et al
    Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD210213. doi: 10.3233/JAD-210213.
    PubMed     Abstract available


  551. PILLAI JA, Bena J, Bekris LM, Foldvary-Schaefer N, et al
    Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201573. doi: 10.3233/JAD-201573.
    PubMed     Abstract available


  552. LI LL, Ma YH, Bi YL, Sun FR, et al
    Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201192. doi: 10.3233/JAD-201192.
    PubMed     Abstract available


  553. FENG LIU Q, Kanmani S, Lee J, Kim GW, et al
    Neoline Improves Memory Impairment and Reduces Amyloid-beta Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Mar 26. pii: JAD201614. doi: 10.3233/JAD-201614.
    PubMed     Abstract available


  554. TEITSDOTTIR UD, Halldorsson S, Rolfsson O, Lund SH, et al
    Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    J Alzheimers Dis. 2021 Mar 25. pii: JAD200964. doi: 10.3233/JAD-200964.
    PubMed     Abstract available


  555. IKEDA S, Mimura M, Ikeda M, Wada-Isoe K, et al
    Economic Burden of Alzheimer's Disease Dementia in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD210075. doi: 10.3233/JAD-210075.
    PubMed     Abstract available


  556. MORRIS R, Luboff H, Jose RP, Eckhoff K, et al
    Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201551. doi: 10.3233/JAD-201551.
    PubMed     Abstract available


  557. DOUROS A, Santella C, Dell'Aniello S, Azoulay L, et al
    Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201534. doi: 10.3233/JAD-201534.
    PubMed     Abstract available


  558. ASHIZAWA T, Igarashi A, Sakata Y, Azuma M, et al
    Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201514. doi: 10.3233/JAD-201514.
    PubMed     Abstract available


  559. KLEIMAN MJ, Barenholtz E, Galvin JE
    Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201377. doi: 10.3233/JAD-201377.
    PubMed     Abstract available


  560. WONG D, Broberg DN, Doad J, Umoh JU, et al
    Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    J Alzheimers Dis. 2021 Mar 22. pii: JAD201137. doi: 10.3233/JAD-201137.
    PubMed     Abstract available


  561. ASTROM DO, Adolfsson R, Segersson D, Forsberg B, et al
    Local Contrasts in Concentration of Ambient Particulate Air Pollution (PM2.5) and Incidence of Alzheimer's Disease and Dementia: Results from the Betula Cohort in Northern Sweden.
    J Alzheimers Dis. 2021 Mar 18. pii: JAD201538. doi: 10.3233/JAD-201538.
    PubMed     Abstract available



  562. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD219002. doi: 10.3233/JAD-219002.
    PubMed    


  563. NI R, Rojdner J, Voytenko L, Dyrks T, et al
    In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201344. doi: 10.3233/JAD-201344.
    PubMed     Abstract available


  564. FONSECA LM, Mattar GP, Haddad GG, Ekaterina B, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201009. doi: 10.3233/JAD-201009.
    PubMed     Abstract available


  565. GAUDREAULT R, Herve V, van de Ven TGM, Mousseau N, et al
    Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201549. doi: 10.3233/JAD-201549.
    PubMed     Abstract available


  566. MA YH, Wang YY, Tan L, Xu W, et al
    Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201426. doi: 10.3233/JAD-201426.
    PubMed     Abstract available


  567. ARAYA J, Bello F, Shivashankar G, Neira D, et al
    Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201195. doi: 10.3233/JAD-201195.
    PubMed     Abstract available


  568. YANG J, Jia L, Li Y, Qiu Q, et al
    Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201068. doi: 10.3233/JAD-201068.
    PubMed     Abstract available


  569. MIRANDA A, Montiel E, Ulrich H, Paz C, et al
    Selective Secretase Targeting for Alzheimer's Disease Therapy.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201027. doi: 10.3233/JAD-201027.
    PubMed     Abstract available


  570. DIAS IHK, Griffiths HR
    Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210121. doi: 10.3233/JAD-210121.
    PubMed     Abstract available


  571. TONG Q, Chen L
    Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210114. doi: 10.3233/JAD-210114.
    PubMed     Abstract available


  572. VALOTASSIOU V, Sifakis N, Tzavara C, Lykou E, et al
    Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD201434. doi: 10.3233/JAD-201434.
    PubMed     Abstract available


  573. DRAKE JD, Chambers AB, Ott BR, Daiello LA, et al
    Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD200759. doi: 10.3233/JAD-200759.
    PubMed     Abstract available


  574. TASLIMA F, Jung CG, Zhou C, Abdelhamid M, et al
    Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD201055. doi: 10.3233/JAD-201055.
    PubMed     Abstract available


  575. GUPTA HV, Beach TG, Mehta SH, Shill HA, et al
    Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD200323. doi: 10.3233/JAD-200323.
    PubMed     Abstract available


  576. MOUSSAVI NIK SH, Porter T, Newman M, Bartlett B, et al
    Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Mar 7. pii: JAD201133. doi: 10.3233/JAD-201133.
    PubMed     Abstract available


  577. ELVERMAN KH, Paitel ER, Figueroa CM, McKindles RJ, et al
    Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201559. doi: 10.3233/JAD-201559.
    PubMed     Abstract available


  578. PEREZ-VALERO E, Lopez-Gordo MA, Morillas C, Pelayo F, et al
    A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201455. doi: 10.3233/JAD-201455.
    PubMed     Abstract available


  579. JOUINI N, Saied Z, Ben Sassi S, Nebli F, et al
    Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201250. doi: 10.3233/JAD-201250.
    PubMed     Abstract available


  580. DODICH A, Crespi C, Chiara Santi G, Luzzi S, et al
    Diagnostic Accuracy of Affective Social Tasks in the Clinical Classification Between the Behavioral Variant of Frontotemporal Dementia and Other Neurodegenerative Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201210. doi: 10.3233/JAD-201210.
    PubMed     Abstract available


  581. WHITE B, Lyketsos CG, Rosenberg PB, Oh ES, et al
    Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201415. doi: 10.3233/JAD-201415.
    PubMed     Abstract available


  582. VINUELA F, Barro A
    Assessment of a Potential Synergistic Effect of Souvenaid (R) in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201357. doi: 10.3233/JAD-201357.
    PubMed     Abstract available


  583. ZHANG B, Lin L, Wu S
    A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD201274. doi: 10.3233/JAD-201274.
    PubMed     Abstract available


  584. DEVOUS MD, Fleisher AS, Pontecorvo MJ, Lu M, et al
    Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD200808. doi: 10.3233/JAD-200808.
    PubMed     Abstract available


    February 2021
  585. AN N, Fu Y, Shi J, Guo HN, et al
    Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala.
    J Alzheimers Dis. 2021 Feb 26. pii: JAD201162. doi: 10.3233/JAD-201162.
    PubMed     Abstract available


  586. HINTEREGGER B, Loeffler T, Flunkert S, Neddens J, et al
    Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201204. doi: 10.3233/JAD-201204.
    PubMed     Abstract available


  587. RYMAN SG, Yutsis M, Tian L, Henderson VW, et al
    Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201187. doi: 10.3233/JAD-201187.
    PubMed     Abstract available


  588. LOPIS D, Pape TL, Manetta C, Conty L, et al
    Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200841. doi: 10.3233/JAD-200841.
    PubMed     Abstract available


  589. KIM S, Kim K, Nho K, Myung W, et al
    Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200671. doi: 10.3233/JAD-200671.
    PubMed     Abstract available


  590. LIU X, Chen X, Zhou X, Shang Y, et al
    Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2021 Feb 24. pii: JAD200936. doi: 10.3233/JAD-200936.
    PubMed     Abstract available


  591. MERIGHI S, Battistello E, Casetta I, Gragnaniello D, et al
    Upregulation of Cortical A2A Adenosine Receptors is Reflected in Platelets of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD201437. doi: 10.3233/JAD-201437.
    PubMed     Abstract available


  592. CUTTLER JM, Abdellah E, Goldberg Y, Al-Shamaa S, et al
    Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD200620. doi: 10.3233/JAD-200620.
    PubMed     Abstract available


  593. MONLLOR P, Giraldo E, Badia MC, de la Asuncion JG, et al
    Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201443. doi: 10.3233/JAD-201443.
    PubMed     Abstract available


  594. NAGARAJ S, Duong TQ
    Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201438. doi: 10.3233/JAD-201438.
    PubMed     Abstract available


  595. KLEIN J, Yan X, Johnson A, Tomljanovic Z, et al
    Olfactory Impairment is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201149. doi: 10.3233/JAD-201149.
    PubMed     Abstract available


  596. CHUNG M, Chung WK
    Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD210042. doi: 10.3233/JAD-210042.
    PubMed     Abstract available


  597. CIERI F, Yang Z, Cordes D, Jessica Caldwell ZK, et al
    Sex Differences of Brain Functional Topography Revealed in Normal Aging and Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201596. doi: 10.3233/JAD-201596.
    PubMed     Abstract available


  598. JIN H, Wang R
    Alzheimer-Associated Neuronal Thread Protein: Research Course and Prospects for the Future.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201273. doi: 10.3233/JAD-201273.
    PubMed     Abstract available


  599. LEYTON E, Matus D, Espinoza S, Benitez JM, et al
    DEF8 and Autophagy-Associated Genes are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients and a Transgenic Model of the Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201264. doi: 10.3233/JAD-201264.
    PubMed     Abstract available


  600. ZHANG G, Zhang Y, Shen Y, Wang Y, et al
    The Potential Role of Ferroptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201369. doi: 10.3233/JAD-201369.
    PubMed     Abstract available


  601. KHODADADI H, Lopes Salles E, Jarrahi A, Costigliola V, et al
    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD210026. doi: 10.3233/JAD-210026.
    PubMed     Abstract available


  602. WANG YY, Huang ZT, Yuan MH, Jing F, et al
    Role of Hypoxia Inducible Factor-1alpha in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201448. doi: 10.3233/JAD-201448.
    PubMed     Abstract available


  603. INDOREWALLA KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, et al
    Modifiable Barriers for Recruitment and Retention of Oldeult Participants from Underrepresented Minorities in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201081. doi: 10.3233/JAD-201081.
    PubMed     Abstract available


  604. SHOUP TM, Griciuc A, Normandin MD, Quinti L, et al
    Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201419. doi: 10.3233/JAD-201419.
    PubMed     Abstract available


  605. WANG YZ, Meng L, Zhuang QS, Shen L, et al
    Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201336. doi: 10.3233/JAD-201336.
    PubMed     Abstract available


  606. LLADO A, Froelich L, Khandker RK, Roset M, et al
    Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201172. doi: 10.3233/JAD-201172.
    PubMed     Abstract available


  607. SOOD A, Pavlik V, Darby E, Chan W, et al
    Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201124. doi: 10.3233/JAD-201124.
    PubMed     Abstract available


  608. LIBARD S, Walter J, Alafuzoff I
    In vivo Characterization of Biochemical Variants of Amyloid-beta in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201469. doi: 10.3233/JAD-201469.
    PubMed     Abstract available


  609. MA D, Yee E, Stocks JK, Jenkins LM, et al
    Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201591. doi: 10.3233/JAD-201591.
    PubMed     Abstract available


  610. DANIELE S, Baldacci F, Piccarducci R, Palermo G, et al
    alpha-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201038. doi: 10.3233/JAD-201038.
    PubMed     Abstract available


  611. SHEN LX, Yang YX, Kuo K, Li HQ, et al
    Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201442. doi: 10.3233/JAD-201442.
    PubMed     Abstract available


  612. FUTAMURA A, Hieda S, Mori Y, Kasuga K, et al
    Toxic Amyloid-beta42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201407. doi: 10.3233/JAD-201407.
    PubMed     Abstract available


  613. WANG J, Guo X, Lu W, Liu J, et al
    Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201381. doi: 10.3233/JAD-201381.
    PubMed     Abstract available


  614. YAO W, Chen H, Luo C, Sheng X, et al
    Hyperconnectivity of Self-Referential Network as a Predictive Biomarker of the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201376. doi: 10.3233/JAD-201376.
    PubMed     Abstract available


  615. YU E, Liao Z, Fan W, Hu W, et al
    The Economic Burden of Alzheimer's Disease in Zhejiang Province.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201285. doi: 10.3233/JAD-201285.
    PubMed     Abstract available


  616. ROSTAMZADEH A, Schwegler C, Gil-Navarro S, Rosende-Roca M, et al
    Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Study Protocol of the PreDADQoL Project.
    J Alzheimers Dis. 2021 Feb 4. pii: JAD200484. doi: 10.3233/JAD-200484.
    PubMed     Abstract available


  617. CHALKIAS E, Topouzis F, Tegos T, Tsolaki M, et al
    The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201516. doi: 10.3233/JAD-201516.
    PubMed     Abstract available


  618. KHALSA DS, Newberg A
    Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201433. doi: 10.3233/JAD-201433.
    PubMed     Abstract available


  619. RIPHAGEN JM, Van Egroo M, Jacobs HIL
    Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201411. doi: 10.3233/JAD-201411.
    PubMed     Abstract available


  620. KHATAMI SG, Domingo-Fernandez D, Mubeen S, Hoyt CT, et al
    A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201397. doi: 10.3233/JAD-201397.
    PubMed     Abstract available


  621. PIUBELLI L, Murtas G, Rabattoni V, Pollegioni L, et al
    The Role of D-Amino Acids in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201217. doi: 10.3233/JAD-201217.
    PubMed     Abstract available


    January 2021
  622. RIGBY T, Johnson DK, Taylor A, Galvin JE, et al
    Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201326. doi: 10.3233/JAD-201326.
    PubMed     Abstract available


  623. LI M, Li R, Lyu JH, Chen JH, et al
    Relationship Between Alzheimer's Disease and Retinal Choroidal Thickness: A Cross-Sectional Study.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201142. doi: 10.3233/JAD-201142.
    PubMed     Abstract available


  624. CHUANG YC, Chiu MJ, Chen TF, Chang YL, et al
    An Exploration of the Own-Age Effect on Facial Emotion Recognition in Normal Elderly People and Individuals with the Preclinical and Demented Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 27. pii: JAD200916. doi: 10.3233/JAD-200916.
    PubMed     Abstract available


  625. YU F, Vock DM, Zhang L, Salisbury D, et al
    Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201100. doi: 10.3233/JAD-201100.
    PubMed     Abstract available


  626. GUO M, Peng J, Huang X, Xiao L, et al
    Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201040. doi: 10.3233/JAD-201040.
    PubMed     Abstract available


  627. MACEDO A, Gomez C, Rebelo MA, Poza J, et al
    Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD200963. doi: 10.3233/JAD-200963.
    PubMed     Abstract available


  628. LLANO DA, Devanarayan V
    Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201420. doi: 10.3233/JAD-201420.
    PubMed     Abstract available


  629. ZHUANG QS, Meng L, Wang Z, Shen L, et al
    Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201235. doi: 10.3233/JAD-201235.
    PubMed     Abstract available


  630. JORGE L, Martins R, Canario N, Xavier C, et al
    Investigating the Spatial Associations Between Amyloid-beta Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD200840. doi: 10.3233/JAD-200840.
    PubMed     Abstract available


  631. CHEN F, Zhang Y, Wang L, Wang T, et al
    PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer's Disease and Multiple Sclerosis.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201140. doi: 10.3233/JAD-201140.
    PubMed     Abstract available


  632. GUZMAN-MARTINEZ L, Calfio C, Farias GA, Vilches C, et al
    New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201059. doi: 10.3233/JAD-201059.
    PubMed     Abstract available


  633. CUERVO-ZANATTA D, Garcia-Mena J, Perez-Cruz C
    Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD201367. doi: 10.3233/JAD-201367.
    PubMed     Abstract available


  634. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD200946. doi: 10.3233/JAD-200946.
    PubMed     Abstract available


  635. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 18. pii: JAD201254. doi: 10.3233/JAD-201254.
    PubMed     Abstract available


  636. MEHDER RH, Bennett BM, Andrew RD
    Age-Related Neuronal Deterioration Specifically Within the Dorsal CA1 Region of the Hippocampus in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201024. doi: 10.3233/JAD-201024.
    PubMed     Abstract available


  637. HAYASHI T, Shimonaka S, Elahi M, Matsumoto SE, et al
    Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer's Disease Brain Extract in Mouse Brains.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201002. doi: 10.3233/JAD-201002.
    PubMed     Abstract available


  638. LEHINGUE E, Gueniat J, Jourdaa S, Hardouin JB, et al
    Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201088. doi: 10.3233/JAD-201088.
    PubMed     Abstract available


  639. QIAN X, Zhang S, Duan L, Yang F, et al
    Periodontitis Deteriorates Cognitive Function and Impairs Neurons and Glia in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201007. doi: 10.3233/JAD-201007.
    PubMed     Abstract available


  640. SHAFFER RM, Li G, Adar SD, Dirk Keene C, et al
    Fine Particulate Matter and Markers of Alzheimer's Disease Neuropathology at Autopsy in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201005. doi: 10.3233/JAD-201005.
    PubMed     Abstract available


  641. LAO K, Zhang R, Luan J, Zhang Y, et al
    Therapeutic Strategies Targeting Amyloid-beta Receptors and Transporters in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD200851. doi: 10.3233/JAD-200851.
    PubMed     Abstract available


  642. LY M, Raji CA, Yu GZ, Wang Q, et al
    Obesity and White Matter Neuroinflammation Related Edema in Alzheimer Disease Dementia Biomarker Negative Cognitively Normal Individuals.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201242. doi: 10.3233/JAD-201242.
    PubMed     Abstract available


  643. LOEFFLER DA
    Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201182. doi: 10.3233/JAD-201182.
    PubMed     Abstract available


  644. MERCERON-MARTINEZ D, Ibaceta-Gonzalez C, Salazar C, Almaguer-Melian W, et al
    Alzheimer's Disease, Neural Plasticity, and Functional Recovery.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201178. doi: 10.3233/JAD-201178.
    PubMed     Abstract available


  645. FERINI-STRAMBI L, Hensley M, Salsone M
    Decoding Causal Links Between Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201066. doi: 10.3233/JAD-201066.
    PubMed     Abstract available


  646. CHEN YS, Shu K, Kang HC
    Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201141. doi: 10.3233/JAD-201141.
    PubMed     Abstract available


  647. PRAKASH M, Abdelaziz M, Zhang L, Strange BA, et al
    Quantitative Longitudinal Predictions of Alzheimer's Disease by Multi-Modal Predictive Learning.
    J Alzheimers Dis. 2021 Jan 12. pii: JAD200906. doi: 10.3233/JAD-200906.
    PubMed     Abstract available


  648. BARIL AA, Beiser AS, Redline S, McGrath ER, et al
    Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD200545. doi: 10.3233/JAD-200545.
    PubMed     Abstract available


  649. MAI Y, Yu Q, Zhu F, Luo Y, et al
    AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201033. doi: 10.3233/JAD-201033.
    PubMed     Abstract available


  650. DELIC V, Ratliff WA, Citron BA
    Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201378. doi: 10.3233/JAD-201378.
    PubMed     Abstract available


  651. CASTAGNA A, Fabbo A, Manzo C, Lacava R, et al
    A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201211. doi: 10.3233/JAD-201211.
    PubMed     Abstract available


  652. DE LA TORRE JC
    Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201165. doi: 10.3233/JAD-201165.
    PubMed     Abstract available


  653. DARST BF, Huo Z, Jonaitis EM, Koscik RL, et al
    Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200176. doi: 10.3233/JAD-200176.
    PubMed    


  654. PARK JH, Ah Lee S
    The Fragility of Temporal Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200892. doi: 10.3233/JAD-200892.
    PubMed     Abstract available


  655. WU R, Gu J, Zhou D, Tung YC, et al
    Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201290. doi: 10.3233/JAD-201290.
    PubMed     Abstract available


  656. HYUN LEE Y, Jeon S, Soo Yoo H, Jong Chung S, et al
    Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201094. doi: 10.3233/JAD-201094.
    PubMed     Abstract available


  657. JING J, Zhang F, Zhao L, Xie J, et al
    Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201335. doi: 10.3233/JAD-201335.
    PubMed     Abstract available


  658. KHAN MJ, Desaire H, Lopez OL, Kamboh MI, et al
    Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201318. doi: 10.3233/JAD-201318.
    PubMed     Abstract available


  659. YAN Y, Wu X, Wang X, Geng Z, et al
    The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD200971. doi: 10.3233/JAD-200971.
    PubMed     Abstract available


  660. SOHRABI M, Pecoraro HL, Combs CK
    Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-beta Plaque Deposition in the AppNL - G - F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 3. pii: JAD201099. doi: 10.3233/JAD-201099.
    PubMed     Abstract available


  661. RADHAKRISHNAN NS, Mufti M, Ortiz D, Maye ST, et al
    Implementing Delirium Prevention in the Era of COVID-19.
    J Alzheimers Dis. 2021;79:31-36.
    PubMed     Abstract available


  662. CLARK IA, Vissel B
    Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
    J Alzheimers Dis. 2021;79:931-948.
    PubMed     Abstract available


  663. CARCAVILLA N, Pozo AS, Gonzalez B, Moral-Cuesta D, et al
    Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.
    J Alzheimers Dis. 2021;80:533-537.
    PubMed     Abstract available


  664. TAM MT, Dosso JA, Robillard JM
    The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.
    J Alzheimers Dis. 2021;80:865-875.
    PubMed     Abstract available



  665. Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021;81:1343.
    PubMed    


  666. DAVOUDI A, Dion C, Amini S, Tighe PJ, et al
    Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.
    J Alzheimers Dis. 2021;82:47-57.
    PubMed     Abstract available


  667. TONIOLO S, Scarioni M, Di Lorenzo F, Hort J, et al
    Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.
    J Alzheimers Dis. 2021;82:883-898.
    PubMed     Abstract available


  668. SUH SW, Kim YJ, Kwak KP, Kim K, et al
    A 9-Year Comparison of Dementia Prevalence in Korea: Results of NaSDEK 2008 and 2017.
    J Alzheimers Dis. 2021;81:821-831.
    PubMed     Abstract available


  669. LIU X, Chen KL, Wang Y, Huang YY, et al
    A Novel ITM2B Mutation Associated with Familial Chinese Dementia.
    J Alzheimers Dis. 2021;81:499-505.
    PubMed     Abstract available


  670. SCHMIDT SL, Boechat YEM, Schmidt GJ, Nicaretta D, et al
    Clinical Utility of a Reaction-Time Attention Task in the Evaluation of Cognitive Impairment in Elderly with High Educational Disparity.
    J Alzheimers Dis. 2021;81:691-697.
    PubMed     Abstract available


  671. MARTINEZ-FLOREZ JF, Osorio JD, Cediel JC, Rivas JC, et al
    Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
    J Alzheimers Dis. 2021;81:729-742.
    PubMed     Abstract available


  672. KANATOME A, Ano Y, Shinagawa K, Ide Y, et al
    beta-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial.
    J Alzheimers Dis. 2021;81:787-796.
    PubMed     Abstract available


  673. WANG X, Bui H, Vemuri P, Graff-Radford J, et al
    Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2021;81:533-543.
    PubMed     Abstract available


  674. HALAAS NB, Zetterberg H, Idland AV, Knapskog AB, et al
    Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
    J Alzheimers Dis. 2021;81:667-677.
    PubMed     Abstract available


  675. HIRAO K, Yamashita F, Tsugawa A, Haime R, et al
    Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:877-883.
    PubMed     Abstract available


  676. QUINT WH, Matecko-Burmann I, Schilcher I, Loffler T, et al
    Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
    J Alzheimers Dis. 2021;80:813-829.
    PubMed     Abstract available


  677. YUAN L, Zhang J, Guo JH, Holscher C, et al
    DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    J Alzheimers Dis. 2021;80:695-713.
    PubMed     Abstract available


  678. SAHU B, Mackos AR, Floden AM, Wold LE, et al
    Particulate Matter Exposure Exacerbates Amyloid-beta Plaque Deposition and Gliosis in APP/PS1 Mice.
    J Alzheimers Dis. 2021;80:761-774.
    PubMed     Abstract available


  679. SATO K, Mano T, Iwata A, Toda T, et al
    Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
    J Alzheimers Dis. 2021;82:1333-1344.
    PubMed     Abstract available


  680. UMEGAKI H, Suzuki Y, Komiya H, Watanabe K, et al
    Frequencies and Neuropsychological Characteristics of Errors in the Clock Drawing Test.
    J Alzheimers Dis. 2021;82:1291-1300.
    PubMed     Abstract available


  681. GONZALEZ-ALCAIDE G, Fernandez-Rios M, Redolat R, Serra E, et al
    Research on Emotion Recognition and Dementias: Foundations and Prospects.
    J Alzheimers Dis. 2021;82:939-950.
    PubMed     Abstract available


  682. EDLUND AK, Chen K, Lee W, Protas H, et al
    Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers.
    J Alzheimers Dis. 2021;81:339-354.
    PubMed     Abstract available


  683. STONNINGTON CM, Wu J, Zhang J, Shi J, et al
    Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2021;81:209-220.
    PubMed     Abstract available


  684. RHODES E, Insel PS, Butters MA, Morin R, et al
    The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    J Alzheimers Dis. 2021;80:991-1002.
    PubMed     Abstract available


  685. PEIRA E, Grazzini M, Bauckneht M, Sensi F, et al
    Probing the Role of a Regional Quantitative Assessment of Amyloid PET.
    J Alzheimers Dis. 2021;80:383-396.
    PubMed     Abstract available


  686. LI X, Shen M, Jin Y, Jia S, et al
    Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    J Alzheimers Dis. 2021;80:371-381.
    PubMed     Abstract available


  687. COSTA AS, Pinho J, Kucikiene D, Reich A, et al
    Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    J Alzheimers Dis. 2021;79:1661-1672.
    PubMed     Abstract available


  688. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    The Free and Cued Selective Reminding Test Predicts Braak Stage.
    J Alzheimers Dis. 2021;80:175-183.
    PubMed     Abstract available


  689. DENNISON JL, Ricciardi NR, Lohse I, Volmar CH, et al
    Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    J Alzheimers Dis. 2021;80:41-52.
    PubMed     Abstract available


  690. GNANAPRAKASH M, Staniszewski A, Zhang H, Pitstick R, et al
    Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    J Alzheimers Dis. 2021;79:1813-1829.
    PubMed     Abstract available


  691. MARTINEZ-MALDONADO A, Ontiveros-Torres MA, Harrington CR, Montiel-Sosa JF, et al
    Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    J Alzheimers Dis. 2021;79:1517-1531.
    PubMed     Abstract available


  692. BASCUNANA P, Brackhan M, Pahnke J
    Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-beta Deposits and Activated Microglia.
    J Alzheimers Dis. 2021;79:597-605.
    PubMed     Abstract available


  693. BERGER M, Cooter M, Roesler AS, Chung S, et al
    APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.
    J Alzheimers Dis. 2021;79:511-530.
    PubMed     Abstract available


  694. NIU J, Iqbal K, Liu F, Hu W, et al
    Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.
    J Alzheimers Dis. 2021;82:855-869.
    PubMed     Abstract available


  695. KORPIOJA A, Kruger J, Koivuluoma S, Pylkas K, et al
    Novel Rare SORL1 Variants in Early-Onset Dementia.
    J Alzheimers Dis. 2021;82:761-770.
    PubMed     Abstract available


  696. SHINOHARA M, Suzuki K, Bu G, Sato N, et al
    Interaction Between APOE Genotype and Diabetes in Longevity.
    J Alzheimers Dis. 2021;82:719-726.
    PubMed     Abstract available


  697. SVENSSON J, Blomqvist M, Kettunen P, Eckerstrom C, et al
    Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2021;82:781-790.
    PubMed     Abstract available


  698. ZILLI EM, O'Donnell A, Salinas J, Aparicio HJ, et al
    Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study.
    J Alzheimers Dis. 2021;82:593-605.
    PubMed     Abstract available


  699. YERSTEIN O, Parand L, Liang LJ, Isaac A, et al
    Benson's Disease or Posterior Cortical Atrophy, Revisited.
    J Alzheimers Dis. 2021;82:493-502.
    PubMed     Abstract available


  700. KARANTH SD, Schmitt FA, Nelson PT, Katsumata Y, et al
    Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies.
    J Alzheimers Dis. 2021;82:647-659.
    PubMed     Abstract available


  701. XIAO T, Wijnant SRA, Licher S, Terzikhan N, et al
    Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.
    J Alzheimers Dis. 2021;82:621-630.
    PubMed     Abstract available


  702. RIEGEROVA P, Brejcha J, Bezdekova D, Chum T, et al
    Expression and Localization of AbetaPP in SH-SY5Y Cells Depends on Differentiation State.
    J Alzheimers Dis. 2021;82:485-491.
    PubMed     Abstract available


  703. CHAPARRO D, Flores-Gaspar A, Ali-Torres J
    Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer's Disease.
    J Alzheimers Dis. 2021;82.
    PubMed     Abstract available


  704. SHENG C, Lin L, Lin H, Wang X, et al
    Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    J Alzheimers Dis. 2021;82:513-526.
    PubMed     Abstract available


  705. WOODWORTH DC, Scambray KA, Corrada MM, Kawas CH, et al
    Neuroimaging in the Oldest-Old: A Review of the Literature.
    J Alzheimers Dis. 2021;82:129-147.
    PubMed     Abstract available


  706. NG KP, Cheng GH, Yatawara C, Rosa-Neto P, et al
    Baseline Neurodegeneration Influences the Longitudinal Effects of Tau on Cognition.
    J Alzheimers Dis. 2021;82:159-167.
    PubMed     Abstract available


  707. ALMKVIST O, Bruggen K, Nordberg A
    Subcortical and Cortical Regions of Amyloid-beta Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients.
    J Alzheimers Dis. 2021;81:1613-1624.
    PubMed     Abstract available


  708. ZHANG H, D'Agostino C, Forman HJ, Cacciottolo M, et al
    Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.
    J Alzheimers Dis. 2021;82:307-316.
    PubMed     Abstract available


  709. WANG YY, Ge YJ, Tan CC, Cao XP, et al
    The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.
    J Alzheimers Dis. 2021;81:1331-1339.
    PubMed     Abstract available


  710. SIMONSEN AH, Musaeus CS, Christensen GL, Hasselbalch SG, et al
    Upwards Drift of Cerebrospinal Fluid Amyloid-beta 42 Over Twelve Years in a Consecutive Clinical Cohort.
    J Alzheimers Dis. 2021;81:1369-1373.
    PubMed     Abstract available


  711. PAIS M, Loureiro J, do Vale V, Radanovic M, et al
    Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study.
    J Alzheimers Dis. 2021;81:949-962.
    PubMed     Abstract available


  712. BEISHON LC, Panerai RB, Budgeon C, Subramaniam H, et al
    The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow.
    J Alzheimers Dis. 2021;80:1567-1581.
    PubMed     Abstract available


  713. LUKKARINEN H, Tesseur I, Pemberton D, Van Der Ark P, et al
    Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;80:1629-1642.
    PubMed     Abstract available


  714. TANNER JJ, Hanchate S, Price CC, Garvan C, et al
    Relationships Between Chronic Pain Stage, Cognition, Temporal Lobe Cortex, and Sociodemographic Variables.
    J Alzheimers Dis. 2021;80:1539-1551.
    PubMed     Abstract available


  715. DING XL, Tuo QZ, Lei P
    An Introduction to Ultrasensitive Assays for Plasma Tau Detection.
    J Alzheimers Dis. 2021;80:1353-1362.
    PubMed     Abstract available


  716. JARDEL A, Hopes L, Malaplate C, Roch V, et al
    Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study.
    J Alzheimers Dis. 2021;80:1389-1394.
    PubMed     Abstract available


  717. CLARK AL, Weigand AJ, Thomas KR, Solders SK, et al
    Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:1451-1463.
    PubMed     Abstract available


  718. GJORA L, Strand BH, Bergh S, Borza T, et al
    Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.
    J Alzheimers Dis. 2021;79:1213-1226.
    PubMed     Abstract available


  719. GRUTERS AAA, Ramakers IHGB, Stiekema APM, Verhey FRJ, et al
    An Exploratory Study of the Development and Pilot Testing of an Interactive Visual Tool of Neuropsychological Test Results in Memory Clinics.
    J Alzheimers Dis. 2021;79:1157-1170.
    PubMed     Abstract available


  720. KUMON H, Yoshino Y, Funahashi Y, Mori H, et al
    PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.
    J Alzheimers Dis. 2021;79:1055-1062.
    PubMed     Abstract available


  721. BASTA M, Zaganas I, Simos P, Koutentaki E, et al
    Apolipoprotein E varepsilon4 (APOE varepsilon4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    J Alzheimers Dis. 2021;79:763-771.
    PubMed     Abstract available


  722. BALEA-FERNANDEZ FJ, Martinez-Vega B, Ortega S, Fabelo H, et al
    Analysis of Risk Factors in Dementia Through Machine Learning.
    J Alzheimers Dis. 2021;79:845-861.
    PubMed     Abstract available


  723. OVIEDO DC, Perez-Lao AR, Flores-Cuadra JA, Villarreal AE, et al
    Apolipoprotein varepsilon4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
    J Alzheimers Dis. 2021;82.
    PubMed     Abstract available


  724. STOJAKOVIC A, Chang SY, Nesbitt J, Pichurin NP, et al
    Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
    J Alzheimers Dis. 2021;79:335-353.
    PubMed     Abstract available


  725. SUN L, Li W, Yue L, Xiao S, et al
    Blood TDP-43 Combined with Demographics Information Predicts Dementia Occurrence in Community Non-Dementia Elderly.
    J Alzheimers Dis. 2021;79:301-309.
    PubMed     Abstract available


  726. SOARES JZ, Pettersen R, Benth JS, Persson K, et al
    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
    J Alzheimers Dis. 2021;79:311-321.
    PubMed     Abstract available


  727. VITTAL RAO H, Bihaqi SW, Iannucci J, Sen A, et al
    Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.
    J Alzheimers Dis. 2021;79:211-224.
    PubMed     Abstract available


  728. TUENA C, Mancuso V, Stramba-Badiale C, Pedroli E, et al
    Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.
    J Alzheimers Dis. 2021;79:95-116.
    PubMed     Abstract available


  729. RODRIGUEZ-SALGADO AM, Llibre-Guerra JJ, Tsoy E, Penalver-Guia AI, et al
    A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.
    J Alzheimers Dis. 2021;79:85-94.
    PubMed     Abstract available


  730. TRAN L, Jung J, Carlin C, Lee S, et al
    Use of Direct-Acting Antiviral Agents and Survival Among Medicare Beneficiaries with Dementia and Chronic Hepatitis C.
    J Alzheimers Dis. 2021;79:71-83.
    PubMed     Abstract available


  731. YLA-HERTTUALA S, Hakulinen M, Poutiainen P, Laitinen TM, et al
    Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-beta Deposition.
    J Alzheimers Dis. 2021;79:153-161.
    PubMed     Abstract available


  732. ZHU M, Jia L, Jia J
    Inhibition of miR-96-5p May Reduce Abeta42/Abeta40 Ratio via Regulating ATP-binding cassette transporter A1.
    J Alzheimers Dis. 2021;83:367-377.
    PubMed     Abstract available


  733. TAKAO H, Amemiya S, Abe O
    Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
    J Alzheimers Dis. 2021;83:281-290.
    PubMed     Abstract available


  734. VAN DER LEE SJ, van Steenoven I, van de Beek M, Tesi N, et al
    Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;83:269-279.
    PubMed     Abstract available


  735. KAWAMURA K, Miyajima M, Nakajima M, Kanai M, et al
    Cerebrospinal Fluid Amyloid-beta Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;83:179-190.
    PubMed     Abstract available


  736. IBANEZ A, Fittipaldi S, Trujillo C, Jaramillo T, et al
    Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes.
    J Alzheimers Dis. 2021;83:227-248.
    PubMed     Abstract available


  737. JONES E, Aigbogun MS, Pike J, Berry M, et al
    Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System.
    J Alzheimers Dis. 2021;83:89-101.
    PubMed     Abstract available


  738. PARK J, Galvin JE
    Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;82:1847-1859.
    PubMed     Abstract available


  739. QUATTRINI G, Marizzoni M, Pizzini FB, Galazzo IB, et al
    Convergent and Discriminant Validity of Default Mode Network and Limbic Network Perfusion in Amnestic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2021;82:1797-1808.
    PubMed     Abstract available


  740. MORI H, Funahashi Y, Yoshino Y, Kumon H, et al
    Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases.
    J Alzheimers Dis. 2021;82:1737-1744.
    PubMed     Abstract available


  741. WANG WZ, Li MW, Chen Y, Liu LY, et al
    3xTg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-beta Production and Tau Hyperphosphorylation.
    J Alzheimers Dis. 2021;82:1635-1649.
    PubMed     Abstract available


  742. ELMALEH DR, Downey MA, Kundakovic L, Wilkinson JE, et al
    New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease.
    J Alzheimers Dis. 2021;82:1373-1401.
    PubMed     Abstract available


  743. BARRETT T, Stangis KA, Saito T, Saido T, et al
    Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
    J Alzheimers Dis. 2021;82:1683-1702.
    PubMed     Abstract available


  744. SAKAKIBARA Y, Hirota Y, Ibaraki K, Takei K, et al
    Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-beta Amyloidosis.
    J Alzheimers Dis. 2021;82:1513-1530.
    PubMed     Abstract available


  745. LI W, Wang S, Zhang H, Li B, et al
    Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
    J Alzheimers Dis. 2021;82:1475-1485.
    PubMed     Abstract available


  746. LAZAROVA MI, Tsekova DS, Tancheva LP, Kirilov KT, et al
    New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity.
    J Alzheimers Dis. 2021;83:1211-1220.
    PubMed     Abstract available


  747. SAKURAI K, Kaneda D, Uchida Y, Inui S, et al
    Can Medial Temporal Impairment Be an Imaging Red Flag for Neurodegeneration in Disproportionately Enlarged Subarachnoid Space Hydrocephalus?
    J Alzheimers Dis. 2021;83:1199-1209.
    PubMed     Abstract available


  748. FELISBERTI FM
    Hedonic Preferences to Audio and Visual Stimulation in Seniors with Cognitive Impairments.
    J Alzheimers Dis. 2021;83:1353-1366.
    PubMed     Abstract available


  749. SCHENNING KJ, Holden S, Davis BA, Mulford A, et al
    Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.
    J Alzheimers Dis. 2021;83:1251-1268.
    PubMed     Abstract available


  750. SIERRA-FONSECA JA, Rodriguez M, Themann A, Lira O, et al
    Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.
    J Alzheimers Dis. 2021;83:1691-1702.
    PubMed     Abstract available


  751. MORRIS R, Umeukeje G, Bu K, Cheng F, et al
    The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021;83:1061-1071.
    PubMed     Abstract available


  752. JORDA A, Aldasoro M, Aldasoro C, Valles SL, et al
    Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice.
    J Alzheimers Dis. 2021;83:1051-1060.
    PubMed     Abstract available


  753. GOUILLY D, Tisserand C, Nogueira L, Saint-Lary L, et al
    Taking the A Train? Limited Consistency of Abeta42 and the Abeta42/40 Ratio in the AT(N) Classification.
    J Alzheimers Dis. 2021;83:1033-1038.
    PubMed     Abstract available


  754. SIQUEIRA LD, Celes APM, Santos HD, Ferreira ST, et al
    A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-beta Oligomers in Mice.
    J Alzheimers Dis. 2021;83:1113-1124.
    PubMed     Abstract available


  755. POPE CA, Wilkins HM, Swerdlow RH, Wolfe MS, et al
    Mutations in the Amyloid-beta Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-beta Peptide.
    J Alzheimers Dis. 2021;83:1039-1049.
    PubMed     Abstract available


  756. SUBRAMANIAM S, Blake DT, Constantinidis C
    Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders.
    J Alzheimers Dis. 2021;83:491-503.
    PubMed     Abstract available


  757. DHANA K, James BD, Agarwal P, Aggarwal NT, et al
    MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2021;83:683-692.
    PubMed     Abstract available


  758. YANG L, Wu C, Tucker L, Dong Y, et al
    Photobiomodulation Therapy Attenuates Anxious-Depressive-Like Behavior in the TgF344 Rat Model.
    J Alzheimers Dis. 2021;83:1415-1429.
    PubMed     Abstract available


  759. ASO Y, Kimura N, Matsubara E
    Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition.
    J Alzheimers Dis. 2021;84:905-914.
    PubMed     Abstract available


  760. YIN X, Zhou Z, Qiu Y, Fan X, et al
    SIRT1 Regulates Tau Expression and Tau Synaptic Pathology.
    J Alzheimers Dis. 2021;84:895-904.
    PubMed     Abstract available


  761. DAI S, Zhou F, Sun J, Li Y, et al
    NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-beta42 by Inhibiting GSK3beta Activation in N2a/APP695swe Cells.
    J Alzheimers Dis. 2021;84:869-881.
    PubMed     Abstract available


  762. FINK A, Doblhammer G, Tamguney G
    Recurring Gastrointestinal Infections Increase the Risk of Dementia.
    J Alzheimers Dis. 2021;84:797-806.
    PubMed     Abstract available


  763. LAZAROVA M, Tancheva L, Alexandrova A, Tsvetanova E, et al
    Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice.
    J Alzheimers Dis. 2021;84:671-690.
    PubMed     Abstract available


  764. KITANI-MORII F, Friedland RP, Yoshida H, Mizuno T, et al
    Drosophila as a Model for Microbiota Studies of Neurodegeneration.
    J Alzheimers Dis. 2021;84:479-490.
    PubMed     Abstract available


  765. LAZRIS D, Perkins MM, Bay AA, Hackney ME, et al
    Qualitative Evaluation Informs Understanding of Motor Cognition and Therapies in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;84:691-703.
    PubMed     Abstract available


  766. WEI S, Shang S, Dang L, Gao F, et al
    Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-beta Transport: A Population-Based Cross-Sectional Study.
    J Alzheimers Dis. 2021;84:303-314.
    PubMed     Abstract available


  767. XIA L, Pang Y, Li J, Wu B, et al
    Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    J Alzheimers Dis. 2021;84:239-248.
    PubMed     Abstract available


  768. DEFEIS B, Ying G, Kurasz AM, De Wit L, et al
    Latent Factor Structure of Outcome Measures Used in the HABIT(R) Mild Cognitive Impairment Intervention Programs.
    J Alzheimers Dis. 2021;84:193-205.
    PubMed     Abstract available


  769. GAN J, Liu S, Wang XD, Hu W, et al
    The Association Between Hyperhidrosis and Dementia: A Community-Based Research.
    J Alzheimers Dis. 2021;84:1657-1667.
    PubMed     Abstract available


  770. UPITE J, Bruning T, Mohle L, Brackhan M, et al
    A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-beta Compounds.
    J Alzheimers Dis. 2021;84:1677-1690.
    PubMed     Abstract available


  771. GALVIN JE, Chrisphonte S, Chang LC
    Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.
    J Alzheimers Dis. 2021;84:1563-1576.
    PubMed     Abstract available


  772. FOUCARD C, Palisson J, Belin C, Bereaux C, et al
    The Diagnostic Value of a Short Memory Test: The TNI-93.
    J Alzheimers Dis. 2021;84:1461-1471.
    PubMed     Abstract available


  773. HOILUND-CARLSEN PF, Alavi A
    Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data.
    J Alzheimers Dis. 2021;84:1457-1460.
    PubMed     Abstract available


  774. NAKAHATA N, Nakamura T, Kawarabayashi T, Seino Y, et al
    Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion Project.
    J Alzheimers Dis. 2021;84:1233-1245.
    PubMed     Abstract available


  775. TIAN T, Qin X, Wang Y, Shi Y, et al
    40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.
    J Alzheimers Dis. 2021;84:983-993.
    PubMed     Abstract available


  776. FILIPPONE A, Li JG, Pratico D
    VPS35 Downregulation Alters Degradation Pathways in Neuronal Cells.
    J Alzheimers Dis. 2021;84:1079-1089.
    PubMed     Abstract available


    December 2020
  777. SOLDEVILA-DOMENECH N, Forcano L, Boronat A, Lorenzo T, et al
    Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 31. pii: JAD201408. doi: 10.3233/JAD-201408.
    PubMed     Abstract available


  778. GONZALEZ C, Tommasi NS, Briggs D, Properzi MJ, et al
    Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201122. doi: 10.3233/JAD-201122.
    PubMed     Abstract available


  779. FU Z, Zhao M, Wang X, He Y, et al
    Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201116. doi: 10.3233/JAD-201116.
    PubMed    


  780. BARTHELSON K, Pederson SM, Newman M, Lardelli M, et al
    Brain Transcriptome Analysis of a Protein-Truncating Mutation in Sortilin-Related Receptor 1 Associated With Early-Onset Familial Alzheimer's Disease Indicates Early Effects on Mitochondrial and Ribosome Function.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201383. doi: 10.3233/JAD-201383.
    PubMed     Abstract available


  781. TRUMBORE CN
    Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer's and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201025. doi: 10.3233/JAD-201025.
    PubMed     Abstract available


  782. RYAN M, Tan VTY, Thompson N, Guevremont D, et al
    Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD200757. doi: 10.3233/JAD-200757.
    PubMed     Abstract available


  783. BABULAL GM, Johnson A, Fagan AM, Morris JC, et al
    Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201294. doi: 10.3233/JAD-201294.
    PubMed     Abstract available


  784. STREIT WJ, Khoshbouei H, Bechmann I
    The Role of Microglia in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201248. doi: 10.3233/JAD-201248.
    PubMed     Abstract available


  785. FUTAMURA A, Hieda S, Mori Y, Sugimoto A, et al
    Cingulate Island Sign in Single Photon Emission Computed Tomography: Clinical Biomarker Correlations in Lewy Body Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201145. doi: 10.3233/JAD-201145.
    PubMed     Abstract available


  786. HOANG MT, Kareholt I, von Euler M, von Koch L, et al
    Satisfaction with Stroke Care Among Patients with Alzheimer's and Other Dementias: A Swedish Register-Based Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200976. doi: 10.3233/JAD-200976.
    PubMed     Abstract available


  787. BAO YW, Chau ACM, Chiu PK, Shea YF, et al
    Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200890. doi: 10.3233/JAD-200890.
    PubMed     Abstract available


  788. TROMP K, Smedinga M, Richard E, Perry M, et al
    Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200884. doi: 10.3233/JAD-200884.
    PubMed     Abstract available


  789. YUAN J, Maserejian N, Liu Y, Devine S, et al
    Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    J Alzheimers Dis. 2020 Dec 20. pii: JAD200786. doi: 10.3233/JAD-200786.
    PubMed     Abstract available


  790. MINTA K, Brinkmalm G, Portelius E, Johansson P, et al
    Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD201039. doi: 10.3233/JAD-201039.
    PubMed     Abstract available


  791. WU W, Lee I, Spratt H, Fang X, et al
    tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD200917. doi: 10.3233/JAD-200917.
    PubMed     Abstract available


  792. PETERSEN ME, Rafii MS, Zhang F, Hall J, et al
    Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD201167. doi: 10.3233/JAD-201167.
    PubMed     Abstract available


  793. ORJUELA A, Lakey-Beitia J, Mojica-Flores R, Hegde ML, et al
    Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-beta Monomers and Fibrils: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD200941. doi: 10.3233/JAD-200941.
    PubMed     Abstract available


  794. MOZERSKY J, Hartz S, Linnenbringer E, Levin L, et al
    Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200993. doi: 10.3233/JAD-200993.
    PubMed     Abstract available


  795. FANET H, Tournissac M, Leclerc M, Caron V, et al
    Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-beta and Tau Pathologies.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200637. doi: 10.3233/JAD-200637.
    PubMed     Abstract available


  796. MURCHISON CF, Kennedy RE, McConathy JE, Roberson ED, et al
    Racial Differences in Alzheimer's Disease Specialist Encounters are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
    J Alzheimers Dis. 2020 Dec 14. pii: JAD200796. doi: 10.3233/JAD-200796.
    PubMed     Abstract available


  797. ROMANO RR, Carter MA, Dietrich MS, Cowan RL, et al
    Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201293. doi: 10.3233/JAD-201293.
    PubMed     Abstract available


  798. TEIPEL SJ, Marie Temp AG, Levin F, Dyrba M, et al
    Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201032. doi: 10.3233/JAD-201032.
    PubMed     Abstract available


  799. IBI D, Hirashima K, Kojima Y, Sumiya K, et al
    Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD200972. doi: 10.3233/JAD-200972.
    PubMed     Abstract available


  800. WANG Q, Chen B, Zhong X, Zhou H, et al
    Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201168. doi: 10.3233/JAD-201168.
    PubMed     Abstract available


  801. ETTCHETO M, Busquets O, Cano A, Sanchez-Lopez E, et al
    Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 2. pii: JAD201106. doi: 10.3233/JAD-201106.
    PubMed     Abstract available


  802. BEACH TG, Malek-Ahmadi M
    Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD201213. doi: 10.3233/JAD-201213.
    PubMed     Abstract available


  803. FLAX J, Wilkins HM, Miller R, Griffith S, et al
    OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200996. doi: 10.3233/JAD-200996.
    PubMed     Abstract available


  804. BIRKENBIHL C, Westwood S, Shi L, Nevado-Holgado A, et al
    ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200948. doi: 10.3233/JAD-200948.
    PubMed     Abstract available


  805. JAYATUNGA DPW, Hone E, Bharadwaj P, Garg M, et al
    Targeting Mitophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD191258. doi: 10.3233/JAD-191258.
    PubMed     Abstract available


    November 2020
  806. DENIZ K, Ho CCG, Malphrus KG, Reddy JS, et al
    Plasma Biomarkers of Alzheimer's Disease in African Americans.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200828. doi: 10.3233/JAD-200828.
    PubMed     Abstract available


  807. BASTRUP J, Hansen KH, Poulsen TBG, Kastaniegaard K, et al
    Anti-Abeta Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200715. doi: 10.3233/JAD-200715.
    PubMed     Abstract available


  808. KOYCHEV I, Jansen K, Dette A, Shi L, et al
    Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2020 Nov 24. pii: JAD200900. doi: 10.3233/JAD-200900.
    PubMed     Abstract available


  809. SOTO-MERCADO V, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C, et al
    Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.
    J Alzheimers Dis. 2020 Nov 23. pii: JAD201045. doi: 10.3233/JAD-201045.
    PubMed     Abstract available


  810. GIL R, Arroyo-Anllo EM
    Alzheimer's Disease and Face Masks in Times of COVID-19.
    J Alzheimers Dis. 2020 Nov 22. pii: JAD201233. doi: 10.3233/JAD-201233.
    PubMed     Abstract available


  811. YEE E, Ma D, Popuri K, Wang L, et al
    Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200830. doi: 10.3233/JAD-200830.
    PubMed     Abstract available


  812. SERGOTT RC, Raji A, Kost J, Sur C, et al
    Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200735. doi: 10.3233/JAD-200735.
    PubMed     Abstract available


  813. VAN WAALWIJK VAN DOORN LJC, Ghafoorian M, van Leijsen EMC, Claassen JAHR, et al
    White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200496. doi: 10.3233/JAD-200496.
    PubMed     Abstract available


  814. FLORES-CUADRA JA, Madrid A, Fernandez PL, Perez-Lao AR, et al
    Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    J Alzheimers Dis. 2020 Nov 20. pii: JAD200870. doi: 10.3233/JAD-200870.
    PubMed     Abstract available


  815. BUSQUETS O, Parcerisas A, Verdaguer E, Ettcheto M, et al
    c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations.
    J Alzheimers Dis. 2020 Nov 18. pii: JAD201053. doi: 10.3233/JAD-201053.
    PubMed     Abstract available


  816. RADESTIG MA, Skoog J, Zetterberg H, Kern J, et al
    Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200751. doi: 10.3233/JAD-200751.
    PubMed     Abstract available


  817. YANG B, Yang S, Zhang Y, Liu W, et al
    Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P).
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200652. doi: 10.3233/JAD-200652.
    PubMed     Abstract available


  818. FEMMINELLA GD, Harold D, Scott J, Williams J, et al
    The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200578. doi: 10.3233/JAD-200578.
    PubMed     Abstract available


  819. BECKER S, Boettinger O, Sulzer P, Hobert MA, et al
    Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200256. doi: 10.3233/JAD-200256.
    PubMed     Abstract available


  820. MADERNA E, Visona S, Bolcato V, Redaelli V, et al
    Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes.
    J Alzheimers Dis. 2020 Nov 13. pii: JAD201085. doi: 10.3233/JAD-201085.
    PubMed     Abstract available


  821. BARKER W, Quinonez C, Greig MT, Behar R, et al
    Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    J Alzheimers Dis. 2020 Nov 13. pii: JAD200901. doi: 10.3233/JAD-200901.
    PubMed     Abstract available


  822. GUARNIERI B, Maestri M, Cucchiara F, Lo Gerfo A, et al
    Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences.
    J Alzheimers Dis. 2020 Nov 11. pii: JAD200632. doi: 10.3233/JAD-200632.
    PubMed     Abstract available


  823. SINGH A, Allen D, Fracassi A, Tumurbaatar B, et al
    Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200716. doi: 10.3233/JAD-200716.
    PubMed     Abstract available


  824. WALKER JD, Spiro G, Loewen K, Jacklin K, et al
    Alzheimer's Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200704. doi: 10.3233/JAD-200704.
    PubMed     Abstract available


  825. HONG T, Hirano S, Sakurai T, Nakano Y, et al
    The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200676. doi: 10.3233/JAD-200676.
    PubMed     Abstract available


  826. LI X, Xuan W, Chen D, Gao H, et al
    Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200770. doi: 10.3233/JAD-200770.
    PubMed     Abstract available


  827. DE LA FUENTE GARCIA S, Ritchie C, Luz S
    Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200888. doi: 10.3233/JAD-200888.
    PubMed     Abstract available


  828. YANG YX, Ku K, Li HQ, Shen XN, et al
    Investigating Causal Relations Between Risk Tolerance, Risky Behaviors, and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200773. doi: 10.3233/JAD-200773.
    PubMed     Abstract available


  829. ARMSTRONG TD, Suwannasual U, Kennedy CL, Thasma A, et al
    Exposure to Traffic-Generated Pollutants Exacerbates the Expression of Factors Associated with the Pathophysiology of Alzheimer's Disease in Aged C57BL/6 Wild-Type Mice.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200929. doi: 10.3233/JAD-200929.
    PubMed     Abstract available


  830. RICHTER N, Bischof G, Dronse J, Nellessen N, et al
    Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200835. doi: 10.3233/JAD-200835.
    PubMed     Abstract available


    October 2020
  831. POPLE CB, Meng Y, Li DZ, Bigioni L, et al
    Neuromodulation in the Treatment of Alzheimer's Disease: Current and Emerging Approaches.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200913. doi: 10.3233/JAD-200913.
    PubMed     Abstract available


  832. YILMAZ A, Ustun I, Ugur Z, Akyol S, et al
    A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200305. doi: 10.3233/JAD-200305.
    PubMed     Abstract available


  833. BARTELS C, Kogel A, Schweda M, Wiltfang J, et al
    Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200794. doi: 10.3233/JAD-200794.
    PubMed     Abstract available


  834. LIU KY, Costello H, Reeves S, Howard R, et al
    The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200516. doi: 10.3233/JAD-200516.
    PubMed     Abstract available


  835. FIELDS TN, Mueller KD, Koscik RL, Johnson SC, et al
    Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 17. pii: JAD200701. doi: 10.3233/JAD-200701.
    PubMed     Abstract available


  836. GIBSON GE, Luchsinger JA, Cirio R, Chen H, et al
    Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200896. doi: 10.3233/JAD-200896.
    PubMed     Abstract available


  837. RESCHKE-HERNANDEZ AE, Belfi AM, Guzman-Velez E, Tranel D, et al
    Hooked on a Feeling: Influence of Brief Exposure to Familiar Music on Feelings of Emotion in Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200889. doi: 10.3233/JAD-200889.
    PubMed     Abstract available


  838. CROCCO E, Curiel-Cid RE, Kitaigorodsky M, Gonzalez-Jimenez CJ, et al
    A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200790. doi: 10.3233/JAD-200790.
    PubMed     Abstract available


  839. MENNE F, Schipke CG, Klostermann A, Fuentes-Casan M, et al
    Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200710. doi: 10.3233/JAD-200710.
    PubMed     Abstract available


  840. KRITIKOS M, Gandy S, Meliker JR, Luft BJ, et al
    Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200679. doi: 10.3233/JAD-200679.
    PubMed     Abstract available


  841. MARIZZONI M, Cattaneo A, Mirabelli P, Festari C, et al
    Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 14. pii: JAD200306. doi: 10.3233/JAD-200306.
    PubMed     Abstract available


  842. KHALSA DS
    The End of Alzheimer's Protocol: The First Protocol to Enhance Cognition and Reverse Decline at Any Age by Dale Bredesen, Avery, 2020, 352 pp.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD201157. doi: 10.3233/JAD-201157.
    PubMed    


  843. ITZHAKI RF
    Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200986. doi: 10.3233/JAD-200986.
    PubMed     Abstract available


  844. MATIAS-GUIU JA, Pytel V, Matias-Guiu J
    Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200940. doi: 10.3233/JAD-200940.
    PubMed     Abstract available


  845. DUGGAN MR, Torkzaban B, Ahooyi TM, Khalili K, et al
    Potential Role for Herpesviruses in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200814. doi: 10.3233/JAD-200814.
    PubMed     Abstract available


  846. GABERE M, Thu Pham NT, Graff-Radford J, Machulda MM, et al
    Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200625. doi: 10.3233/JAD-200625.
    PubMed     Abstract available


  847. LOUPY KM, Lee T, Zambrano CA, Elsayed AI, et al
    Alzheimer's Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200568. doi: 10.3233/JAD-200568.
    PubMed     Abstract available


  848. ZHANG T, Han X, Zhang X, Chen Z, et al
    Dietary Fatty Acid Factors in Alzheimer's Disease: A Mini-Review.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200558. doi: 10.3233/JAD-200558.
    PubMed     Abstract available


  849. RUITER M, Herstel LJ, Wierenga CJ
    Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200527. doi: 10.3233/JAD-200527.
    PubMed     Abstract available


  850. ROSIN ER, Blasco D, Pilozzi AR, Yang LH, et al
    A Narrative Review of Alzheimer's Disease Stigma.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200932. doi: 10.3233/JAD-200932.
    PubMed     Abstract available


  851. HUTTENRAUCH M, Lopez-Noguerola JS, Castro-Obregon S
    Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200743. doi: 10.3233/JAD-200743.
    PubMed     Abstract available


  852. RAVONA-SPRINGER R, Sharvit-Ginon I, Ganmore I, Greenbaum L, et al
    The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200623. doi: 10.3233/JAD-200623.
    PubMed     Abstract available


  853. CHANG KH, Huang CC, Chen CM, Wu HC, et al
    Differences in Clinical Presentation of Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease According to Sex and Education Level.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200507. doi: 10.3233/JAD-200507.
    PubMed     Abstract available


  854. STONNINGTON CM, Velgos SN, Chen Y, Syed S, et al
    Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200132. doi: 10.3233/JAD-200132.
    PubMed     Abstract available


  855. LEE JH, Byun MS, Yi D, Ko K, et al
    Long-Term Exposure to PM10 and in vivo Alzheimer's Disease Pathologies.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200694. doi: 10.3233/JAD-200694.
    PubMed     Abstract available


  856. GAVRIEL Y, Rabinovich-Nikitin I, Ezra A, Barbiro B, et al
    Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200506. doi: 10.3233/JAD-200506.
    PubMed     Abstract available


  857. GAO L, Wang J, Jiang Y, Wei S, et al
    Relationship Between Peripheral Transport Proteins and Plasma Amyloid-beta in Patients with Alzheimer's Disease were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD191320. doi: 10.3233/JAD-191320.
    PubMed     Abstract available


    September 2020
  858. POSADA-DUQUE RA, Cardona-Gomez GP
    CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200730. doi: 10.3233/JAD-200730.
    PubMed     Abstract available


  859. SI Z, Wang X
    The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200720. doi: 10.3233/JAD-200720.
    PubMed     Abstract available


  860. GEERTS H, Spiros A
    Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200688. doi: 10.3233/JAD-200688.
    PubMed     Abstract available


  861. DUARTE-GUTERMAN P, Albert AY, Inkster AM, Barha CK, et al
    Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200982. doi: 10.3233/JAD-200982.
    PubMed     Abstract available


  862. TORRES-ACOSTA N, O'Keefe JH, O'Keefe EL, Isaacson R, et al
    Therapeutic Potential of TNF-alpha Inhibition for Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200711. doi: 10.3233/JAD-200711.
    PubMed     Abstract available


  863. TALAN J
    A Life Committed to Changing the Face of Alzheimer's.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD201108. doi: 10.3233/JAD-201108.
    PubMed    


  864. LI D, Liu Y, Zeng X, Xiong Z, et al
    Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200843. doi: 10.3233/JAD-200843.
    PubMed     Abstract available


  865. YUAN X, Wang L, Tendon N, Sun H, et al
    Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200594. doi: 10.3233/JAD-200594.
    PubMed     Abstract available


  866. CARDOSO R, Lemos C, Oliveiros B, Rosario Almeida M, et al
    APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200556. doi: 10.3233/JAD-200556.
    PubMed     Abstract available


  867. ABDELNOUR C, Esteban de Antonio E, Perez-Cordon A, Lafuente A, et al
    Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundacio ACE in Barcelona, Spain.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200750. doi: 10.3233/JAD-200750.
    PubMed     Abstract available


  868. MOREIRA NCDS, Lima JEBF, Chierrito TPC, Carvalho I, et al
    Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200425. doi: 10.3233/JAD-200425.
    PubMed     Abstract available


  869. KATHERINE BLUJUS J, Elizabeth Korthauer L, Awe E, Frahmand M, et al
    Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    J Alzheimers Dis. 2020 Sep 20. pii: JAD200444. doi: 10.3233/JAD-200444.
    PubMed     Abstract available


  870. XIA Y, Yassi N, Raniga P, Bourgeat P, et al
    Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200419. doi: 10.3233/JAD-200419.
    PubMed     Abstract available


  871. LI Y, Li S, Xu S, Yu H, et al
    Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200233. doi: 10.3233/JAD-200233.
    PubMed     Abstract available


  872. CALDERON-GARCIDUENAS L, Torres-Jardon R, Franco-Lira M, Kulesza R, et al
    Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
    J Alzheimers Dis. 2020 Sep 18. pii: JAD200891. doi: 10.3233/JAD-200891.
    PubMed     Abstract available


  873. SANDAU US, Wiedrick JT, Smith SJ, McFarland TJ, et al
    Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Sep 16. pii: JAD200396. doi: 10.3233/JAD-200396.
    PubMed     Abstract available


  874. WATERMEYER T, Marroig A, Ritchie CW, Ritchie K, et al
    Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort.
    J Alzheimers Dis. 2020 Sep 11. pii: JAD200514. doi: 10.3233/JAD-200514.
    PubMed     Abstract available


  875. MOLD MJ, O'Farrell A, Morris B, Exley C, et al
    Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200838. doi: 10.3233/JAD-200838.
    PubMed     Abstract available


  876. KARKI R, Madan S, Gadiya Y, Domingo-Fernandez D, et al
    Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200752. doi: 10.3233/JAD-200752.
    PubMed     Abstract available


  877. GU Y, Wu Z, Zeng F, Jiang M, et al
    Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis Induces Bone Loss-Correlated Alzheimer's Disease-Like Pathologies in Middle-Aged Mice.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200689. doi: 10.3233/JAD-200689.
    PubMed     Abstract available


  878. BERGERON D, Beauregard JM, Soucy JP, Verret L, et al
    Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200567. doi: 10.3233/JAD-200567.
    PubMed     Abstract available


  879. VILA-CASTELAR C, Guzman-Velez E, Pardilla-Delgado E, Buckley R, et al
    Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200723. doi: 10.3233/JAD-200723.
    PubMed     Abstract available


  880. PISANO F, Caltagirone C, Satriano F, Perri R, et al
    Can Alzheimer's Disease Be Prevented? First Evidence from Spinal Stimulation Efficacy on Executive Functions.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200695. doi: 10.3233/JAD-200695.
    PubMed     Abstract available


  881. HULME B, Didikoglu A, Bradburn S, Robinson A, et al
    Epigenetic Regulation of BMAL1 with Sleep Disturbances and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200634. doi: 10.3233/JAD-200634.
    PubMed     Abstract available


  882. GHOWERI AO, Gagolewicz P, Frazier HN, Gant JC, et al
    Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200617. doi: 10.3233/JAD-200617.
    PubMed     Abstract available


  883. CHAE S, Park J, Soo Byun M, Yi D, et al
    Decreased Alpha Reactivity from Eyes-Closed to Eyes-Open in Non-Demented Older Adults with Alzheimer's Disease: A Combined EEG and [18F]florbetaben PET Study.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200442. doi: 10.3233/JAD-200442.
    PubMed     Abstract available


  884. BLAZEL MM, Lazar KK, Van Hulle CA, Ma Y, et al
    Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200394. doi: 10.3233/JAD-200394.
    PubMed     Abstract available


  885. SIBLE IJ, Nation DA
    Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200221. doi: 10.3233/JAD-200221.
    PubMed     Abstract available


  886. DUTT S, Li Y, Mather M, Nation DA, et al
    Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200187. doi: 10.3233/JAD-200187.
    PubMed     Abstract available


  887. XU H, Jia J
    Immune-Related Hub Genes and the Competitive Endogenous RNA Network in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200081. doi: 10.3233/JAD-200081.
    PubMed     Abstract available


    August 2020
  888. GELMAN S, Palma J, Ghavami A
    Axonal Conduction Velocity in CA1 Area of Hippocampus is Reduced in Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200661. doi: 10.3233/JAD-200661.
    PubMed     Abstract available


  889. PADALA PR, Boozer EM, Lensing SY, Parkes CM, et al
    Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200640. doi: 10.3233/JAD-200640.
    PubMed     Abstract available


  890. SANTANGELO R, Huang SC, Bernasconi MP, Falautano M, et al
    Neuro-Retina Might Reflect Alzheimer's Disease Stage.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200043. doi: 10.3233/JAD-200043.
    PubMed     Abstract available


  891. TSUGAWA A, Sakurai S, Inagawa Y, Hirose D, et al
    Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 27. pii: JAD200832. doi: 10.3233/JAD-200832.
    PubMed     Abstract available


  892. GROSSMANN K
    Anticoagulants for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 26. pii: JAD200610. doi: 10.3233/JAD-200610.
    PubMed     Abstract available


  893. RAI SP, Bascunana P, Brackhan M, Krohn M, et al
    Detection and Prediction of Mild Cognitive Impairment in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 Aug 20. pii: JAD200675. doi: 10.3233/JAD-200675.
    PubMed     Abstract available


  894. SHI L, Winchester LM, Liu BY, Killick R, et al
    Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 Aug 20. pii: JAD200208. doi: 10.3233/JAD-200208.
    PubMed     Abstract available


  895. CHU TH, Cummins K, Stys PK
    Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer's Mouse Spinal Cord.
    J Alzheimers Dis. 2020 Aug 19. pii: JAD200387. doi: 10.3233/JAD-200387.
    PubMed     Abstract available


  896. ENACHE D, Pereira JB, Jelic V, Winblad B, et al
    Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 18. pii: JAD200498. doi: 10.3233/JAD-200498.
    PubMed     Abstract available


  897. VAN ENGELEN ME, Gossink FT, de Vijlder LS, Meursing JRA, et al
    End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 18. pii: JAD200337. doi: 10.3233/JAD-200337.
    PubMed     Abstract available


  898. LIM YY, Maruff P, Kaneko N, Doecke J, et al
    Plasma Amyloid-beta Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 17. pii: JAD200475. doi: 10.3233/JAD-200475.
    PubMed     Abstract available


  899. BERGLAND AK, Proitsi P, Kirsebom BE, Soennesyn H, et al
    Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200441. doi: 10.3233/JAD-200441.
    PubMed     Abstract available


  900. MA YH, Wu JH, Xu W, Shen XN, et al
    Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200410. doi: 10.3233/JAD-200410.
    PubMed     Abstract available


  901. SUTOVSKY S, Petrovic R, Fischerova M, Haverlikova V, et al
    Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200321. doi: 10.3233/JAD-200321.
    PubMed     Abstract available


  902. PARKER AF, Smart CM, Scarapicchia V, Gawryluk JR, et al
    Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200299. doi: 10.3233/JAD-200299.
    PubMed     Abstract available


  903. HUANG J, Beach P, Bozoki A, Zhu DC, et al
    Alzheimer's Disease Progressively Alters the Face-Evoked Visual-Processing Network.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200173. doi: 10.3233/JAD-200173.
    PubMed     Abstract available


  904. TOURNIER BB, Tsartsalis S, Ceyzeriat K, Fraser BH, et al
    Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200136. doi: 10.3233/JAD-200136.
    PubMed     Abstract available


  905. LI J, Long X, Huang H, Tang J, et al
    Resilience of Alzheimer's Disease to COVID-19.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200649. doi: 10.3233/JAD-200649.
    PubMed     Abstract available


  906. SHI JQ, Wang BR, Jiang T, Gao L, et al
    NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 11. pii: JAD200359. doi: 10.3233/JAD-200359.
    PubMed     Abstract available


  907. REJC L, Gomez-Vallejo V, Rios X, Cossio U, et al
    Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-beta Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200570. doi: 10.3233/JAD-200570.
    PubMed     Abstract available


  908. HELLER A, Coffman SS, Jarvis K
    Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200535. doi: 10.3233/JAD-200535.
    PubMed     Abstract available


  909. ROCCARO I, Smirni D
    Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer's Disease Sleep Disorders.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200478. doi: 10.3233/JAD-200478.
    PubMed     Abstract available


  910. CIMINELLI BM, Menduti G, Benussi L, Ghidoni R, et al
    Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200429. doi: 10.3233/JAD-200429.
    PubMed     Abstract available


  911. WANG RZ, Yang YX, Li HQ, Shen XN, et al
    Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200415. doi: 10.3233/JAD-200415.
    PubMed     Abstract available


  912. ZHANG M, Zhong X, Shi H, Vanmechelen E, et al
    BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200362. doi: 10.3233/JAD-200362.
    PubMed     Abstract available


  913. BEGIC E, Hadzidedic S, Obradovic S, Begic Z, et al
    Increased Levels of Coagulation Factor XI in Plasma Are Related to Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200358. doi: 10.3233/JAD-200358.
    PubMed     Abstract available


  914. ZHANG LN, Li MJ, Shang YH, Zhao FF, et al
    Independent and Correlated Role of Apolipoprotein E varepsilon4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200607. doi: 10.3233/JAD-200607.
    PubMed     Abstract available


  915. DENNER J, Tanzi R, Jacobson S
    Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200591. doi: 10.3233/JAD-200591.
    PubMed     Abstract available


  916. RAJI CA, Torosyan N, Silverman DHS
    Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200487. doi: 10.3233/JAD-200487.
    PubMed     Abstract available


  917. QUACH TT, Moutal A, Khanna R, Deems NP, et al
    Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200721. doi: 10.3233/JAD-200721.
    PubMed     Abstract available


  918. DEATON CA, Johnson GVW
    Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200598. doi: 10.3233/JAD-200598.
    PubMed     Abstract available


    July 2020
  919. WANG YJ, Gong WG, Ren QG, Zhang ZJ, et al
    Escitalopram Alleviates Alzheimer's Disease-Type Tau Pathologies in the Aged P301L Tau Transgenic Mice.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200401. doi: 10.3233/JAD-200401.
    PubMed     Abstract available


  920. GONZLEZ A, Guzmn-Martinez L, Maccioni RB
    Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200386. doi: 10.3233/JAD-200386.
    PubMed     Abstract available


  921. FURTADO A, Astaburuaga R, Costa A, Duarte AC, et al
    The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200331. doi: 10.3233/JAD-200331.
    PubMed     Abstract available


  922. AKSNES M, Muller EG, Tiiman A, Edwin TH, et al
    Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200237. doi: 10.3233/JAD-200237.
    PubMed     Abstract available


  923. CALIGIORE D, Silvetti M, D'Amelio M, Puglisi-Allegra S, et al
    Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200276. doi: 10.3233/JAD-200276.
    PubMed     Abstract available


  924. XU A, Tang Y, Zeng Q, Wang X, et al
    Electroacupuncture Enhances Cognition by Promoting Brain Glucose Metabolism and Inhibiting Inflammation in the APP/PS1 Mouse Model of Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200242. doi: 10.3233/JAD-200242.
    PubMed     Abstract available


  925. KIM J, Lee Y, Lee S, Kim K, et al
    Mesenchymal Stem Cell Therapy and Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200219. doi: 10.3233/JAD-200219.
    PubMed     Abstract available


  926. KELEMAN A, Wisch JK, Bollinger RM, Grant EA, et al
    Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200192. doi: 10.3233/JAD-200192.
    PubMed     Abstract available


  927. CARUSO G, Perri R, Fadda L, Caltagirone C, et al
    Recall and Recognition in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200126. doi: 10.3233/JAD-200126.
    PubMed     Abstract available


  928. TRAMMELL AR, McDaniel DJ, Obideen M, Okafor M, et al
    Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200089. doi: 10.3233/JAD-200089.
    PubMed     Abstract available


  929. BADJI A, de la Colina AN, Boshkovski T, Sabra D, et al
    A Cross-Sectional Study on the Impact of Arterial Stiffness on the Corpus Callosum, a Key White Matter Tract Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200668. doi: 10.3233/JAD-200668.
    PubMed     Abstract available


  930. FUNG S, Smith CL, Prater KE, Case A, et al
    Early-Onset Familial Alzheimer's Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200492. doi: 10.3233/JAD-200492.
    PubMed     Abstract available


  931. FU P, Yung KKL
    Air Pollution and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200483. doi: 10.3233/JAD-200483.
    PubMed     Abstract available


  932. PEDRINI S, Hone E, Gupta VB, James I, et al
    Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200291. doi: 10.3233/JAD-200291.
    PubMed     Abstract available


  933. MCKEOWN A, Turner A, Angehrn Z, Gove D, et al
    Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.
    J Alzheimers Dis. 2020 Jul 21. pii: JAD191300. doi: 10.3233/JAD-191300.
    PubMed     Abstract available


  934. BREUZA L, Arighi CN, Argoud-Puy G, Casals-Casas C, et al
    A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200206. doi: 10.3233/JAD-200206.
    PubMed     Abstract available


  935. LUIU AL, Favez N, Betrancourt M, Szilas N, et al
    Family Relationships and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200125. doi: 10.3233/JAD-200125.
    PubMed     Abstract available


  936. VIDONI ED, Kamat A, Gahan WP, Ourso V, et al
    Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200122. doi: 10.3233/JAD-200122.
    PubMed     Abstract available


  937. LOMBARDI G, Pupi A, Bessi V, Polito C, et al
    Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200119. doi: 10.3233/JAD-200119.
    PubMed     Abstract available


  938. GAO Y, Zhang N, Lv C, Li N, et al
    lncRNA SNHG1 Knockdown Alleviates Amyloid-beta-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 18. pii: JAD191303. doi: 10.3233/JAD-191303.
    PubMed     Abstract available


  939. ARROYO-ANLLO EM, Sanchez JC, Gil R
    Could Self-Consciousness Be Enhanced in Alzheimer's Disease? An Approach from Emotional Sensorial Stimulation.
    J Alzheimers Dis. 2020 Jul 16. pii: JAD200408. doi: 10.3233/JAD-200408.
    PubMed     Abstract available


  940. LIM S, Mohaimin S, Min D, Roberts T, et al
    Alzheimer's Disease and its Related Dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A Scoping Review.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200509. doi: 10.3233/JAD-200509.
    PubMed     Abstract available


  941. MELGAREJO JD, Aguirre-Acevedo DC, Gaona C, Chavez CA, et al
    Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200430. doi: 10.3233/JAD-200430.
    PubMed     Abstract available


  942. STYPA V, Haussermann P, Fleiner T, Neumann S, et al
    Validity and Reliability of the German Quality of Life-Alzheimer's Disease (QoL-AD) Self-Report Scale.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200400. doi: 10.3233/JAD-200400.
    PubMed     Abstract available


  943. FERGUSON AC, Tank R, Lyall LM, Ward J, et al
    Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769).
    J Alzheimers Dis. 2020 Jul 9. pii: JAD200338. doi: 10.3233/JAD-200338.
    PubMed     Abstract available


  944. GOTO T, Kuramoto E, Dhar A, Wang RP, et al
    Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3xTg-AD Model Mice.
    J Alzheimers Dis. 2020 Jul 9. pii: JAD200257. doi: 10.3233/JAD-200257.
    PubMed     Abstract available


  945. FAN KH, Feingold E, Rosenthal SL, Demirci FY, et al
    Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers.
    J Alzheimers Dis. 2020 Jul 8. pii: JAD200037. doi: 10.3233/JAD-200037.
    PubMed     Abstract available


  946. CALFIO C, Gonzalez A, Singh SK, Rojo LE, et al
    The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200443. doi: 10.3233/JAD-200443.
    PubMed     Abstract available


  947. BAKULSKI KM, Seo YA, Hickman RC, Brandt D, et al
    Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200282. doi: 10.3233/JAD-200282.
    PubMed     Abstract available


  948. HAKIM MA, Behringer EJ
    Development of Alzheimer's Disease Progressively Alters Sex-Dependent KCa and Sex-Independent KIR Channel Function in Cerebrovascular Endothelium.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200085. doi: 10.3233/JAD-200085.
    PubMed     Abstract available


  949. SUN Z, Sun L, Tu L
    GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD191032. doi: 10.3233/JAD-191032.
    PubMed     Abstract available


  950. COPPALLE R, Mauger C, Quernet S, Dewald A, et al
    New Long-Term Encoding in Severely Amnesic Alzheimer's Disease Patients Revealed Through Repeated Exposure to Artistic Items.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD191318. doi: 10.3233/JAD-191318.
    PubMed     Abstract available


  951. SCHWAB S, Afyouni S, Chen Y, Han Z, et al
    Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 4. pii: JAD191113. doi: 10.3233/JAD-191113.
    PubMed     Abstract available


  952. WARAGAI M, Ho G, Takamatsu Y, Wada R, et al
    Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 2. pii: JAD200416. doi: 10.3233/JAD-200416.
    PubMed     Abstract available


    June 2020
  953. KAUR H, Golovko S, Golovko MY, Singh S, et al
    Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 29. pii: JAD200436. doi: 10.3233/JAD-200436.
    PubMed     Abstract available


  954. HAYASHI K, Gonzales TK, Kapoor A, Ziegler TE, et al
    Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.
    J Alzheimers Dis. 2020 Jun 29. pii: JAD200418. doi: 10.3233/JAD-200418.
    PubMed     Abstract available


  955. LI T, Martin E, Abada YS, Boucher C, et al
    Effects of Chronic Masitinib Treatment in APPPS1dE9 Transgenic Mice Modeling Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 27. pii: JAD200466. doi: 10.3233/JAD-200466.
    PubMed     Abstract available


  956. SHI Y, Zhang L, Gao X, Zhang J, et al
    Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
    J Alzheimers Dis. 2020 Jun 27. pii: JAD200227. doi: 10.3233/JAD-200227.
    PubMed     Abstract available


  957. KIM DY, Choi SH, Lee JS, Kim HJ, et al
    Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 25. pii: JAD200026. doi: 10.3233/JAD-200026.
    PubMed     Abstract available


  958. FUENTES M, Klostermann A, Kleineidam L, Bauer C, et al
    Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease via Lead-Lag Analysis.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200230. doi: 10.3233/JAD-200230.
    PubMed     Abstract available


  959. LIANG Y, Raven F, Ward JF, Zhen S, et al
    Upregulation of Alzheimer's Disease Amyloid-beta Protein Precursor in Astrocytes Both in vitro and in vivo.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200128. doi: 10.3233/JAD-200128.
    PubMed     Abstract available


  960. DUAN W, Sehrawat P, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200034. doi: 10.3233/JAD-200034.
    PubMed     Abstract available


  961. SOLIS E, Hascup KN, Hascup ER
    Alzheimer's Disease: The Link Between Amyloid-beta and Neurovascular Dysfunction.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD200473. doi: 10.3233/JAD-200473.
    PubMed     Abstract available


  962. HABIBA U, Merlin S, Lim JKH, Wong VHY, et al
    Age-Specific Retinal and Cerebral Immunodetection of Amyloid-beta Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191346. doi: 10.3233/JAD-191346.
    PubMed     Abstract available


  963. ANGEHRN Z, Sostar J, Nordon C, Turner A, et al
    Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191159. doi: 10.3233/JAD-191159.
    PubMed     Abstract available


  964. MACCIONI RB, Navarrete LP, Gonzalez A, Gonzalez-Canacer A, et al
    Inflammation: A Major Target for Compounds to Control Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191014. doi: 10.3233/JAD-191014.
    PubMed     Abstract available


  965. WING JJ, Levine DA, Ramamurthy A, Reider C, et al
    Alzheimer's Disease and Related Disorders Prevalence Differs by Appalachian Residence in Ohio.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD200491. doi: 10.3233/JAD-200491.
    PubMed     Abstract available


  966. RESENDE R, Ferreira-Marques M, Moreira P, Coimbra JRM, et al
    New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AbetaPPbeta Cleavage Decreasing Amyloid-beta Production and Accumulation in Alzheimer's Disease Models.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD200381. doi: 10.3233/JAD-200381.
    PubMed     Abstract available


  967. GRISWOLD AJ, Sivasankaran SK, Van Booven D, Gardner OK, et al
    Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD190855. doi: 10.3233/JAD-190855.
    PubMed     Abstract available


  968. SCHINDLER SE, Jicha GA, Nelson PT, Keene CD, et al
    Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19.
    J Alzheimers Dis. 2020 Jun 19. pii: JAD200684. doi: 10.3233/JAD-200684.
    PubMed     Abstract available


  969. BOUTOLEAU-BRETONNIERE C, Pouclet-Courtemanche H, Gillet A, Bernard A, et al
    The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200604. doi: 10.3233/JAD-200604.
    PubMed     Abstract available


  970. NARUKAWA M, Takahashi S, Saito T, Saido TC, et al
    Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200284. doi: 10.3233/JAD-200284.
    PubMed     Abstract available


  971. GUTHRIE H, Honig LS, Lin H, Sink KM, et al
    xSafety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-To-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200134. doi: 10.3233/JAD-200134.
    PubMed     Abstract available


  972. THORDARDOTTIR S, Almkvist O, Johansson C, Zetterberg H, et al
    Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD191261. doi: 10.3233/JAD-191261.
    PubMed     Abstract available


  973. WANG SY, Gong PY, Yan E, Zhang YD, et al
    The Role of TREML2 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 16. pii: JAD200406. doi: 10.3233/JAD-200406.
    PubMed     Abstract available


  974. LIU RM, Chong Z, Chen JC
    Ozone and Particulate Matter Exposure and Alzheimer's Disease: A Review of Human and Animal Studies.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200435. doi: 10.3233/JAD-200435.
    PubMed     Abstract available


  975. ATTADEMO L, Bernardini F
    Air Pollution as Risk Factor for Mental Disorders: In Search for a Possible Link with Alzheimer's Disease and Schizophrenia.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200289. doi: 10.3233/JAD-200289.
    PubMed     Abstract available


  976. TAKEMOTO M, Ohta Y, Hishikawa N, Yamashita T, et al
    The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200247. doi: 10.3233/JAD-200247.
    PubMed     Abstract available


  977. CUTTLER K, Bignoux MJ, Otgaar TC, Chigumba S, et al
    LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer's Disease Cell Culture Models.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200244. doi: 10.3233/JAD-200244.
    PubMed     Abstract available


  978. ROY M, Rheault F, Croteau E, Castellano CA, et al
    Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200213. doi: 10.3233/JAD-200213.
    PubMed     Abstract available


  979. LAKEY-BEITIA J, Burillo AM, La Penna G, Hegde ML, et al
    Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200185. doi: 10.3233/JAD-200185.
    PubMed     Abstract available


  980. RAJJI TK, Bowie CR, Herrmann N, Pollock BG, et al
    Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200141. doi: 10.3233/JAD-200141.
    PubMed     Abstract available


  981. NAUGHTON SX, Raval U, Pasinetti GM
    Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
    J Alzheimers Dis. 2020 Jun 12. pii: JAD200537. doi: 10.3233/JAD-200537.
    PubMed     Abstract available


  982. MOTTA C, Finardi A, Toniolo S, Di Lorenzo F, et al
    Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype.
    J Alzheimers Dis. 2020 Jun 8. pii: JAD191250. doi: 10.3233/JAD-191250.
    PubMed     Abstract available


  983. HE Y, Zhang H, Wang T, Han Z, et al
    Impact of Serum Calcium Levels on Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Jun 8. pii: JAD191249. doi: 10.3233/JAD-191249.
    PubMed     Abstract available


  984. PIAMONTE BLC, Espiritu AI, Anlacan VMM
    Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200378. doi: 10.3233/JAD-200378.
    PubMed     Abstract available


  985. HERNANDES-ALEJANDRO M, Montano S, Harrington CR, Wischik CM, et al
    Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200146. doi: 10.3233/JAD-200146.
    PubMed     Abstract available


  986. BARTHOLD D, Joyce G, Ferido P, Drabo EF, et al
    Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200133. doi: 10.3233/JAD-200133.
    PubMed     Abstract available


  987. FOWLER ME, Triebel KL, Cutter GR, Schneider LS, et al
    Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200108. doi: 10.3233/JAD-200108.
    PubMed     Abstract available


  988. STRICKER NH, Lundt ES, Albertson SM, Machulda MM, et al
    Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200087. doi: 10.3233/JAD-200087.
    PubMed     Abstract available


  989. PRIETO S, Valerio KE, Moody JN, Hayes SM, et al
    Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD191312. doi: 10.3233/JAD-191312.
    PubMed     Abstract available


  990. BEAM CR, Kaneshiro C, Jang JY, Reynolds CA, et al
    A Twin Study of Sex Differences in Genetic Risk for All Dementia, Alzheimer's Disease (AD), and Non-AD Dementia.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD191192. doi: 10.3233/JAD-191192.
    PubMed     Abstract available


  991. PANZARELLA V, Mauceri R, Baschi R, Maniscalco L, et al
    Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2020 Jun 4. pii: JAD200385. doi: 10.3233/JAD-200385.
    PubMed     Abstract available


  992. RAJI CA, Meysami S, Merrill DA, Porter VR, et al
    Brain Structure in Bilingual Compared to Monolingual Individuals with Alzheimer's Disease: Proof of Concept.
    J Alzheimers Dis. 2020 Jun 1. pii: JAD200200. doi: 10.3233/JAD-200200.
    PubMed     Abstract available


    May 2020
  993. TRAINI E, Carotenuto A, Fasanaro AM, Amenta F, et al
    Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial.
    J Alzheimers Dis. 2020 May 30. pii: JAD190623. doi: 10.3233/JAD-190623.
    PubMed     Abstract available


  994. CHEN M, Xia W
    Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    J Alzheimers Dis. 2020 May 26. pii: JAD200110. doi: 10.3233/JAD-200110.
    PubMed     Abstract available


  995. LIM WLF, Huynh K, Chatterjee P, Martins I, et al
    Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 26. pii: JAD191304. doi: 10.3233/JAD-191304.
    PubMed     Abstract available


  996. RABIPOUR S, Rajagopal S, Yu E, Pasvanis S, et al
    APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.
    J Alzheimers Dis. 2020 May 26. pii: JAD191292. doi: 10.3233/JAD-191292.
    PubMed     Abstract available


  997. BENHAMRON S, Nitzan K, Valitsky M, Lax N, et al
    Cerebrospinal Fluid (CSF) Exchange Therapy with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Cognitive Deficits and Brain Pathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 May 26. pii: JAD191219. doi: 10.3233/JAD-191219.
    PubMed     Abstract available


  998. NICASTRO N, Malpetti M, Cope TE, Bevan-Jones WR, et al
    Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 May 22. pii: JAD200246. doi: 10.3233/JAD-200246.
    PubMed     Abstract available


  999. PARIZKOVA M, Lerch O, Andel R, Kalinova J, et al
    Spatial Pattern Separation in Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 20. pii: JAD200093. doi: 10.3233/JAD-200093.
    PubMed     Abstract available


  1000. SHI Y, Gao F, Yang X, Liu D, et al
    Increase of BACE1, Brain-Renal Risk Factor, Contributes to Kidney Damage in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2020 May 19. pii: JAD200204. doi: 10.3233/JAD-200204.
    PubMed     Abstract available


  1001. SCHWABER EJ, Thompson AC, Smilnak G, Stinnett SS, et al
    Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis.
    J Alzheimers Dis. 2020 May 19. pii: JAD200111. doi: 10.3233/JAD-200111.
    PubMed     Abstract available


  1002. WANG X, Zimmermann HR, Lockhart SN, Craft S, et al
    Decreased Levels of Blood AMPKalpha1 but not AMPKalpha2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 May 19. pii: JAD191189. doi: 10.3233/JAD-191189.
    PubMed     Abstract available


  1003. GUEIB C, Pop A, Bannay A, Nassau E, et al
    Impact of a Healing Garden on Self-Consciousness in Patients with Advanced Alzheimer's Disease: An Exploratory Study1.
    J Alzheimers Dis. 2020 May 19. pii: JAD190748. doi: 10.3233/JAD-190748.
    PubMed     Abstract available


  1004. JACUS JP, Mayelle A, Voltzenlogel V, Cuervo-Lombard CV, et al
    Modeling Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 14. pii: JAD200017. doi: 10.3233/JAD-200017.
    PubMed     Abstract available


  1005. PEI YA, Davies J, Zhang M, Zhang HT, et al
    The Role of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 14. pii: JAD191334. doi: 10.3233/JAD-191334.
    PubMed     Abstract available


  1006. KRAMARZ B, Huntley RP, Rodriguez-Lopez M, Roncaglia P, et al
    Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.
    J Alzheimers Dis. 2020 May 13. pii: JAD200207. doi: 10.3233/JAD-200207.
    PubMed     Abstract available


  1007. VECCHIO F, Miraglia F, Alu F, Menna M, et al
    Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
    J Alzheimers Dis. 2020 May 11. pii: JAD200171. doi: 10.3233/JAD-200171.
    PubMed     Abstract available


  1008. RAI SP, Krohn M, Pahnke J
    Early Cognitive Training Rescues Remote Spatial Memory but Reduces Cognitive Flexibility in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 May 11. pii: JAD200161. doi: 10.3233/JAD-200161.
    PubMed     Abstract available


  1009. KAWASAKI A, Ouanes S, Crippa SV, Popp J, et al
    Early-Stage Alzheimer's Disease Does Not Alter Pupil Responses to Colored Light Stimuli.
    J Alzheimers Dis. 2020 May 11. pii: JAD200120. doi: 10.3233/JAD-200120.
    PubMed     Abstract available


  1010. COURAULT P, Emery S, Bouvard S, Liger F, et al
    Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer's Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P.
    J Alzheimers Dis. 2020 May 11. pii: JAD191278. doi: 10.3233/JAD-191278.
    PubMed     Abstract available


  1011. WILLIAMS OA, An Y, Armstrong NM, Kitner-Triolo M, et al
    Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    J Alzheimers Dis. 2020 May 8. pii: JAD191268. doi: 10.3233/JAD-191268.
    PubMed     Abstract available


  1012. ZIBRANDTSEN IC, Agger M, Kjaer TW
    Gamma Entrainment in a Large Retrospective Cohort: Implications for Photic Stimulation Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 7. pii: JAD200083. doi: 10.3233/JAD-200083.
    PubMed     Abstract available


  1013. ANDRADE V, Cortes N, Pastor G, Gonzalez A, et al
    N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 7. pii: JAD200067. doi: 10.3233/JAD-200067.
    PubMed     Abstract available


  1014. ENENGL J, Hamblin MR, Dungel P
    Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application.
    J Alzheimers Dis. 2020 May 7. pii: JAD191210. doi: 10.3233/JAD-191210.
    PubMed     Abstract available


  1015. ROBERT C, Wilson CS, Lipton RB, Arreto CD, et al
    Evolution of the Research Literature and the Scientific Community of Alzheimer's Disease from 1983-2017: A 35-Year Survey.
    J Alzheimers Dis. 2020 May 6. pii: JAD191281. doi: 10.3233/JAD-191281.
    PubMed     Abstract available


  1016. HADITSCH U, Roth T, Rodriguez L, Hancock S, et al
    Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.
    J Alzheimers Dis. 2020 May 5. pii: JAD200393. doi: 10.3233/JAD-200393.
    PubMed     Abstract available


  1017. FIALA M, Lau YCC, Aghajani A, Bhargava S, et al
    Omega-3 Fatty Acids Increase Amyloid-beta Immunity, Energy, and Circadian Rhythm for Cognitive Protection of Alzheimer's Disease Patients Beyond Cholinesterase Inhibitors.
    J Alzheimers Dis. 2020 May 4. pii: JAD200252. doi: 10.3233/JAD-200252.
    PubMed     Abstract available


  1018. PYUN JM, Kang MJ, Ryoo N, Suh J, et al
    Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD200104. doi: 10.3233/JAD-200104.
    PubMed     Abstract available


  1019. WANG P, Zhou B, Yao H, Xie S, et al
    Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 May 4. pii: JAD200066. doi: 10.3233/JAD-200066.
    PubMed     Abstract available


  1020. BABIC LEKO M, Nikolac Perkovic M, Klepac N, Strac DS, et al
    IL-1beta, IL-6, IL-10, and TNFalpha Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 May 4. pii: JAD200056. doi: 10.3233/JAD-200056.
    PubMed     Abstract available


  1021. WROOLIE T, Roat-Shumway S, Watson K, Reiman E, et al
    Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD191090. doi: 10.3233/JAD-191090.
    PubMed     Abstract available


  1022. WIMO A, Handels R, Winblad B, Black CM, et al
    Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2020 May 4. pii: JAD191055. doi: 10.3233/JAD-191055.
    PubMed     Abstract available


  1023. IACCARINO L, Sala A, Caminiti SP, Presotto L, et al
    In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD190954. doi: 10.3233/JAD-190954.
    PubMed     Abstract available


  1024. LIM HJ, Park JE, Kim BC, Choi SM, et al
    Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging.
    J Alzheimers Dis. 2020 May 2. pii: JAD191331. doi: 10.3233/JAD-191331.
    PubMed     Abstract available


    April 2020
  1025. DEVANAND DP, Liu X, Chunga RE, Cohen H, et al
    Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD200021. doi: 10.3233/JAD-200021.
    PubMed     Abstract available


  1026. INNES KE, Sambamoorthi U
    The Association of Osteoarthritis and Related Pain Burden to Incident Alzheimer's Disease and Related Dementias: A Retrospective Cohort Study of U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD191311. doi: 10.3233/JAD-191311.
    PubMed     Abstract available


  1027. KAUR G, Poljak A, Braidy N, Crawford JD, et al
    Fluid Biomarkers and APOE Status of Early Onset Alzheimer's Disease Variants: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Apr 23. pii: JAD200052. doi: 10.3233/JAD-200052.
    PubMed     Abstract available


  1028. LEE SH, Byun MS, Lee JH, Yi D, et al
    Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    J Alzheimers Dis. 2020 Apr 18. pii: JAD191216. doi: 10.3233/JAD-191216.
    PubMed     Abstract available


  1029. CAI HB, Fan ZZ, Tian T, Li ZC, et al
    Diabetes-Induced H3K9 Hyperacetylation Promotes Development of Alzheimer's Disease Through CDK5.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200163. doi: 10.3233/JAD-200163.
    PubMed     Abstract available


  1030. LIU B, Liu J, Shi JS
    SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200063. doi: 10.3233/JAD-200063.
    PubMed     Abstract available


  1031. HUANG SY, Zhu JX, Shen XN, Xu W, et al
    Prevalence of the Preclinical Stages of Alzheimer's Disease in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200059. doi: 10.3233/JAD-200059.
    PubMed     Abstract available


  1032. WESTFALL S, Dinh DM, Pasinetti GM
    Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191328. doi: 10.3233/JAD-191328.
    PubMed     Abstract available


  1033. HENDERSON ST, Morimoto BH, Cummings JL, Farlow MR, et al
    A Placebo-Controlled, Parallel Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191302. doi: 10.3233/JAD-191302.
    PubMed     Abstract available


  1034. YOUN YC, Lee BS, Kim GJ, Ryu JS, et al
    Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD200061. doi: 10.3233/JAD-200061.
    PubMed     Abstract available


  1035. KIM BH, Choi YH, Yang JJ, Kim S, et al
    Identification of Novel Genes Associated with Cortical Thickness in Alzheimer's Disease: Systems Biology Approach to Neuroimaging Endophenotype.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD191175. doi: 10.3233/JAD-191175.
    PubMed     Abstract available


  1036. CLAY F, Howett D, FitzGerald J, Fletcher P, et al
    Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Apr 8. pii: JAD191218. doi: 10.3233/JAD-191218.
    PubMed     Abstract available


  1037. JIN J, Guo J, Cai H, Zhao C, et al
    M2-Like Microglia Polarization Attenuates Neuropathic Pain Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200099. doi: 10.3233/JAD-200099.
    PubMed     Abstract available


  1038. LI N, Wang G, Lu H
    Development of Alzheimer's Disease after Myocardial Infarction.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200068. doi: 10.3233/JAD-200068.
    PubMed     Abstract available


  1039. BEYDOUN MA, Beydoun HA, Hossain S, El-Hajj ZW, et al
    Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer's Disease Dementia in a Large National Survey.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200064. doi: 10.3233/JAD-200064.
    PubMed     Abstract available


  1040. SCHEDIN-WEISS S, Nilsson P, Sandebring-Matton A, Axenhus M, et al
    Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Abeta42-Induced Pathways to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200028. doi: 10.3233/JAD-200028.
    PubMed     Abstract available


  1041. LU MH, Zhao XY, Xu DE, Chen JB, et al
    Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200010. doi: 10.3233/JAD-200010.
    PubMed     Abstract available


  1042. OU YN, Zhu JX, Hou XH, Shen XN, et al
    Associations of Infectious Agents with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD191337. doi: 10.3233/JAD-191337.
    PubMed     Abstract available


  1043. CHENG Y, Ahmed A, Zamrini E, Tsuang DW, et al
    Alzheimer's Disease and Alzheimer's Disease-Related Dementias in Older African American and White Veterans.
    J Alzheimers Dis. 2020 Apr 3. pii: JAD191188. doi: 10.3233/JAD-191188.
    PubMed     Abstract available


  1044. KUMAR VV, Huang H, Zhao L, Verble DD, et al
    Baseline Results: The Association between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study.
    J Alzheimers Dis. 2020 Apr 3. pii: JAD191103. doi: 10.3233/JAD-191103.
    PubMed     Abstract available


  1045. QIAO Y, Xie XY, Lin GZ, Zou Y, et al
    Computer-Assisted Speech Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study from Shanghai, China.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD191056. doi: 10.3233/JAD-191056.
    PubMed     Abstract available


  1046. HORVATH A, Salman Z, Quinlan P, Wallin A, et al
    Patients with Alzheimer's Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190921. doi: 10.3233/JAD-190921.
    PubMed     Abstract available


  1047. BASSENDINE MF, Taylor-Robinson SD, Fertleman M, Khan M, et al
    Is Alzheimer's Disease a Liver Disease of the Brain?
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190848. doi: 10.3233/JAD-190848.
    PubMed     Abstract available


  1048. YAMOAH A, Tripathi P, Sechi A, Kohler C, et al
    Aggregates of RNA Binding Proteins and ER Chaperones Linked to Exosomes in Granulovacuolar Degeneration of the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190722. doi: 10.3233/JAD-190722.
    PubMed     Abstract available


  1049. DALY T, Houot M, Barberousse A, Agid Y, et al
    Amyloid-beta in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019.
    J Alzheimers Dis. 2020 Apr 1. pii: JAD191321. doi: 10.3233/JAD-191321.
    PubMed     Abstract available


  1050. RACINE AM, Touroutoglou A, Abrantes T, Wong B, et al
    Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.
    J Alzheimers Dis. 2020 Apr 1. pii: JAD190380. doi: 10.3233/JAD-190380.
    PubMed     Abstract available


    March 2020
  1051. CHUANG YF, Varma V, An Y, Tanaka T, et al
    Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD191335. doi: 10.3233/JAD-191335.
    PubMed     Abstract available


  1052. ROBINSON RL, Rentz DM, Andrews JS, Zagar A, et al
    Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD191212. doi: 10.3233/JAD-191212.
    PubMed     Abstract available


  1053. PEREIRA MLGF, Camargo MVZA, Bellan AFR, Tahira AC, et al
    Visual Search Efficiency in Mild Cognitive Impairment and Alzheimer's Disease: An Eye Movement Study.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD190690. doi: 10.3233/JAD-190690.
    PubMed     Abstract available


  1054. HARRISON JR, Mistry S, Muskett N, Escott-Price V, et al
    From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Mar 30. pii: JAD191233. doi: 10.3233/JAD-191233.
    PubMed     Abstract available


  1055. LUCHSINGER JA, Palta P, Rippon B, Soto L, et al
    Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2020 Mar 30. pii: JAD191183. doi: 10.3233/JAD-191183.
    PubMed     Abstract available


  1056. FEINKOHL I, Schipke CG, Kruppa J, Menne F, et al
    Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    J Alzheimers Dis. 2020 Mar 11. pii: JAD200046. doi: 10.3233/JAD-200046.
    PubMed     Abstract available


  1057. COUNIL H, Krantic S
    Synaptic Activity and (Neuro)Inflammation in Alzheimer's Disease: Could Exosomes be an Additional Link?
    J Alzheimers Dis. 2020 Mar 11. pii: JAD191237. doi: 10.3233/JAD-191237.
    PubMed     Abstract available


  1058. YANG HJ, Kang NR, Jung YE, Kim MD, et al
    "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
    J Alzheimers Dis. 2020 Mar 11. pii: JAD190983. doi: 10.3233/JAD-190983.
    PubMed     Abstract available


  1059. OESTERHUS R, Dalen I, Bergland AK, Aarsland D, et al
    Risk of Hospitalization in Patients with Alzheimer's Disease and Lewy Body Dementia: Time to and Length of Stay.
    J Alzheimers Dis. 2020 Mar 5. pii: JAD191141. doi: 10.3233/JAD-191141.
    PubMed     Abstract available


  1060. TERRERA GM, Harrison JE, Ritchie CW, Ritchie K, et al
    Cognitive Functions as Predictors of Alzheimer's Disease Biomarker Status in the European Prevention of Alzheimer's Dementia Cohort.
    J Alzheimers Dis. 2020 Mar 5. pii: JAD191108. doi: 10.3233/JAD-191108.
    PubMed     Abstract available


  1061. IHARA M, Saito S
    Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
    J Alzheimers Dis. 2020 Mar 3. pii: JAD200049. doi: 10.3233/JAD-200049.
    PubMed     Abstract available


  1062. ASCHENBRENNER AJ, Gordon BA, Fagan AM, Schindler SE, et al
    Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD200018. doi: 10.3233/JAD-200018.
    PubMed     Abstract available


  1063. MEHDER RH, Bennett BM, Andrew RD
    Morphometric Analysis of Hippocampal and Neocortical Pyramidal Neurons in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD191067. doi: 10.3233/JAD-191067.
    PubMed     Abstract available


  1064. WISCH JK, Roe CM, Babulal GM, Schindler SE, et al
    Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD191039. doi: 10.3233/JAD-191039.
    PubMed     Abstract available


    February 2020
  1065. ZHANG H, Wang T, Han Z, Wang L, et al
    Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Feb 27. pii: JAD191051. doi: 10.3233/JAD-191051.
    PubMed     Abstract available


  1066. TOMASZEWSKI N, He X, Solomon V, Lee M, et al
    Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    J Alzheimers Dis. 2020 Feb 27. pii: JAD191017. doi: 10.3233/JAD-191017.
    PubMed     Abstract available


  1067. MARIANO LI, Caramelli P, Guimaraes HC, Gambogi LB, et al
    Can Social Cognition Measurements Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Apathy?
    J Alzheimers Dis. 2020 Feb 27. pii: JAD190861. doi: 10.3233/JAD-190861.
    PubMed     Abstract available


  1068. POPOVAC A, Mladenovic I, Krunic J, Trifkovic B, et al
    Apolipoprotein E4 Allele and Dental Occlusion Deficiency as Risk Factors for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191283. doi: 10.3233/JAD-191283.
    PubMed     Abstract available


  1069. ARNALDI D, Donniaquio A, Mattioli P, Massa F, et al
    Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191315. doi: 10.3233/JAD-191315.
    PubMed     Abstract available


  1070. KAPOOR A, Bartha R, Black SE, Borrie M, et al
    Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Ye
    J Alzheimers Dis. 2020 Feb 24. pii: JAD191097. doi: 10.3233/JAD-191097.
    PubMed     Abstract available


  1071. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology.
    J Alzheimers Dis. 2020 Feb 22. pii: JAD190907. doi: 10.3233/JAD-190907.
    PubMed     Abstract available


  1072. SILVA D, Cardoso S, Guerreiro M, Maroco J, et al
    Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 20. pii: JAD191133. doi: 10.3233/JAD-191133.
    PubMed     Abstract available


  1073. TEIMOURI E, Rainey-Smith SR, Bharadwaj P, Verdile G, et al
    Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change.
    J Alzheimers Dis. 2020 Feb 17. pii: JAD191033. doi: 10.3233/JAD-191033.
    PubMed     Abstract available


  1074. OKAFOR M, Nye JA, Shokouhi M, Shaw L, et al
    18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 12. pii: JAD191330. doi: 10.3233/JAD-191330.
    PubMed     Abstract available


  1075. CIPOLLARI E, Szapary HJ, Picataggi A, Billheimer JT, et al
    Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 11. pii: JAD191246. doi: 10.3233/JAD-191246.
    PubMed     Abstract available


  1076. PATEL H, Iniesta R, Stahl D, Dobson RJB, et al
    Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 11. pii: JAD191163. doi: 10.3233/JAD-191163.
    PubMed     Abstract available


  1077. TONIOLO S, Serra L, Olivito G, Caltagirone C, et al
    Cerebellar White Matter Disruption in Alzheimer's Disease Patients: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2020 Feb 10. pii: JAD191125. doi: 10.3233/JAD-191125.
    PubMed     Abstract available


  1078. LIGUORI C, Spanetta M, Izzi F, Franchini F, et al
    Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.
    J Alzheimers Dis. 2020 Feb 10. pii: JAD191124. doi: 10.3233/JAD-191124.
    PubMed     Abstract available


  1079. JAMES HJ, Van Houtven CH, Lippmann S, Burke JR, et al
    How Accurately Do Patients and Their Care Partners Report Results of Amyloid-beta PET Scans for Alzheimer's Disease Assessment?
    J Alzheimers Dis. 2020 Feb 10. pii: JAD190922. doi: 10.3233/JAD-190922.
    PubMed     Abstract available


  1080. BHARADWAJ P, Martins RN
    PRKAG2 Gene Expression Is Elevated and its Protein Levels Are Associated with Increased Amyloid-beta Accumulation in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2020 Feb 6. pii: JAD190948. doi: 10.3233/JAD-190948.
    PubMed     Abstract available


  1081. TOBEY H, Lucas T, Paul S, Berr SS, et al
    Mechanoceutics Alters Alzheimer's Disease Phenotypes in Transgenic Rats: A Pilot Study.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD191071. doi: 10.3233/JAD-191071.
    PubMed     Abstract available


  1082. CEYZERIAT K, Tournier BB, Millet P, Frisoni GB, et al
    Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease?
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190984. doi: 10.3233/JAD-190984.
    PubMed     Abstract available


  1083. GOLDWASER EL, Acharya NK, Wu H, Godsey GA, et al
    Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-beta1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190962. doi: 10.3233/JAD-190962.
    PubMed     Abstract available


  1084. WHITWELL JL, Tosakulwong N, Weigand SD, Graff-Radford J, et al
    Longitudinal Amyloid-beta PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190699. doi: 10.3233/JAD-190699.
    PubMed     Abstract available


  1085. MARTINS TS, Magalhaes S, Rosa IM, Vogelgsang J, et al
    Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.
    J Alzheimers Dis. 2020 Feb 3. pii: JAD191034. doi: 10.3233/JAD-191034.
    PubMed     Abstract available


    January 2020
  1086. JAASKELAINEN O, Hall A, Tiainen M, van Gils M, et al
    Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 28. pii: JAD191226. doi: 10.3233/JAD-191226.
    PubMed     Abstract available


  1087. YANG H, Wang W, Jia L, Qin W, et al
    The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2020 Jan 28. pii: JAD191045. doi: 10.3233/JAD-191045.
    PubMed     Abstract available


  1088. MALEK-AHMADI M, Perez SE, Chen K, Mufson EJ, et al
    Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 24. pii: JAD191151. doi: 10.3233/JAD-191151.
    PubMed     Abstract available


  1089. MENDES FR, Leclerc JL, Liu L, Kamat PK, et al
    Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2020 Jan 24. pii: JAD191069. doi: 10.3233/JAD-191069.
    PubMed     Abstract available


  1090. WESTWOOD S, Baird AL, Anand SN, Nevado-Holgado AJ, et al
    Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
    J Alzheimers Dis. 2020 Jan 22. pii: JAD190434. doi: 10.3233/JAD-190434.
    PubMed     Abstract available


  1091. JIA J, Wei C, Chen W, Jia L, et al
    Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 21. pii: JAD190940. doi: 10.3233/JAD-190940.
    PubMed     Abstract available


  1092. DOREY JM, Rouch I, Padovan C, Boublay N, et al
    Neuroticism-Withdrawal and Neuroticism-Volatility Differently Influence the Risk of Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190884. doi: 10.3233/JAD-190884.
    PubMed     Abstract available


  1093. EZZATI A, Lipton RB
    Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190822. doi: 10.3233/JAD-190822.
    PubMed     Abstract available


  1094. BEYER L, Brendel M, Scheiwein F, Sauerbeck J, et al
    Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190818. doi: 10.3233/JAD-190818.
    PubMed     Abstract available


  1095. NAKANISHI M, Igarashi A, Ueda K, Brnabic AJM, et al
    Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    J Alzheimers Dis. 2020 Jan 19. pii: JAD190811. doi: 10.3233/JAD-190811.
    PubMed     Abstract available


  1096. RAUCHMANN BS, Sadlon A, Perneczky R
    Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191120. doi: 10.3233/JAD-191120.
    PubMed     Abstract available


  1097. WONG D, Atiya S, Fogarty J, Montero-Odasso M, et al
    Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190773. doi: 10.3233/JAD-190773.
    PubMed     Abstract available


  1098. COEBERGH JAF, McDowell S, van Woerkom TCAM, Koopman JP, et al
    Auditory Agnosia for Environmental Sounds in Alzheimer's Disease: Not Hearing and Not Listening?
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190431. doi: 10.3233/JAD-190431.
    PubMed     Abstract available


  1099. FERNANDO WMADB, Martins IJ, Morici M, Bharadwaj P, et al
    Sodium Butyrate Reduces Brain Amyloid-beta Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190120. doi: 10.3233/JAD-190120.
    PubMed     Abstract available


  1100. MOLD M, Linhart C, Gomez-Ramirez J, Villegas-Lanau A, et al
    Aluminum and Amyloid-beta in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191140. doi: 10.3233/JAD-191140.
    PubMed     Abstract available


  1101. FAURA J, Bustamante A, Penalba A, Giralt D, et al
    CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190753. doi: 10.3233/JAD-190753.
    PubMed     Abstract available


  1102. HASHIGUCHI D, Campos HC, Wuo-Silva R, Faber J, et al
    Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190729. doi: 10.3233/JAD-190729.
    PubMed     Abstract available


  1103. PLANTON M, Saint-Aubert L, Raposo N, Payoux P, et al
    Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190625. doi: 10.3233/JAD-190625.
    PubMed     Abstract available


  1104. ONO K, Zhao D, Wu Q, Simon J, et al
    Pine Bark Polyphenolic Extract Attenuates Amyloid-beta and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190543. doi: 10.3233/JAD-190543.
    PubMed     Abstract available


  1105. PRIKHODKO O, Rynearson KD, Sekhon T, Mante MM, et al
    The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190442. doi: 10.3233/JAD-190442.
    PubMed     Abstract available


  1106. TUZZI E, Balla DZ, Loureiro JRA, Neumann M, et al
    Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190424. doi: 10.3233/JAD-190424.
    PubMed     Abstract available


  1107. FALGAS N, Balasa M, Bargallo N, Borrego-Ecija S, et al
    Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191167. doi: 10.3233/JAD-191167.
    PubMed     Abstract available


  1108. BUCIUC M, Wennberg AM, Weigand SD, Murray ME, et al
    Effect Modifiers of TDP-43 Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
    J Alzheimers Dis. 2020 Jan 9. pii: JAD191040. doi: 10.3233/JAD-191040.
    PubMed     Abstract available


  1109. CHINTAPALUDI SR, Uyar A, Jackson HM, Acklin CJ, et al
    Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
    J Alzheimers Dis. 2020 Jan 9. pii: JAD190793. doi: 10.3233/JAD-190793.
    PubMed     Abstract available


  1110. ZHAO T, Quan M, Jia J
    Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD191065. doi: 10.3233/JAD-191065.
    PubMed     Abstract available


  1111. XU C, Apostolova LG, Oblak AL, Gao S, et al
    Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD191023. doi: 10.3233/JAD-191023.
    PubMed     Abstract available


  1112. ANO Y, Ohya R, Takaichi Y, Washinuma T, et al
    beta-Lactolin, a Whey-Derived Lacto-Tetrapeptide, Prevents Alzheimer's Disease Pathologies and Cognitive Decline.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190997. doi: 10.3233/JAD-190997.
    PubMed     Abstract available


  1113. MELENDEZ JC, Satorres E, Oliva I
    Comparing the Effect of Interference on an Emotional Stroop Task in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190989. doi: 10.3233/JAD-190989.
    PubMed     Abstract available


  1114. DEVYATKIN VA, Redina OE, Kolosova NG, Muraleva NA, et al
    Single-Nucleotide Polymorphisms Associated with the Senescence-Accelerated Phenotype of OXYS Rats: A Focus on Alzheimer's Disease-Like and Age-Related-Macular-Degeneration-Like Pathologies.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190956. doi: 10.3233/JAD-190956.
    PubMed     Abstract available


  1115. ALZUBAIDI H, Saidawi W, Hussein A, Hasan S, et al
    Critical Role of Pharmacists in Caring for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190804. doi: 10.3233/JAD-190804.
    PubMed     Abstract available


  1116. GIIL LM, Aarsland D
    Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190731. doi: 10.3233/JAD-190731.
    PubMed     Abstract available


  1117. PALMER JC, Tayler HM, Dyer L, Kehoe PG, et al
    Zibotentan, an Endothelin Alzheimer's Disease Receptor Antagonist, Prevents Amyloid-beta-Induced Hypertension and Maintains Cerebral Perfusion.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190630. doi: 10.3233/JAD-190630.
    PubMed     Abstract available


  1118. BOUBLAY N, Bouet R, Dorey JM, Padovan C, et al
    Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190612. doi: 10.3233/JAD-190612.
    PubMed     Abstract available


  1119. TURCHETTA CS, De Simone MS, Perri R, Fadda L, et al
    Forgetting Rates on the Recency Portion of a Word List Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190509. doi: 10.3233/JAD-190509.
    PubMed     Abstract available


  1120. LAMPELA P, Tolppanen AM, Koponen M, Tanskanen A, et al
    Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190850. doi: 10.3233/JAD-190850.
    PubMed     Abstract available



  1121. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2020;74:407.
    PubMed    


  1122. KUHN AJ, Raskatov J
    Is the p3 Peptide (Abeta17-40, Abeta17-42) Relevant to the Pathology of Alzheimer's Disease?1.
    J Alzheimers Dis. 2020;74:43-53.
    PubMed     Abstract available



  1123. The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2020;74:1011.
    PubMed    



  1124. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2020;74:407.
    PubMed    


  1125. HATADA Y, Hashimoto M, Shiraishi S, Ishikawa T, et al
    Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2020;75:361.
    PubMed    



  1126. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2020;75:683.
    PubMed    


  1127. PERRY G
    Alzheimer's Disease Patients in the Crosshairs of COVID-19.
    J Alzheimers Dis. 2020;76:1.
    PubMed    



  1128. Christin Nance, B.A, and Sarah Banks, Ph.D., recipients of the 2019 Alzheimer Award.
    J Alzheimers Dis. 2020;76:443-444.
    PubMed    


  1129. ONO K, Zhao D, Wu Q, Simon J, et al
    Pine Bark Polyphenolic Extract Attenuates Amyloid-beta and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2020;77:457.
    PubMed    



  1130. The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2020;74:1011.
    PubMed    


  1131. HAMILTON RKB, Phelan CH, Chin NA, Wyman MF, et al
    The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research.
    J Alzheimers Dis. 2020;73:431-442.
    PubMed     Abstract available


  1132. WANG YL, Chen W, Cai WJ, Hu H, et al
    Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    J Alzheimers Dis. 2020;73:759-768.
    PubMed     Abstract available


  1133. ECKERSTROM C, Eckerstrom M, Gothlin M, Molinder A, et al
    Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia.
    J Alzheimers Dis. 2020;73:597-607.
    PubMed     Abstract available


  1134. REIMAND J, Groot C, Teunissen CE, Windhorst AD, et al
    Why Is Amyloid-beta PET Requested After Performing CSF Biomarkers?
    J Alzheimers Dis. 2020;73:559-569.
    PubMed     Abstract available


  1135. ROBINSON AC, Chew-Graham S, Davidson YS, Horan MA, et al
    A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    J Alzheimers Dis. 2020;73:619-632.
    PubMed     Abstract available


  1136. KLINEDINST BS, Le ST, Larsen B, Pappas C, et al
    Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
    J Alzheimers Dis. 2020;78:1245-1257.
    PubMed     Abstract available


  1137. ZHANG Y, Hao Y, Li L, Xia K, et al
    A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2020;78:1217-1228.
    PubMed     Abstract available


  1138. SRIVASTAVA A, Das B, Yao AY, Yan R, et al
    Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    J Alzheimers Dis. 2020;78:1345-1361.
    PubMed     Abstract available


  1139. LIU N, Sun J, Wang X, Zhao M, et al
    The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020;78:1775-1782.
    PubMed     Abstract available


  1140. KRESGE HA, Liu D, Gupta DK, Moore EE, et al
    Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    J Alzheimers Dis. 2020;74:965-974.
    PubMed     Abstract available


  1141. WATT G, Shang K, Zieba J, Olaya J, et al
    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Abeta40 Levels in 12-Month-Old Male AbetaPPswe/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2020;74:937-950.
    PubMed     Abstract available


  1142. GRONTVEDT GR, Lauridsen C, Berge G, White LR, et al
    The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.
    J Alzheimers Dis. 2020;74:829-837.
    PubMed     Abstract available


  1143. RICHARDSON K, Wharton SB, Grossi CM, Matthews FE, et al
    Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
    J Alzheimers Dis. 2020;74:999-1009.
    PubMed     Abstract available


  1144. ZHANG J, Hua XF, Gu J, Chen F, et al
    High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2020;74:851-864.
    PubMed     Abstract available


  1145. SUNDSTROM A, Sorman DE, Hansson P, Ljungberg JK, et al
    Mental Demands at Work and Risk of Dementia.
    J Alzheimers Dis. 2020;74:735-740.
    PubMed     Abstract available


  1146. BREWER GJ, Herrera RA, Philipp S, Sosna J, et al
    Age-Related Intraneuronal Aggregation of Amyloid-beta in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    J Alzheimers Dis. 2020;73:229-246.
    PubMed     Abstract available


  1147. VERGOUW LJM, Bosman B, van de Beek M, Salome M, et al
    Family History is Associated with Phenotype in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2020;73:269-275.
    PubMed     Abstract available


  1148. ARFANAKIS K, Evia AM, Leurgans SE, Cardoso LFC, et al
    Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    J Alzheimers Dis. 2020;73:333-345.
    PubMed     Abstract available


  1149. TSUNODA K, Yamashita T, Osakada Y, Sasaki R, et al
    Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020;73:209-215.
    PubMed     Abstract available


  1150. DAVIDOWITZ EJ, Krishnamurthy PK, Lopez P, Jimenez H, et al
    In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    J Alzheimers Dis. 2020;73:147-161.
    PubMed     Abstract available


  1151. PARVAND M, Rankin CH
    Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
    J Alzheimers Dis. 2020;73:1-21.
    PubMed     Abstract available


    December 2019
  1152. LIU H, Reynolds GP, Wei X
    Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD191111. doi: 10.3233/JAD-191111.
    PubMed     Abstract available


  1153. ZUPANIC E, Kramberger MG, von Euler M, Norrving B, et al
    Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD191011. doi: 10.3233/JAD-191011.
    PubMed     Abstract available


  1154. MUSA G, Slachevsky A, Munoz-Neira C, Mendez C, et al
    Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190924. doi: 10.3233/JAD-190924.
    PubMed     Abstract available


  1155. SUN M, Ma K, Wen J, Wang G, et al
    A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190872. doi: 10.3233/JAD-190872.
    PubMed     Abstract available


  1156. CHAMBERLAIN S, Gabriel H, Strittmatter W, Didsbury J, et al
    An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190864. doi: 10.3233/JAD-190864.
    PubMed     Abstract available


  1157. COGLIATI S, Clementi V, Francisco M, Crespo C, et al
    Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190837. doi: 10.3233/JAD-190837.
    PubMed     Abstract available


  1158. FISCHER CE, Ismail Z, Youakim JM, Creese B, et al
    Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190828. doi: 10.3233/JAD-190828.
    PubMed     Abstract available



  1159. The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD199670. doi: 10.3233/JAD-199670.
    PubMed    


  1160. YASSI N, Hilal S, Xia Y, Lim YY, et al
    Influence of Comorbidity of Cerebrovascular Disease and Amyloid-beta on Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD191028. doi: 10.3233/JAD-191028.
    PubMed     Abstract available


  1161. KHATIB T, Chisholm DR, Whiting A, Platt B, et al
    Decay in Retinoic Acid Signaling in Varied Models of Alzheimer's Disease and In-Vitro Test of Novel Receptor Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190931. doi: 10.3233/JAD-190931.
    PubMed     Abstract available


  1162. LIU Y, Wang H
    Modeling Sporadic Alzheimer's Disease by Efficient Direct Reprogramming of the Elderly Derived Disease Dermal Fibroblasts into Neural Stem Cells.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190614. doi: 10.3233/JAD-190614.
    PubMed     Abstract available


  1163. SUN R, Wang H, Shi Y, Sun Z, et al
    Changes in the Morphology, Number, and Pathological Protein Levels of Plasma Exosomes May Help Diagnose Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190497. doi: 10.3233/JAD-190497.
    PubMed     Abstract available


  1164. GOTHLIN M, Eckerstrom M, Lindwall M, Rolstad S, et al
    Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    J Alzheimers Dis. 2019 Dec 17. pii: JAD190515. doi: 10.3233/JAD-190515.
    PubMed     Abstract available


  1165. VAN HAVRE Z, Maruff P, Villemagne V, Mengersen K, et al
    Identification of Pre-Clinical Alzheimer's Disease in a Population of Elderly Cognitively Normal Participants.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD191095. doi: 10.3233/JAD-191095.
    PubMed     Abstract available


  1166. CHEN Y, Lin C, Guo Z, Zhao S, et al
    Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190926. doi: 10.3233/JAD-190926.
    PubMed     Abstract available


  1167. KOULOUSAKIS P, van den Hove D, Visser-Vandewalle V, Sesia T, et al
    Cognitive Improvements After Intermittent Deep Brain Stimulation of the Nucleus Basalis of Meynert in a Transgenic Rat Model for Alzheimer's Disease: A Preliminary Approach.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190919. doi: 10.3233/JAD-190919.
    PubMed     Abstract available


  1168. WILSON EN, Do Carmo S, Welikovitch LA, Hall H, et al
    NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190862. doi: 10.3233/JAD-190862.
    PubMed     Abstract available


  1169. CHUNG SJ, Jeon S, Yoo HS, Lee YH, et al
    Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190814. doi: 10.3233/JAD-190814.
    PubMed     Abstract available


  1170. WANG X, Sun Y, Li T, Cai Y, et al
    Amyloid-beta as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190714. doi: 10.3233/JAD-190714.
    PubMed     Abstract available


  1171. ALBARET G, Sifre E, Floch P, Laye S, et al
    Alzheimer's Disease and Helicobacter pylori Infection: Inflammation from Stomach to Brain?
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190496. doi: 10.3233/JAD-190496.
    PubMed     Abstract available


  1172. ROGERS NK, Romero C, SanMartin CD, Ponce DP, et al
    Inverse Relationship Between Alzheimer's Disease and Cancer: How Immune Checkpoints Might Explain the Mechanisms Underlying Age-Related Diseases.
    J Alzheimers Dis. 2019 Dec 9. pii: JAD190839. doi: 10.3233/JAD-190839.
    PubMed     Abstract available


  1173. FANI L, Hilal S, Sedaghat S, Broer L, et al
    Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.
    J Alzheimers Dis. 2019 Dec 9. pii: JAD190759. doi: 10.3233/JAD-190759.
    PubMed     Abstract available


  1174. ITZHAKI RF
    A Turning Point in Alzheimer's Disease: Microbes Matter.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD191171. doi: 10.3233/JAD-191171.
    PubMed    


  1175. HE JT, Zhao X, Xu L, Mao CY, et al
    Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190764. doi: 10.3233/JAD-190764.
    PubMed     Abstract available


  1176. WANG L, Qiao Y, Zhang H, Zhang Y, et al
    Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190713. doi: 10.3233/JAD-190713.
    PubMed     Abstract available


  1177. EMRANI S, Lamar M, Price CC, Wasserman V, et al
    Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190654. doi: 10.3233/JAD-190654.
    PubMed     Abstract available


  1178. YOON B, Choi SH, Jeong JH, Park KW, et al
    Balance and Mobility Performance Along the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190601. doi: 10.3233/JAD-190601.
    PubMed     Abstract available


    November 2019
  1179. FRANCIS N, Robison LS, Popescu DL, Michaelos M, et al
    Voluntary Wheel Running Reduces Amyloid-beta42 and Rescues Behavior in Aged Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190810. doi: 10.3233/JAD-190810.
    PubMed     Abstract available


  1180. SCHNAIDER L, Arnon Z, Gazit E
    Reevaluating the Microbial Infection Link to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190765. doi: 10.3233/JAD-190765.
    PubMed     Abstract available


  1181. BOUJI M, Lecomte A, Gamez C, Blazy K, et al
    Impact of Cerebral Radiofrequency Exposures on Oxidative Stress and Corticosterone in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190593. doi: 10.3233/JAD-190593.
    PubMed     Abstract available


  1182. CHEN H, Liang L, Xu H, Xu J, et al
    Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life.
    J Alzheimers Dis. 2019 Nov 23. pii: JAD190945. doi: 10.3233/JAD-190945.
    PubMed     Abstract available


  1183. AGCA C, Klakotskaia D, Stopa EG, Schachtman TR, et al
    Ovariectomy Influences Cognition and Markers of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 23. pii: JAD190935. doi: 10.3233/JAD-190935.
    PubMed     Abstract available


  1184. BASTRUP J, Kastaniegaard K, Asuni AA, Volbracht C, et al
    Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 21. pii: JAD190652. doi: 10.3233/JAD-190652.
    PubMed     Abstract available


  1185. AGARWAL P, Brockman JD, Wang Y, Schneider JA, et al
    Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2019 Nov 21. pii: JAD190646. doi: 10.3233/JAD-190646.
    PubMed     Abstract available


  1186. SONG S, Chen J, Xiao P, Duan H, et al
    Role of Macrophages in Status Epilepticus Predisposing to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 20. pii: JAD190994. doi: 10.3233/JAD-190994.
    PubMed     Abstract available


  1187. KURODA E, Takata K, Nishimura K, Oka H, et al
    Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-beta Burden and Ameliorate Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 20. pii: JAD190974. doi: 10.3233/JAD-190974.
    PubMed     Abstract available


  1188. WADA-ISOE K, Kikuchi T, Umeda-Kameyama Y, Mori T, et al
    ABC Dementia Scale Classifies Alzheimer's Disease Patients into Subgroups Characterized by Activities of Daily Living, Behavioral and Psychological Symptoms of Dementia, and Cognitive Function.
    J Alzheimers Dis. 2019 Nov 19. pii: JAD190767. doi: 10.3233/JAD-190767.
    PubMed     Abstract available


  1189. YEH TS, Wang JD, Ku LJ
    Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
    J Alzheimers Dis. 2019 Nov 19. pii: JAD181060. doi: 10.3233/JAD-181060.
    PubMed     Abstract available


  1190. ABE K, Shang J, Shi X, Yamashita T, et al
    A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD191016. doi: 10.3233/JAD-191016.
    PubMed     Abstract available


  1191. IMAI M, Tanaka M, Sakata M, Wagatsuma K, et al
    Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD190843. doi: 10.3233/JAD-190843.
    PubMed     Abstract available


  1192. LEE TL, Liu CH, Chang YM, Lin TY, et al
    The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD190762. doi: 10.3233/JAD-190762.
    PubMed     Abstract available


  1193. BABIC LEKO M, Nikolac Perkovic M, Klepac N, Svob Strac D, et al
    Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
    J Alzheimers Dis. 2019 Nov 16. pii: JAD190991. doi: 10.3233/JAD-190991.
    PubMed     Abstract available


  1194. SHIMIZU S, Takenoshita N, Inagawa Y, Tsugawa A, et al
    Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190958. doi: 10.3233/JAD-190958.
    PubMed     Abstract available


  1195. YARE K, Woodward M
    Hormone Therapy and Effects on Sporadic Alzheimer's Disease in Postmenopausal Women: Importance of Nomenclature.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190896. doi: 10.3233/JAD-190896.
    PubMed     Abstract available


  1196. CIOFFI F, Adam RHI, Broersen K
    Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190863. doi: 10.3233/JAD-190863.
    PubMed     Abstract available


  1197. HEGDE V, Dhurandhar NV, Reddy PH
    Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190808. doi: 10.3233/JAD-190808.
    PubMed     Abstract available


  1198. JIA J, Ji Y, Feng T, Ye Q, et al
    Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190791. doi: 10.3233/JAD-190791.
    PubMed     Abstract available


  1199. DEFRANCESCO M, Marksteiner J, Kemmler G, Dal-Bianco P, et al
    Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190662. doi: 10.3233/JAD-190662.
    PubMed     Abstract available


  1200. GARCIA-SEGURA ME, Fischer CE, Schweizer TA, Munoz DG, et al
    APOE varepsilon4/varepsilon4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190643. doi: 10.3233/JAD-190643.
    PubMed     Abstract available


  1201. NEWKIRK LA, Dao VL, Jordan JT, Alving LI, et al
    Factors Associated with Supportive Care Service Use Among California Alzheimer's Disease Patients and Their Caregivers.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190438. doi: 10.3233/JAD-190438.
    PubMed     Abstract available


  1202. LIECHTI C, Caviezel MP, Muller S, Reichert CF, et al
    Correlation Between Hippocampal Volume and Autobiographical Memory Depending on Retrieval Frequency in Healthy Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190047. doi: 10.3233/JAD-190047.
    PubMed     Abstract available


  1203. ALI F, Baringer SL, Neal A, Choi EY, et al
    Parvalbumin-Positive Neuron Loss and Amyloid-beta Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD181190. doi: 10.3233/JAD-181190.
    PubMed     Abstract available


  1204. ULAMEK-KOZIOL M, Czuczwar SJ, Kocki J, Januszewski S, et al
    Dysregulation of Autophagy, Mitophagy, and Apoptosis Genes in the CA3 Region of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.
    J Alzheimers Dis. 2019 Nov 7. pii: JAD190966. doi: 10.3233/JAD-190966.
    PubMed     Abstract available


  1205. ORDING AG, Veres K, Horvath-Puho E, Glymour MM, et al
    Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.
    J Alzheimers Dis. 2019 Nov 7. pii: JAD190867. doi: 10.3233/JAD-190867.
    PubMed     Abstract available


    October 2019
  1206. ABDULLAH M, Kimura N, Akatsu H, Hashizume Y, et al
    Flotillin is a Novel Diagnostic Blood Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190908. doi: 10.3233/JAD-190908.
    PubMed     Abstract available


  1207. POZUETA A, Lage C, Garcia-Martinez M, Kazimierczak M, et al
    Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190877. doi: 10.3233/JAD-190877.
    PubMed     Abstract available


  1208. AL RIHANI SB, Lan RS, Kaddoumi A
    Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190849. doi: 10.3233/JAD-190849.
    PubMed     Abstract available


  1209. GATT A, Whitfield DR, Ballard C, Doherty P, et al
    Alzheimer's Disease Progression in the 5xFAD Mouse Captured with a Multiplex Gene Expression Array.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190805. doi: 10.3233/JAD-190805.
    PubMed     Abstract available


  1210. WANG ZJ, Zhao F, Wang CF, Zhang XM, et al
    Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190796. doi: 10.3233/JAD-190796.
    PubMed     Abstract available


  1211. CHRISTL J, Verhulsdonk S, Pessanha F, Menge T, et al
    Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190550. doi: 10.3233/JAD-190550.
    PubMed     Abstract available


  1212. MASSA F, Farotti L, Eusebi P, Capello E, et al
    Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190539. doi: 10.3233/JAD-190539.
    PubMed     Abstract available


  1213. DOWJAT K, Adayev T, Wojda U, Brzozowska K, et al
    Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190475. doi: 10.3233/JAD-190475.
    PubMed     Abstract available



  1214. Abeta42/Abeta40 and Abeta42/Abeta38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199010. doi: 10.3233/JAD-199010.
    PubMed    



  1215. Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199009. doi: 10.3233/JAD-199009.
    PubMed    


  1216. SCHELTER BO, Shiells H, Baddeley TC, Rubino CM, et al
    Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190772. doi: 10.3233/JAD-190772.
    PubMed     Abstract available


  1217. CLARK LR, Norton D, Berman SE, Johnson SC, et al
    Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190645. doi: 10.3233/JAD-190645.
    PubMed     Abstract available


  1218. BOCCARDI V, Paolacci L, Remondini D, Giampieri E, et al
    Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific "Cytokinome Signature".
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190480. doi: 10.3233/JAD-190480.
    PubMed     Abstract available


  1219. FUCHSBERGER T, Yuste R, Martinez-Bellver S, Blanco-Gandia MC, et al
    Oral Monosodium Glutamate Administration Causes Early Onset of Alzheimer's Disease-Like Pathophysiology in APP/PS1 Mice.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190274. doi: 10.3233/JAD-190274.
    PubMed     Abstract available


  1220. POPTSI E, Tsardoulias E, Moraitou D, Symeonidis AL, et al
    REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    J Alzheimers Dis. 2019 Oct 18. pii: JAD190798. doi: 10.3233/JAD-190798.
    PubMed     Abstract available


  1221. PATHAK GA, Silzer TK, Sun J, Zhou Z, et al
    Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities.
    J Alzheimers Dis. 2019 Oct 18. pii: JAD190634. doi: 10.3233/JAD-190634.
    PubMed     Abstract available


  1222. WAN Y, Liang Y, Liang F, Shen N, et al
    A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-beta Protein by Modulating AbetaPP Processing and Autophagy.
    J Alzheimers Dis. 2019 Oct 17. pii: JAD190562. doi: 10.3233/JAD-190562.
    PubMed     Abstract available


  1223. NITZAN K, Benhamron S, Valitsky M, Kesner E, et al
    Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2019 Oct 14. pii: JAD190853. doi: 10.3233/JAD-190853.
    PubMed     Abstract available


  1224. ELSHATOURY H, Avots E, Anbarjafari G
    Volumetric Histogram-Based Alzheimer's Disease Detection Using Support Vector Machine.
    J Alzheimers Dis. 2019 Oct 9. pii: JAD190704. doi: 10.3233/JAD-190704.
    PubMed     Abstract available


  1225. TURRIZIANI P, Smirni D, Mangano GR, Zappala G, et al
    Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex Enhances Recognition Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 8. pii: JAD190888. doi: 10.3233/JAD-190888.
    PubMed     Abstract available


  1226. TIAN J, Wang T, Wang Q, Guo L, et al
    MK0677, a Ghrelin Mimetic Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190779. doi: 10.3233/JAD-190779.
    PubMed     Abstract available


  1227. KEHOE PG, Al Mulhim N, Zetterberg H, Blennow K, et al
    Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190721. doi: 10.3233/JAD-190721.
    PubMed     Abstract available


  1228. ROSSINI PM, Cappa SF, Lattanzio F, Perani D, et al
    The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190670. doi: 10.3233/JAD-190670.
    PubMed     Abstract available


  1229. AULSTON B, Liu Q, Mante M, Florio J, et al
    Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190656. doi: 10.3233/JAD-190656.
    PubMed     Abstract available


  1230. LIU XX, Jiao B, Liao XX, Guo LN, et al
    Analysis of Salivary Microbiome in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190587. doi: 10.3233/JAD-190587.
    PubMed     Abstract available


  1231. ZHOU G, Zhao X, Lou Z, Zhou S, et al
    Impaired Cerebral Autoregulation in Alzheimer's Disease: A Transcranial Doppler Study.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190296. doi: 10.3233/JAD-190296.
    PubMed     Abstract available


  1232. GOLDSTEIN FC, Loring DW, Thomas T, Saleh S, et al
    Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190468. doi: 10.3233/JAD-190468.
    PubMed     Abstract available


  1233. TEIPEL SJ, Kuper-Smith JO, Bartels C, Brosseron F, et al
    Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190446. doi: 10.3233/JAD-190446.
    PubMed     Abstract available


    September 2019
  1234. LIU X, Hebron ML, Mulki S, Wang C, et al
    Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 28. pii: JAD190635. doi: 10.3233/JAD-190635.
    PubMed     Abstract available


  1235. KANG DE, Woo JA
    Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 25. pii: JAD190585. doi: 10.3233/JAD-190585.
    PubMed     Abstract available


  1236. PALEY EL
    Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics.
    J Alzheimers Dis. 2019 Sep 24. pii: JAD190873. doi: 10.3233/JAD-190873.
    PubMed     Abstract available


  1237. MORSY A, Trippier PC
    Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 24. pii: JAD190744. doi: 10.3233/JAD-190744.
    PubMed     Abstract available


  1238. WANG Q, Jiang H, Wang L, Yi H, et al
    Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer's Disease Cell Model via the p38 MAPK/JNK Pathway.
    J Alzheimers Dis. 2019 Sep 23. pii: JAD190640. doi: 10.3233/JAD-190640.
    PubMed     Abstract available


  1239. JINGAMI N, Uemura K, Asada M, Kuzuya A, et al
    Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190775. doi: 10.3233/JAD-190775.
    PubMed     Abstract available


  1240. CHOU PS, Wu MN, Yang CC, Shen CT, et al
    Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190639. doi: 10.3233/JAD-190639.
    PubMed     Abstract available


  1241. ZYSK M, Clausen F, Aguilar X, Sehlin D, et al
    Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190572. doi: 10.3233/JAD-190572.
    PubMed     Abstract available


  1242. AMLIE-WOLF A, Tang M, Way J, Dombroski B, et al
    Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190568. doi: 10.3233/JAD-190568.
    PubMed     Abstract available


  1243. ROBINSON RL, Rentz DM, Bruemmer V, Andrews JS, et al
    Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190430. doi: 10.3233/JAD-190430.
    PubMed     Abstract available


  1244. CASTORA FJ, Conyers BL, Gershon BS, Kerns KA, et al
    The T9861C Mutation in the mtDNA-Encoded Cytochrome C Oxidase Subunit III Gene Occurs in High Frequency but with Unequal Distribution in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190176. doi: 10.3233/JAD-190176.
    PubMed     Abstract available


  1245. SNOWDEN SG, Ebshiana AA, Hye A, Pletnikova O, et al
    Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Sep 19. pii: JAD190577. doi: 10.3233/JAD-190577.
    PubMed     Abstract available


  1246. PANG RQ, Wang XF, Pei FF, Zhang W, et al
    Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2019 Sep 18. pii: JAD190328. doi: 10.3233/JAD-190328.
    PubMed     Abstract available


    January 2019
  1247. IULITA MF, Ganesh A, Pentz R, Flores Aguilar L, et al
    Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
    J Alzheimers Dis. 2019;67:327-341.
    PubMed     Abstract available


  1248. KASKIKALLIO A, Karrasch M, Rinne JO, Tuokkola T, et al
    Cognitive Effects of White Matter Pathology in Normal and Pathological Aging.
    J Alzheimers Dis. 2019;67:489-493.
    PubMed     Abstract available


  1249. BARTON SM, Janve VA, McClure R, Anderson A, et al
    Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.
    J Alzheimers Dis. 2019;67:503-513.
    PubMed     Abstract available


  1250. HVIDSTEN L, Engedal K, Selbaek G, Wyller TB, et al
    Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study.
    J Alzheimers Dis. 2019;67:197-210.
    PubMed     Abstract available


  1251. ZAMMIT AR, Muniz-Terrera G, Katz MJ, Hall CB, et al
    Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.
    J Alzheimers Dis. 2019;67:125-135.
    PubMed     Abstract available


  1252. SCHWARZ CG, Gunter JL, Lowe VJ, Weigand S, et al
    A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.
    J Alzheimers Dis. 2019;67:181-195.
    PubMed     Abstract available


  1253. PAPPAS C, Small BJ, Andel R, Laczo J, et al
    Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.
    J Alzheimers Dis. 2019;67:81-89.
    PubMed     Abstract available


  1254. RIZZO G, De Blasi R, Capozzo R, Tortelli R, et al
    Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2019;67:61-65.
    PubMed     Abstract available


    October 2018
  1255. ABU-RUMEILEH S, Mometto N, Bartoletti-Stella A, Polischi B, et al
    Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    J Alzheimers Dis. 2018 Oct 5. pii: JAD180409. doi: 10.3233/JAD-180409.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: